Any feedback?
Information on EC 3.5.4.4 - adenosine deaminase and Organism(s) Homo sapiens and UniProt Accession Q9NZK5
for references in articles please use BRENDA:EC3.5.4.4Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
3.5.4.4 adenosine deaminaseIUBMB Comments
The enzyme, found in a wide variety of microorganisms, plants, invertebrates, and animals, plays a role in purine metabolism.
Specify your search results
Word Map
- 3.5.4.4
- purine
- nucleoside
- lymphocyte
- immunodeficiency
- inosine
- pleural
-
tuberculous
-
deamination
- effusion
- erythrocyte
- phosphorylase
- agonist
- leukemia
- 5'-nucleotidase
- deoxyadenosine
- marrow
- xanthine
- adenylate
- hypoxanthine
- t-cells
-
lymphoid
- ehna
- dipyridamole
-
purinergic
-
hematopoietic
-
exudative
-
lipolysis
- pleurisy
- meningitis
- theophylline
- datp
-
ecto-5\'-nucleotidase
- s-adenosylhomocysteine
- 2-chloroadenosine
- dpcpx
-
autoinflammatory
- pericarditis
-
acid-fast
- deoxycytidine
-
transudate
-
antilipolytic
-
diphosphohydrolase
-
hypoxanthine-guanine
-
adenosine-induced
- ectonucleotidases
-
n6-cyclopentyladenosine
- empyema
- deaminases
- ntpdases
-
purinoceptors
- medicine
- pharmacology
- drug development
- diagnostics
- analysis
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Synonyms
adenosine deaminase, adenosine deaminase 2, adenosine aminohydrolase, adenosine deaminase 1, adaii, pvada, mj1541, ciada, sco4901, 
more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
ADA
ADA1
Adenosine aminohydrolase
adenosine deaminase
adenosine deaminase 1
ADA
-
-
Adenosine aminohydrolase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION
REACTION DIAGRAM
COMMENTARY
ORGANISM
UNIPROT
LITERATURE
adenosine + H2O = inosine + NH3
reaction mechanism, structure-function relationship of ADA and dipeptidyl peptidase IV
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Deamination
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
adenosine aminohydrolase
The enzyme, found in a wide variety of microorganisms, plants, invertebrates, and animals, plays a role in purine metabolism.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9026-93-1
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
adenosine + H2O
inosine + NH3
isozyme ADA2 is important in lymphocyte activation, and may be active in sites of inflammation and during hypoxia and in areas of tumor growth with elevated adenosine levels and acidic pH, overview
-
-
?
2'-deoxyadenosine + H2O
2'-deoxyinosine + NH3
-
82.8% of the activity with adenosine
-
-
?
2'-deoxyadenosine + H2O
2'-deoxyinosine + NH3
-
the enzyme plays an important role in the immune system
-
-
?
adenosine + H2O
inosine + NH3
-
-
655265, 667870, 668232, 668751, 670393, 670464, 686745, 687290, 697368, 697735, 699651, 699959, 699972, 733602, 733674
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme activity is correlated with the content in malonaldehyde in nasal polyps and nasal mucosa, overview
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme expression and activity is suppressed in normal pregnancy, but not in woman with recurrent spontaneous abortion
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme is involved in differentiation and maturation of the lymphoid system, the enzyme activity is decreased in multiple sclerosis patients irrespective of whether patients have relapsing-remitting or chronic progressive multiple sclerosis, overview
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme plays an important role in the immune system
-
-
?
adenosine + H2O
inosine + NH3
-
metabolization of extracellular adenosine leads to exacerbation of inflammation
-
-
ir
adenosine + H2O
inosine + NH3
-
detailed quantitative structure-activity relationship, QSAR, nonlinear modeling and analysis, descriptor generation and selection, overview
-
-
?
adenosine + H2O
inosine + NH3
-
metabolization of extracellular adenosine
-
-
ir
adenosine + H2O
inosine + NH3
-
adenosine deaminase markedly enhances the agonist and antagonist affinity and abolishes the negative cooperativity on agonist binding to human striatial adenosine A1 receptors
-
-
?
adenosine + H2O
inosine + NH3
the enzyme shows no activity with 5'-methylthioinosine
-
-
ir
additional information
?
-
-
activity with 3'-deoxyadenosine, 2',3'-deoxyadenosine and 2'-O-methyladenosine is less than 0.5% of the activity with adenine
-
-
?
additional information
?
-
-
the large isozyme is bound and complexed by the cell membraneous dipeptidyl peptidase IV, which is identical to the activated immune cell antigen CD26, playing a role in the immune system, overview
-
-
?
additional information
?
-
-
substrate specificities of the large and the small isozyme, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
adenosine + H2O
inosine + NH3
isozyme ADA2 is important in lymphocyte activation, and may be active in sites of inflammation and during hypoxia and in areas of tumor growth with elevated adenosine levels and acidic pH, overview
-
-
?
additional information
?
-
-
the large isozyme is bound and complexed by the cell membraneous dipeptidyl peptidase IV, which is identical to the activated immune cell antigen CD26, playing a role in the immune system, overview
-
-
?
2'-deoxyadenosine + H2O
2'-deoxyinosine + NH3
-
the enzyme plays an important role in the immune system
-
-
?
adenosine + H2O
inosine + NH3
-
-
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme activity is correlated with the content in malonaldehyde in nasal polyps and nasal mucosa, overview
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme expression and activity is suppressed in normal pregnancy, but not in woman with recurrent spontaneous abortion
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme is involved in differentiation and maturation of the lymphoid system, the enzyme activity is decreased in multiple sclerosis patients irrespective of whether patients have relapsing-remitting or chronic progressive multiple sclerosis, overview
-
-
?
adenosine + H2O
inosine + NH3
-
the enzyme plays an important role in the immune system
-
-
?
adenosine + H2O
inosine + NH3
-
metabolization of extracellular adenosine leads to exacerbation of inflammation
-
-
ir
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
(+)-erythro-9-(2-hydroxy-3-nonyl)adenine
specific inhibitor of ADA1
FR234938
-
i.e. 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthyl)ethyl)propyl)1H-imidazole-4-carboxamine, a non-nucleoside inhibitor, the inhibition is blocked by an A2a adenosine receptor antagonist
pentostatin
-
i.e. (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
erythro-9-(2-hydroxy-3-nonyl)adenine
-
i.e. EHNA, specific for isozyme ADA1, no inhibition of isozyme ADA2
additional information
-
no inhibition of the human enzyme by 5'-methylthiocoformycin and 5'-methylthio-2'-deoxycoformycin
-
additional information
-
strong inhibition by the traditional Chinese medicines Rhizoma Chuanxiong and Angelica sinensis
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
5'-nucleotidase deficiency
Ecto-5'-nucleotidase deficiency: association with adenosine deaminase deficiency and nonassociation with deoxyadenosine toxicity.
5'-nucleotidase deficiency
Inborn errors of purine metabolism: clinical update and therapies.
Abortion, Habitual
Interaction between adenosine deaminase and ABO system polymorphisms: effects on intrauterine survival and reproduction.
Abortion, Missed
Adenosine deaminase activity in serum and placenta of patients with anembryonic pregnancies and missed abortions.
Abortion, Missed
Biochemical clinical factors associated with missed abortion independent of maternal age: A retrospective study of 795 cases with missed abortion and 694 cases with normal pregnancy.
Abortion, Spontaneous
Adenosine deaminase activity and its isoenzyme pattern in women with recurrent spontaneous abortions.
Abortion, Spontaneous
Adenosine deaminase and human reproduction: a comparative study of fertile women and women with recurrent spontaneous abortion.
Abortion, Spontaneous
Effect of ADA1 mother-fetus and wife-husband phenotypic differences on the ratio birth weight/placental weight in fertile women and on reproductive success in couples with RSA.
Abortion, Spontaneous
Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms.
Abortion, Spontaneous
The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association.
Abscess
Primary tuberculous abscess of the spleen in an immununocompetent patient diagnosed by biochemical markers and radiologic findings.
Acidosis, Lactic
Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA.
Acne Vulgaris
The activity of adenosine deaminase and oxidative stress biomarkers in scraping samples of acne lesions.
Acquired Immunodeficiency Syndrome
Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS).
Acquired Immunodeficiency Syndrome
Adenosine deaminase activity in cerebrospinal fluid: a useful test for meningeal tuberculosis, even in patients with AIDS.
Acquired Immunodeficiency Syndrome
Adenosine deaminase in cerebrospinal fluid of cerebral toxoplasmosis in AIDS.
Acquired Immunodeficiency Syndrome
Adenosine deaminase in the acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Adenosine deaminase, acquired immunodeficiency syndrome (AIDS), and hepatitis B infection.
Acquired Immunodeficiency Syndrome
Concurrent measurement of adenosine deaminase and dipeptidyl peptidase IV activity in the diagnosis of tuberculous pleural effusion.
Acquired Immunodeficiency Syndrome
Cryptococcal Pleuritis Containing a High Level of Adenosine Deaminase in a Patient with AIDS: A Case Report.
Acquired Immunodeficiency Syndrome
Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome.
Acquired Immunodeficiency Syndrome
Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
Acquired Immunodeficiency Syndrome
Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
Acquired Immunodeficiency Syndrome
In vitro modulation of purine enzyme metabolism and lymphocyte surface marker expression by thymosin fraction 5 in homosexual males.
Acquired Immunodeficiency Syndrome
Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit brain.
Acquired Immunodeficiency Syndrome
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Acquired Immunodeficiency Syndrome
Prognostic value of adenosine deaminase compared to other markers for progression to acquired immunodeficiency syndrome among intravenous drug users.
Acquired Immunodeficiency Syndrome
Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro.
Acquired Immunodeficiency Syndrome
Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2.
Acquired Immunodeficiency Syndrome
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Acquired Immunodeficiency Syndrome
The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy.
Acquired Immunodeficiency Syndrome
[Adenosine deaminase (ADA) and beta 2-microglobulin (beta 2M) as discriminating serum markers of progression to AIDS]
Acquired Immunodeficiency Syndrome
[Adenosine deaminase in the cerebrospinal fluid of patients with acquired immunodeficiency syndrome]
Acquired Immunodeficiency Syndrome
[Cryptococcal meningitis in patients with AIDS: combined treatment with amphotericin B and fluconazole, and high levels of adenosine deaminase in cerebrospinal fluid]
Acute Coronary Syndrome
Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelor.
Acute Kidney Injury
A novel mutation of adenosine deaminase causing SCID presenting as hemophagocytic lymphohistiocytosis with acute kidney injury.
adenine phosphoribosyltransferase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
adenine phosphoribosyltransferase deficiency
Use of intact erythrocytes in the diagnosis of inherited purine and pyrimidine disorders.
Adenocarcinoma
Adenosine deaminase (ADA; E.C. no. 3.5.4.4.) in colorectal adenocarcinoma in man.
Adenocarcinoma
Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies.
Adenocarcinoma
Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells.
Adenocarcinoma
Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas.
Adenocarcinoma
Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.
Adenocarcinoma
[Lactate dehydrogenase, adenosine deaminase and thymidine phosphorylase activity of blood and tissues in breast tumor patients]
Adenocarcinoma of Lung
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Adenofibroma
[Lactate dehydrogenase, adenosine deaminase and thymidine phosphorylase activity of blood and tissues in breast tumor patients]
adenosine deaminase deficiency
"Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children.
adenosine deaminase deficiency
1-Methyladenine in urine of an adenosine deaminase-deficient adult without immunodeficiency.
adenosine deaminase deficiency
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
adenosine deaminase deficiency
2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
adenosine deaminase deficiency
5'-Deoxy-5'-methylthioadenosine inhibition of rat T lymphocyte phosphodiesterase: correlation with inhibition of Con A induced proliferation.
adenosine deaminase deficiency
A case of osteoporosis associated with adenosine deaminase deficiency.
adenosine deaminase deficiency
A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation.
adenosine deaminase deficiency
A clinical score to guide in decision making for monogenic type I IFNopathies.
adenosine deaminase deficiency
A family of adenosine deaminase deficiency with severe combined immunodeficiency.
adenosine deaminase deficiency
A girl with diabetes and severe combined immunodeficiency from adenosine deaminase deficiency.
adenosine deaminase deficiency
A micromethod for determining adenosine deaminase and purine nucleoside phosphorylase activity in cells from human peripheral blood.
adenosine deaminase deficiency
A new approach to detection of heterozygotes for adenosine deaminase deficiency: a hypothetical method.
adenosine deaminase deficiency
A Novel Germline Mutation of ADA2 Gene in Two "Discordant" Homozygous Female Twins Affected by Adenosine Deaminase 2 Deficiency: Description of the Bone-Related Phenotype.
adenosine deaminase deficiency
A novel mutation in the ADA gene causing severe combined immunodeficiency in an Arab patient: a case report.
adenosine deaminase deficiency
A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke.
adenosine deaminase deficiency
A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
adenosine deaminase deficiency
A Rare Case of Adenosine Deaminase 2 Deficiency Presenting With Temporal Arteritis.
adenosine deaminase deficiency
A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme.
adenosine deaminase deficiency
A(2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency.
adenosine deaminase deficiency
Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
adenosine deaminase deficiency
Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency.
adenosine deaminase deficiency
Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.
adenosine deaminase deficiency
Acquired hemoglobin H disease associated with idiopathic myelofibrosis and hereditary adenosine deaminase deficiency.
adenosine deaminase deficiency
Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
adenosine deaminase deficiency
Adenosine and deoxyadenosine metabolism in the erythrocytes of a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Adenosine as a prostaglandin antagonist. Possible mechanism of the defect in combined immunodeficiency disease due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
adenosine deaminase deficiency
Adenosine Deaminase 2 Deficiency: More Than Monogenic Vasculitis.
adenosine deaminase deficiency
Adenosine deaminase activity and superoxide formation during phagocytosis and membrane perturbation of macrophages.
adenosine deaminase deficiency
Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.
adenosine deaminase deficiency
Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase deficiency and chondro-osseous dysplasia.
adenosine deaminase deficiency
Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase deficiency and severe combined immunodeficiency disease.
adenosine deaminase deficiency
Adenosine deaminase deficiency as the first target disorder in gene therapy.
adenosine deaminase deficiency
Adenosine deaminase deficiency can present with features of Omenn syndrome.
adenosine deaminase deficiency
Adenosine deaminase deficiency due to heterozygous abnormality consisting of a deletion of exon 7 and the absence of enzyme mRNA.
adenosine deaminase deficiency
Adenosine deaminase deficiency in a child with severe combined immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase deficiency in combined immunologic deficiency disease.
adenosine deaminase deficiency
Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
adenosine deaminase deficiency
Adenosine deaminase deficiency with altered biochemical parameters in two sisters with late-onset immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.
adenosine deaminase deficiency
Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy.
adenosine deaminase deficiency
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
adenosine deaminase deficiency
Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies.
adenosine deaminase deficiency
Adenosine deaminase deficiency: a model system for human somatic cell gene correction therapy.
adenosine deaminase deficiency
Adenosine deaminase deficiency: another family with "silent" ADA allele and normal ADA activity in two heterozygotes.
adenosine deaminase deficiency
Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
adenosine deaminase deficiency
Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.
adenosine deaminase deficiency
Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.
adenosine deaminase deficiency
Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
adenosine deaminase deficiency
Adenosine deaminase deficiency: molecular basis and recent developments.
adenosine deaminase deficiency
Adenosine deaminase deficiency: the first inborn error of metabolism noted in immunodeficiency disease.
adenosine deaminase deficiency
Adenosine deaminase deficiency: unanticipated benefits from the study of a rare immunodeficiency.
adenosine deaminase deficiency
Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
adenosine deaminase deficiency
Adenosine deaminase is not required for the generation of superoxide anion.
adenosine deaminase deficiency
Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
adenosine deaminase deficiency
Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate.
adenosine deaminase deficiency
Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor.
adenosine deaminase deficiency
Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
adenosine deaminase deficiency
Altered regulation of S-adenosylmethionine dependent methylation in adenosine deaminase deficiency.
adenosine deaminase deficiency
Alveolar-like Stem Cell-derived Myb(neg) Macrophages Promote Recovery and Survival in Airway Disease.
adenosine deaminase deficiency
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
adenosine deaminase deficiency
Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency.
adenosine deaminase deficiency
Aminohydrolases acting on adenine, adenosine and their derivatives.
adenosine deaminase deficiency
An abnormal amino acid pattern in adenosine deaminase deficiency.
adenosine deaminase deficiency
An improved screening test for adenosine deaminase deficiency.
adenosine deaminase deficiency
Animal model for immune dysfunction associated with adenosine deaminase deficiency.
adenosine deaminase deficiency
Another Exciting Data-HCT Successfully Cured Patients with DADA2 : A commentary on "Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients" by Hashem H et al.
adenosine deaminase deficiency
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Are contemporary methods for somatic gene therapy suitable for clinical applications?
adenosine deaminase deficiency
Atmospheric pressure ionization mass spectrometry of purine and pyrimidine markers of inherited metabolic disorders.
adenosine deaminase deficiency
Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.
adenosine deaminase deficiency
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.
adenosine deaminase deficiency
Autoimmune thyroiditis and acquired hypothyroidism in an infant with severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
adenosine deaminase deficiency
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
adenosine deaminase deficiency
Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.
adenosine deaminase deficiency
Basis for the chondro-osseous dysplasia associated with adenosine deaminase deficiency: selective toxicity to immature chondrocytes.
adenosine deaminase deficiency
Beware the lymphopenia: A case of severe combined immunodeficiency.
adenosine deaminase deficiency
Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency.
adenosine deaminase deficiency
Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
adenosine deaminase deficiency
Bone marrow transplantation in a case of severe combined immunodeficiency with adenosine deaminase deficiency [proceedings]
adenosine deaminase deficiency
Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.
adenosine deaminase deficiency
Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency.
adenosine deaminase deficiency
Carrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiency.
adenosine deaminase deficiency
Cellular radiosensitivity in human severe-combined-immunodeficiency (SCID) syndromes.
adenosine deaminase deficiency
Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency.
adenosine deaminase deficiency
Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
adenosine deaminase deficiency
Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
adenosine deaminase deficiency
Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).
adenosine deaminase deficiency
Chronic leg ulcer revealing adenosine deaminase 2 deficiency: an atypical presentation.
adenosine deaminase deficiency
Cicalese MP, Ferrua F, Castagnaro L, et al. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. Blood. 2016;128(1):45-54.
adenosine deaminase deficiency
Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency. A Molecular Defect.
adenosine deaminase deficiency
Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.
adenosine deaminase deficiency
Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
adenosine deaminase deficiency
Comparison of red cell transfusion and polyethylene glycol-modified adenosine deaminase therapy in an adenosine deaminase-deficient child: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
adenosine deaminase deficiency
Complete and partial adenosine deaminase deficiency. Relationship of immune function to metabolite concentrations, enzyme activity, and effects of therapy.
adenosine deaminase deficiency
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
adenosine deaminase deficiency
Consequences of adenosine deaminase deficiency on thymocyte metabolism.
adenosine deaminase deficiency
Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
adenosine deaminase deficiency
Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
adenosine deaminase deficiency
Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
adenosine deaminase deficiency
dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
adenosine deaminase deficiency
dATP causes specific release of cytochrome C from mitochondria.
adenosine deaminase deficiency
Decreased S-adenosylhomocysteine hydrolase in inborn errors of purine metabolism.
adenosine deaminase deficiency
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy.
adenosine deaminase deficiency
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
adenosine deaminase deficiency
Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis.
adenosine deaminase deficiency
Deoxyadenosine blockade of G0 to G1 transition in lymphocytes: possible involvement of protein kinases.
adenosine deaminase deficiency
Deoxyadenosine inhibits DNA synthesis in cultured human fibroblasts.
adenosine deaminase deficiency
Deoxyadenosine toxicity in an adenosine deaminase-inhibited human CCRF-CEM T-lymphoblastoid cell line causes cell swelling.
adenosine deaminase deficiency
Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
adenosine deaminase deficiency
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
adenosine deaminase deficiency
Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
adenosine deaminase deficiency
Deoxycytidine excretion by mouse peritoneal macrophages: its implication in modulation of immunological functions.
adenosine deaminase deficiency
Deoxycytidine therapy in two patients with adenosine deaminase deficiency and severe immunodeficiency disease.
adenosine deaminase deficiency
Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
adenosine deaminase deficiency
Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy.
adenosine deaminase deficiency
Detection of the carrier state in combined immunodeficiency disease associated with adenosine deaminase deficiency.
adenosine deaminase deficiency
Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
adenosine deaminase deficiency
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China.
adenosine deaminase deficiency
Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
adenosine deaminase deficiency
Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency.
adenosine deaminase deficiency
Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
adenosine deaminase deficiency
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.
adenosine deaminase deficiency
Early prenatal investigation of a pregnancy at risk of adenosine deaminase deficiency using chorionic villi.
adenosine deaminase deficiency
Ecto-5'-nucleotidase deficiency: association with adenosine deaminase deficiency and nonassociation with deoxyadenosine toxicity.
adenosine deaminase deficiency
Ecto-enzyme activity of human erythrocyte adenosine deaminase.
adenosine deaminase deficiency
Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease.
adenosine deaminase deficiency
Effect of red cell transfusions on clinical, immunological and biochemical parameters of a child with adenosine deaminase deficiency.
adenosine deaminase deficiency
Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
adenosine deaminase deficiency
Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
adenosine deaminase deficiency
Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
adenosine deaminase deficiency
Elevation of serum IgE level and peripheral eosinophil count during T lymphocyte-directed gene therapy for ADA deficiency: implication of Tc2-like cells after gene transduction procedure.
adenosine deaminase deficiency
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
adenosine deaminase deficiency
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
adenosine deaminase deficiency
Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency.
adenosine deaminase deficiency
Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
adenosine deaminase deficiency
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.
adenosine deaminase deficiency
Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).
adenosine deaminase deficiency
Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.
adenosine deaminase deficiency
Epstein-Barr virus-induced lymphoblastoid cell lines from patients with primary immunodeficiency diseases.
adenosine deaminase deficiency
Errors of morphogenesis and inborn errors of immunity 20 years after the discovery of DiGeorge anomaly.
adenosine deaminase deficiency
Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
adenosine deaminase deficiency
Evaluation of the expanded newborn screening program in New York City.
adenosine deaminase deficiency
Evidence for distinct catabolic pathways of adenine ribonucleotides and deoxyribonucleotides in human T lymphoblastoid cells.
adenosine deaminase deficiency
Evidence that X-linked severe combined immunodeficiency is not a differentiation defect of T lymphocytes.
adenosine deaminase deficiency
Expression of a functional human adenosine deaminase in transgenic tobacco plants.
adenosine deaminase deficiency
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
Food allergy in a patient with adenosine deaminase deficiency undergoing enzyme replacement with polyethylene glycol-modified adenosine deaminase.
adenosine deaminase deficiency
Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
adenosine deaminase deficiency
Gene therapy for adenosine deaminase deficiency.
adenosine deaminase deficiency
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.
adenosine deaminase deficiency
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
adenosine deaminase deficiency
Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency.
adenosine deaminase deficiency
Gene Therapy for the Treatment of Primary Immune Deficiencies.
adenosine deaminase deficiency
Gene therapy in infants with severe combined immunodeficiency.
adenosine deaminase deficiency
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy.
adenosine deaminase deficiency
Gene therapy in The Netherlands: highlights from the Low Countries.
adenosine deaminase deficiency
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.
adenosine deaminase deficiency
Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
adenosine deaminase deficiency
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
adenosine deaminase deficiency
Genetic and biochemical consequences of adenosine deaminase deficiency in humans.
adenosine deaminase deficiency
Genetic Engineering and Manufacturing of Hematopoietic Stem Cells.
adenosine deaminase deficiency
Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines.
adenosine deaminase deficiency
Genetic heterogeneity in partial adenosine deaminase deficiency.
adenosine deaminase deficiency
Genetic manipulation of hematopoietic stem cells in adenosine deaminase deficiency.
adenosine deaminase deficiency
Genotoxicity of retroviral hematopoietic stem cell gene therapy.
adenosine deaminase deficiency
Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
adenosine deaminase deficiency
Giant-cell fibroblastoma in a patient with a bone-marrow transplant.
adenosine deaminase deficiency
Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia.
adenosine deaminase deficiency
Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
adenosine deaminase deficiency
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
adenosine deaminase deficiency
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
adenosine deaminase deficiency
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
adenosine deaminase deficiency
Hereditary adenosine deaminase deficiency detected by screening test.
adenosine deaminase deficiency
Hereditary sever combined immunodeficiency and adenosine deaminase deficiency.
adenosine deaminase deficiency
Heterogeneity for adenosine deaminase deficiency: Expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells.
adenosine deaminase deficiency
Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency.
adenosine deaminase deficiency
HLA typing of amniotic fluid cells for the prenatal determination of therapeutic transplantation options for a fetus affected with adenosine deaminase deficiency.
adenosine deaminase deficiency
HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities.
adenosine deaminase deficiency
Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID).
adenosine deaminase deficiency
Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
adenosine deaminase deficiency
Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
adenosine deaminase deficiency
Human gene therapy in gastrointestinal diseases: in vivo and in vitro approaches.
adenosine deaminase deficiency
Human gene therapy: a brief overview of the genetic revolution.
adenosine deaminase deficiency
Hyperbilirubinemia and Rapid Fatal Hepatic Failure in Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency (ADA-SCID).
adenosine deaminase deficiency
Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
adenosine deaminase deficiency
Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
adenosine deaminase deficiency
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
adenosine deaminase deficiency
Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
adenosine deaminase deficiency
Immunological and metabolic reconstitution following successful bone marrow transplantation from a HLA-identical sibling in an infant with adenosine deaminase deficiency and severe combined immunodeficiency: partial restoration of purine metabolism.
adenosine deaminase deficiency
Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines.
adenosine deaminase deficiency
Impaired germinal center maturation in adenosine deaminase deficiency.
adenosine deaminase deficiency
Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency.
adenosine deaminase deficiency
In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase.
adenosine deaminase deficiency
In vitro platelet abnormality in adenosine deaminase deficiency and severe combined immunodeficiency.
adenosine deaminase deficiency
In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
adenosine deaminase deficiency
In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
adenosine deaminase deficiency
Inability of immunocompetent thymocytes to produce T-cell growth factor under adenosine deaminase deficiency conditions.
adenosine deaminase deficiency
Increased excretion of modified adenine nucleosides by children with adenosine deaminase deficiency.
adenosine deaminase deficiency
Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.
adenosine deaminase deficiency
Inhibition of fetal thymic caspases abrogates the consequences of adenosine deaminase deficiency.
adenosine deaminase deficiency
Inhibition of mitogen mediated lymphocyte blastogenesis by adenosine.
adenosine deaminase deficiency
Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.
adenosine deaminase deficiency
Insights into adenosine deaminase deficiency provided by murine fetal thymic organ culture with 2'-deoxycoformycin.
adenosine deaminase deficiency
Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).
adenosine deaminase deficiency
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.
adenosine deaminase deficiency
Interleukin 2 liberation and absorption capacities of rat T lymphocytes in conditions of severe adenylic nucleotide pool depletion due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.
adenosine deaminase deficiency
Iron overload as a result of transfusion therapy in a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Keratinocyte gene therapy for adenosine deaminase deficiency: a model approach for inherited metabolic disorders.
adenosine deaminase deficiency
Lack of adenosine deaminase deficiency in the mutant mouse wasted.
adenosine deaminase deficiency
Late-onset adenosine deaminase deficiency presenting with Heck's disease.
adenosine deaminase deficiency
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency.
adenosine deaminase deficiency
Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency.
adenosine deaminase deficiency
Liquid-chromatographic measurement of purine nucleotides in blood cells.
adenosine deaminase deficiency
Lithium chloride induces partial responsiveness to LPS in nonresponder B cells.
adenosine deaminase deficiency
Long-term culture and T cell receptor analysis of T cell clones isolated from a patient with adenosine deaminase deficiency and type I diabetes.
adenosine deaminase deficiency
Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells.
adenosine deaminase deficiency
Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency.
adenosine deaminase deficiency
Lymphocyte subpopulations in primary immunodeficiency disorders.
adenosine deaminase deficiency
Lymphocytes as cellular vehicles for gene therapy in mouse and man.
adenosine deaminase deficiency
Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome.
adenosine deaminase deficiency
Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow.
adenosine deaminase deficiency
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
adenosine deaminase deficiency
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
adenosine deaminase deficiency
Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).
adenosine deaminase deficiency
Management options: SCIDS with adenosine deaminase deficiency.
adenosine deaminase deficiency
Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.
adenosine deaminase deficiency
Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
adenosine deaminase deficiency
Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
adenosine deaminase deficiency
Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction.
adenosine deaminase deficiency
Metabolic findings in a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
adenosine deaminase deficiency
Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector.
adenosine deaminase deficiency
Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.
adenosine deaminase deficiency
Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
adenosine deaminase deficiency
Multicentric dermatofibrosarcoma protuberans in a child with severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Neurologic abnormalities in patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Neutropenia among patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Neutropenia and myeloid dysplasia in a patient with delayed-onset adenosine deaminase deficiency.
adenosine deaminase deficiency
New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
adenosine deaminase deficiency
Newborn screening for severe combined immunodeficiency: an opportunity for intervention.
adenosine deaminase deficiency
Non-infectious Lung Disease in Patients with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
adenosine deaminase deficiency
Nonmyeloablative stem cell transplantation for congenital immunodeficiencies.
adenosine deaminase deficiency
Nucleoside kinases in T and B lymphoblasts distinguished by autoradiography.
adenosine deaminase deficiency
Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination.
adenosine deaminase deficiency
Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy.
adenosine deaminase deficiency
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
adenosine deaminase deficiency
Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
adenosine deaminase deficiency
Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency.
adenosine deaminase deficiency
p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency.
adenosine deaminase deficiency
Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
adenosine deaminase deficiency
Partial adenosine deaminase deficiency: another family from southern Africa.
adenosine deaminase deficiency
Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
adenosine deaminase deficiency
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
adenosine deaminase deficiency
Pattern recognitions receptors in immunodeficiency disorders.
adenosine deaminase deficiency
PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years.
adenosine deaminase deficiency
PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
adenosine deaminase deficiency
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).
adenosine deaminase deficiency
Perspectives of gene therapy for primary immunodeficiencies.
adenosine deaminase deficiency
Polyethylene glycol-conjugated adenosine phosphorylase: development of alternative enzyme therapy for adenosine deaminase deficiency.
adenosine deaminase deficiency
Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.
adenosine deaminase deficiency
Positive correlation between adenosine deaminase activity and superoxide formation during phagocytosis.
adenosine deaminase deficiency
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.
adenosine deaminase deficiency
Prenatal detection of a probable heterozygote for ADA deficiency and severe combined immunodeficiency disease using a microradioassay.
adenosine deaminase deficiency
Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.
adenosine deaminase deficiency
Primary hyperoxaluria and adenosine deaminase deficiency without immunodeficiency.
adenosine deaminase deficiency
Probable autoimmune thyroid disease and combined immunodeficiency disease.
adenosine deaminase deficiency
Production of IL-4 and expression of CD40 ligand by human CD8 T cells.
adenosine deaminase deficiency
Progress and prospects: gene therapy for inherited immunodeficiencies.
adenosine deaminase deficiency
Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
adenosine deaminase deficiency
Protection by various deoxynucleosides against deoxyadenosine-induced DNA damage in adenosine deaminase-inactivated lymphocytes.
adenosine deaminase deficiency
Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
adenosine deaminase deficiency
Purine dysfunction in cells from patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
Purine excretion by cultured skin fibroblasts from patients with abnormal purine metabolism.
adenosine deaminase deficiency
Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
adenosine deaminase deficiency
Purine metabolic enzymes in lymphocytes. IV. Effects of enzyme inhibitors and enzyme substrates on the blastogenic responses of human lymphocytes.
adenosine deaminase deficiency
Purine metabolism of lymphocytes. Targets for chemotherapy drug development.
adenosine deaminase deficiency
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency.
adenosine deaminase deficiency
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
adenosine deaminase deficiency
Purine nucleoside modulation of functions of human lymphocytes.
adenosine deaminase deficiency
Rapid prenatal diagnosis of adenosine deaminase deficiency and other purine disorders using foetal blood.
adenosine deaminase deficiency
Recalcitrant palmoplantar warts associated with adult-onset adenosine deaminase deficiency.
adenosine deaminase deficiency
Recent developments and new frontiers in childhood arterial ischemic stroke.
adenosine deaminase deficiency
Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Red-blood-cell adenosine deaminase deficiency in a "healthy" Kung individual.
adenosine deaminase deficiency
Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase.
adenosine deaminase deficiency
Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
adenosine deaminase deficiency
Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases.
adenosine deaminase deficiency
Role of adenosine deaminase in the early stages of precursor T cell maturation.
adenosine deaminase deficiency
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.
adenosine deaminase deficiency
S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
adenosine deaminase deficiency
S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
adenosine deaminase deficiency
Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency.
adenosine deaminase deficiency
Sensorineural deafness in siblings with adenosine deaminase deficiency.
adenosine deaminase deficiency
Severe combined immunodeficiency and adenosine deaminase deficiency.
adenosine deaminase deficiency
Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.
adenosine deaminase deficiency
Severe combined immunodeficiency disease with adenosine deaminase deficiency.
adenosine deaminase deficiency
Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.
adenosine deaminase deficiency
Severe combined immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Severe combined immunodeficiency: a national surveillance study.
adenosine deaminase deficiency
Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.
adenosine deaminase deficiency
Severe Combined Immunodeficiency: A Review for Neonatal Clinicians.
adenosine deaminase deficiency
Severe phenotype of severe combined immunodeficiency caused by adenosine deaminase deficiency in a patient with a homozygous mutation due to uniparental disomy.
adenosine deaminase deficiency
Short stature/short limb skeletal dysplasia with severe combined immunodeficiency and bowing of the femora: report of two patients and review.
adenosine deaminase deficiency
Somatic cell gene therapy: the model of adenosine deaminase deficiency.
adenosine deaminase deficiency
Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
adenosine deaminase deficiency
Strategies for Retrovirus-Based Correction of Severe, Combined Immunodeficiency (SCID).
adenosine deaminase deficiency
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.
adenosine deaminase deficiency
Stroke as Initial Manifestation of Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
Studies of the relationship between adenosine deaminase and immune function.
adenosine deaminase deficiency
Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.
adenosine deaminase deficiency
Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency.
adenosine deaminase deficiency
Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.
adenosine deaminase deficiency
Successful engraftment of haploidentical stem cell transplant with post-transplantation cyclophosphamide in a patient with adenosine deaminase deficiency.
adenosine deaminase deficiency
Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.
adenosine deaminase deficiency
Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
adenosine deaminase deficiency
Testing newborns for adenosine deaminase deficiency not cost effective.
adenosine deaminase deficiency
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
adenosine deaminase deficiency
The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency.
adenosine deaminase deficiency
The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
adenosine deaminase deficiency
The human genes for S-adenosylhomocysteine hydrolase and adenosine deaminase are syntenic on chromosome 20.
adenosine deaminase deficiency
The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
adenosine deaminase deficiency
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
adenosine deaminase deficiency
The role of de novo purine synthesis in lymphocyte transformation.
adenosine deaminase deficiency
The same mutation in a family with adenosine deaminase 2 deficiency.
adenosine deaminase deficiency
The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities.
adenosine deaminase deficiency
Thirty Years of Followup in 3 Patients with Familial Polyarteritis Nodosa due to Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
Toll-like receptor signaling in primary immune deficiencies.
adenosine deaminase deficiency
Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
adenosine deaminase deficiency
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
adenosine deaminase deficiency
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol.
adenosine deaminase deficiency
Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
adenosine deaminase deficiency
Two Cases Presenting With Unilateral Adduction Deficit Associated With Human Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
adenosine deaminase deficiency
Ultra-performance liquid chromatography-tandem mass spectrometry-based multiplex enzyme assay for six enzymes associated with hereditary hemolytic anemia.
adenosine deaminase deficiency
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
adenosine deaminase deficiency
Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency.
adenosine deaminase deficiency
Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.
adenosine deaminase deficiency
Widening the Neuroimaging Features of Adenosine Deaminase 2 Deficiency.
adenosine deaminase deficiency
Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973.
adenosine deaminase deficiency
[A method detecting heterozygotes for adenosine deaminase deficiency with blood samples dried on filter paper]
adenosine deaminase deficiency
[Adenosine deaminase deficiency and severe combined immunodeficiency]
adenosine deaminase deficiency
[Adenosine deaminase deficiency associated severe combined immunodeficiency with disseminated varicella infection after vaccination: a case report]
adenosine deaminase deficiency
[Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)]
adenosine deaminase deficiency
[Adenosine deaminase 1 deficiency, an inborn error of metabolism underlying a severe form of combined immunodeficiency].
adenosine deaminase deficiency
[Clinical study of gene therapy for adenosine deaminase deficiency]
adenosine deaminase deficiency
[Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
adenosine deaminase deficiency
[Gene therapy: a review 6 years after the first trials in man. Round Table No 6 at Giens XIII]
adenosine deaminase deficiency
[Immunological failure caused by adenosine deaminase deficiency]
adenosine deaminase deficiency
[Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency]
adenosine deaminase deficiency
[Polyethylene glycol-adenosine deaminase: a new adenosine deaminase deficiency therapy. Value of deoxyadenosine triphosphate determination for therapeutic monitoring]
adenosine deaminase deficiency
[Present status and future prospects of human gene therapy]
adenosine deaminase deficiency
[Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)]
adenosine deaminase deficiency
[Severe combined immunodeficiency: description of a clinical case]
adenosine deaminase deficiency
[Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency]
adenosine deaminase deficiency
[Treatment of adenosine deaminase deficiency using gene transfer]
adenosine deaminase deficiency
[Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol]
adenosine deaminase deficiency
[Treatment of severe combined immunodeficiency with bone marrow or foetal liver transplants (author's transl)]
adenosine kinase deficiency
Increased expression of one of two adenosine deaminase alleles in a human choriocarcinoma cell line following selection with adenine nucleosides.
adenylate kinase deficiency
Hereditary disorders of erythrocyte enzymes in non-glycolytic metabolic pathways.
Adrenoleukodystrophy
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
Agammaglobulinemia
A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid.
Agammaglobulinemia
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.
Agammaglobulinemia
Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
AIDS-Related Complex
Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
Airway Obstruction
Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction.
Alopecia Areata
Oxidative Stress Biomarkers and Adenosine Deaminase over the Alopecic Area of the Patients with Alopecia Areata.
alpha-Thalassemia
Acquired hemoglobin H disease associated with idiopathic myelofibrosis and hereditary adenosine deaminase deficiency.
Alzheimer Disease
Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology.
amidase deficiency
Adenosine as a prostaglandin antagonist. Possible mechanism of the defect in combined immunodeficiency disease due to adenosine deaminase deficiency.
amidase deficiency
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
amidase deficiency
Cicalese MP, Ferrua F, Castagnaro L, et al. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. Blood. 2016;128(1):45-54.
amidase deficiency
Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
amidase deficiency
Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
amidase deficiency
Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia.
amidase deficiency
Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
amidase deficiency
[Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency]
Amyloidosis
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab.
Amyotrophic Lateral Sclerosis
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
Amyotrophic Lateral Sclerosis
Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
Amyotrophic Lateral Sclerosis
Co-Occurrence of TDP-43 Mislocalization with Reduced Activity of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons.
Amyotrophic Lateral Sclerosis
The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Amyotrophic Lateral Sclerosis
Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout mice.
Anaphylaxis
Effect of adenosine on histamine release and atrioventricular conduction during guinea pig cardiac anaphylaxis.
Anemia
A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke.
Anemia
Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q- syndrome.
Anemia
High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. The DBA Working Group of Société d'Immunologie Pédiatrique (SHIP).
Anemia
Role of adenosine signaling in coordinating cardiomyocyte function and coronary vascular growth in chronic fetal anemia.
Anemia
[Diamond-Blackfan anemia confirmed by RPS19 gene mutation analysis: a case study and literature review of Korean patients]
Anemia
[Influence of iron deficiency anemia on development of thymus and spleen and adenosine deaminase activity in rats]
Anemia, Aplastic
Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA.
Anemia, Diamond-Blackfan
Comparative activity of erythrocyte adenosine deaminase and orotidine decarboxylase in Diamond-Blackfan anemia.
Anemia, Diamond-Blackfan
Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases.
Anemia, Diamond-Blackfan
Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q- syndrome.
Anemia, Diamond-Blackfan
Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia.
Anemia, Diamond-Blackfan
High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. The DBA Working Group of Société d'Immunologie Pédiatrique (SHIP).
Anemia, Hemolytic
Adenosine deaminase (ADA) overproduction associated with congenital hemolytic anemia: case report and molecular analysis.
Anemia, Hemolytic
Autosomal dominant hemolytic anemia and adenosine deaminase overproduction.
Anemia, Hemolytic
Biochemical study of a case of hemolytic anemia with increased (85 fold) red cell adenosine deaminase.
Anemia, Hemolytic
Biochemical study of a case of hemolytic anemia with increased (85-fold) red cell adenosine deaminase.
Anemia, Hemolytic
Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemia.
Anemia, Hemolytic
Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies.
Anemia, Hemolytic
Hereditary disorders of erythrocyte enzymes in non-glycolytic metabolic pathways.
Anemia, Hemolytic
Hereditary overexpression of adenosine deaminase in erythrocytes: evidence for a cis-acting mutation.
Anemia, Hemolytic
Hereditary overexpression of adenosine deaminase in erythrocytes: studies in erythroid cell lines and transgenic mice.
Anemia, Hemolytic
Increased erythrocyte adenosine deaminase activity without haemolytic anaemia.
Anemia, Hemolytic
Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
Anemia, Hemolytic
Overproduction of structurally normal enzyme in man: hereditary haemolytic anaemia with increased red cell adenosine deaminase activity.
Anemia, Hemolytic
Studies on pyruvate kinase deficiency, pyrimidine 5-'nucleotidase deficiency and adenosine deaminase overproduction.
Anemia, Hemolytic
Three kinds of foamy cells in the spleen: comparative histochemical and ultrastructural studies.
Anemia, Hemolytic
[Pathophysiology and laboratory tests of hemolytic anemia: with special reference to erythroenzymopathies]
Anemia, Hemolytic, Autoimmune
Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia.
Anemia, Hemolytic, Congenital
A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan.
Anemia, Hemolytic, Congenital
Adenosine deaminase (ADA) overproduction associated with congenital hemolytic anemia: case report and molecular analysis.
Anemia, Hemolytic, Congenital
Elevated adenosine deaminase activity and hereditary hemolytic anemia. Evidence for abnormal translational control of protein synthesis.
Anemia, Hemolytic, Congenital
Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.
Anemia, Hemolytic, Congenital
Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemia.
Anemia, Hemolytic, Congenital
Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate.
Anemia, Hemolytic, Congenital
Purification and properties of adenosine deaminase in normal and hereditary hemolytic anemia with increased red cell activity.
Anemia, Hypoplastic, Congenital
Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia.
Anemia, Hypoplastic, Congenital
Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.
Anemia, Iron-Deficiency
[Influence of iron deficiency anemia on development of thymus and spleen and adenosine deaminase activity in rats]
Anemia, Pernicious
Adenosine deaminase activity in gastric mucosa of pernicious anemia patients. Effect of treatment with cyanocobalamin (vitamin B12).
Anemia, Sideroblastic
Elevated erythrocyte adenosine deaminase activity in a patient with primary acquired sideroblastic anemia.
Angina, Stable
Adenosine deaminase activity in blood of patients with stable angina pectoris.
Angina, Unstable
5'-nucleotidase and adenosine deaminase activities in blood of patients with unstable angina pectoris.
Antiphospholipid Syndrome
Novel CECR1 gene mutations causing deficiency of adenosine deaminase 2, mimicking antiphospholipid syndrome.
Arrhythmias, Cardiac
Adenosine deaminase and BW A1433U attenuate hypoxia-induced ventricular ectopy.
Arteriosclerosis
[Peripheral blood albumin level in significantly correlated with the severity of atherosclerosis in hypertensive patients].
Arthritis
A fatal case of tuberculous meningitis in a child with juvenile idiopathic arthritis: a diagnostic challenge.
Arthritis
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Arthritis
Diagnostic value of synovial fluid adenosine deaminase level in tuberculous arthritis.
Arthritis
Modulatory effect of eugenol on arginase, nucleotidase, and adenosine deaminase activities of platelets in a carrageenan-induced arthritis rat model: A possible anti-arthritic mechanism of eugenol.
Arthritis
Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis.
Arthritis
Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis.
Arthritis
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
Arthritis
[Activity of adenosine deaminase in the serum of children ill with rheumatism and chronic progressive arthritis]
Arthritis, Experimental
Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
Arthritis, Experimental
Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism.
Arthritis, Gouty
[Adenosine deaminase activity in the lymphocytes of patients with gouty arthritis]
Arthritis, Infectious
Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis.
Arthritis, Juvenile
A clinical score to guide in decision making for monogenic type I IFNopathies.
Arthritis, Juvenile
A fatal case of tuberculous meningitis in a child with juvenile idiopathic arthritis: a diagnostic challenge.
Arthritis, Juvenile
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Arthritis, Juvenile
Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus.
Arthritis, Juvenile
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Arthritis, Juvenile
Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis.
Arthritis, Reactive
Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
Arthritis, Rheumatoid
A study of adenosine-deaminase genetic polymorphism in rheumatoid arthritis.
Arthritis, Rheumatoid
Activities of enzymes that hydrolyze adenine nucleotides in lymphocytes from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Adenosine Deaminase activity and HLA-DRB as diagnostic markers for Rheumatoid Arthritis.
Arthritis, Rheumatoid
Adenosine deaminase and C-reactive protein in diagnosing and monitoring of rheumatoid arthritis.
Arthritis, Rheumatoid
Adenosine Deaminase Gene Polymorphism and Baseline Serum Level of Adenosine Deaminase as a Biomarker of Response to Methotrexate in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
Arthritis, Rheumatoid
Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis.
Arthritis, Rheumatoid
Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy.
Arthritis, Rheumatoid
Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis.
Arthritis, Rheumatoid
Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Effect of cyclosporin on the activity of cytidine deaminase and adenosine deaminase in the serum and polymorphonuclear leukocytes of patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Plasma adenosine deaminase activity in children with rheumatic fever and rheumatoid arthritis.
Arthritis, Rheumatoid
Pleural fluid adenosine deaminase in rheumatoid arthritis and systemic lupus erythematosus.
Arthritis, Rheumatoid
Serum Adenosine Deaminase as Inflammatory Marker in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate.
Arthritis, Rheumatoid
Serum Adenosine Deaminase Level is High But Not Related with Disease Activity Parameters in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Serum adenosine deaminase may predict disease activity in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
Arthritis, Rheumatoid
Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts.
Arthritis, Rheumatoid
Three kinds of foamy cells in the spleen: comparative histochemical and ultrastructural studies.
Arthritis, Rheumatoid
[Aberrant over-expression of adenosine deaminase and its significance on rheumatoid arthritis]
Arthritis, Rheumatoid
[Adenosine deaminase activity in levamisole treatment of patients with rheumatoid arthritis]
Asthma
A genetic basis for heterogeneity of asthma syndrome in pediatric ages: adenosine deaminase phenotypes.
Asthma
A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
Asthma
Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms.
Asthma
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma.
Asthma
Alveolar-like Stem Cell-derived Myb(neg) Macrophages Promote Recovery and Survival in Airway Disease.
Asthma
Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma.
Asthma
Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice.
Asthma
Molecular mechanism of inhibition of COVID-19 main protease by ?-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods.
Asthma
The role of plasma adenosine deaminase in chemoattractant-stimulated oxygen radical production in neutrophils.
Asthma
[The effect of aminophylline on plasma oxypurines in patients with bronchial asthma or cor pulmonale]
Astrocytoma
Novel metabolic aspects related to adenosine deaminase inhibition in a human astrocytoma cell line.
Astrocytoma
The combination of adenosine deaminase inhibition and deoxyadenosine induces apoptosis in a human astrocytoma cell line.
Atherosclerosis
Extracellular Purine Metabolism in Blood Vessels (Part II): Activity of Ecto-Enzymes in Blood Vessels of Patients With Abdominal Aortic Aneurysm.
Atherosclerosis
Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.
Atherosclerosis
Serum Adenosine Deaminase as a Useful Marker to Estimate Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients.
Atrial Fibrillation
A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control study.
Atrioventricular Block
Effect of adenosine on histamine release and atrioventricular conduction during guinea pig cardiac anaphylaxis.
Atrioventricular Block
On augmentation of adenosine-mediated negative dromotropic effect by K+ released during myocardial ischemia.
Atypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
Autoimmune Diseases
Adenosine deaminase activity in plasma and blood cells of patients with haematological and autoimmune diseases.
Autoimmune Diseases
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Autoimmune Diseases
Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity.
Autoimmune Diseases
[Pathogenetic significance of adenosine deaminase in autoimmune diseases]
Azoospermia
Gene and histomorphology alteration analysis in spermatogenesis arrest mouse model: a probable novel approach for infertility.
Bacterial Infections
Epidemiology of patients with central nervous system infections, mainly neurosurgical patients: a retrospective study from 2012 to 2019 in a teaching hospital in China.
Bacterial Infections
Self-remitting Elevation of Adenosine Deaminase Levels in the Cerebrospinal Fluid with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report and Review of the Literature.
Bacterial Infections
Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions.
Bacterial Infections
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
Bacterial Infections
The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis.
Behcet Syndrome
The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behcet's disease.
Bernard-Soulier Syndrome
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
Blast Crisis
5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.
Blast Crisis
Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia.
Blast Crisis
[Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia]
Blast Crisis
[Enzymatic markers in chronic myeloleukemia and their importance for identifying a blast crisis]
Bone Diseases, Developmental
Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
Bone Marrow Failure Disorders
Deficiency of adenosine deaminase 2 (DADA2) in Adults and Children: Experience from India.
Bone Marrow Failure Disorders
Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
Bone Marrow Failure Disorders
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Bone Marrow Failure Disorders
Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).
Bone Marrow Failure Disorders
Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.
Brain Diseases
Adenosine deaminase and protein pattern in serum and cerebrospinal fluid in experimental manganese encephalopathy.
Brain Diseases
Biallelic variants in ADARB1, encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy.
Brain Diseases
Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Brain Infarction
[Juvenile familial vertebrobasilar brain infarctions due to adenosine deaminase 2 deficiency].
Brain Neoplasms
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
Breast Diseases
Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors.
Breast Neoplasms
Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor alpha crosstalk.
Breast Neoplasms
Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities.
Breast Neoplasms
Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
Breast Neoplasms
Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors.
Breast Neoplasms
Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions.
Breast Neoplasms
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
Breast Neoplasms
Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
Breast Neoplasms
Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer.
Breast Neoplasms
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
Breast Neoplasms
Oxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer.
Breast Neoplasms
Serum adenosine deaminase, 5'-nucleotidase & alkaline phosphatase in breast cancer patients.
Breast Neoplasms
Urtica dioica inhibits cell growth and induces apoptosis by targeting Ornithine decarboxylase and Adenosine deaminase as key regulatory enzymes in adenosine and polyamines homeostasis in human breast cancer cell lines.
Breast Neoplasms
[Activity of the enzymes of DNA metabolism in the blood of patients with breast cancer]
Breast Neoplasms
[Lactate dehydrogenase, adenosine deaminase and thymidine phosphorylase activity of blood and tissues in breast tumor patients]
Bronchitis, Chronic
[Changes in adenosine deaminase and antioxidative enzyme activity in patients with lung diseases of dust etiology]
Bronchopulmonary Dysplasia
Adenosine deaminase levels in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Brucellosis
Increased pleural fluid adenosine deaminase in brucellosis is difficult to differentiate from tuberculosis.
Brucellosis
[Activity of adenosine deaminase in acute brucellosis and complicated brucellosis]
Burkitt Lymphoma
Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.
Carcinogenesis
Adenylic acid and adenosine deaminase activities in rat livers during azo-dye carcinogenesis.
Carcinogenesis
Behaviour of adenylic acid and adenosine deaminase in spontaneous mammary carcinogenesis in mice.
Carcinogenesis
Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse.
Carcinogenesis
The lymphocyte activity of adenosine deaminase and enzymes of AMP metabolism in mammary carcinogenesis: the effect of thymostimulin.
Carcinogenesis
Three Nordic berries inhibit intestinal tumorigenesis in multiple intestinal neoplasia/+ mice by modulating beta-catenin signaling in the tumor and transcription in the mucosa.
Carcinogenesis
[Influence of thymostimulin on the activity of certain enzymes of adenosine and AMP metabolism in lymphocytes of rats with mammary cancer]
Carcinoma
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Carcinoma
Activities of serum Ada, GGT and alp in carcinoma breast-a case control study for diagnostic and prognostic significance.
Carcinoma
ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
Carcinoma
Adenosine Deaminase - a Novel Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Carcinoma
Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma.
Carcinoma
Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies.
Carcinoma
Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases. I. Bronchogenic carcinoma.
Carcinoma
Adenosine deaminase and purine phosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx.
Carcinoma
Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue.
Carcinoma
Adenosine deaminase, 5' nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues.
Carcinoma
Adenosine deaminase, xanthine oxidase, superoxide dismutase, glutathione peroxidase activities and malondialdehyde levels in the sera of patients with head and neck carcinoma.
Carcinoma
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.
Carcinoma
Characterization of adenosine deaminase from normal human epidermis and squamous cell carcinoma of the skin.
Carcinoma
Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma.
Carcinoma
Effects of 8-azaadenosine and formycin on cell lethality and the synthesis and methylation of nucleic acids in human colon carcinoma cells in culture.
Carcinoma
Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein.
Carcinoma
High adenosine deaminase level in pleural effusion due to bronchoalveolar carcinoma.
Carcinoma
Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma.
Carcinoma
Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
Carcinoma
Reinforcement of antitumor effect of Cordyceps sinensis by 2'-deoxycoformycin, an adenosine deaminase inhibitor.
Carcinoma
Serum Adenosine Deaminase Levels and Human Papillomavirus as Prognostic and Predictive Factors for Laryngeal and Pharyngeal Carcinomas.
Carcinoma
Serum adenosine deaminase, 5'-nucleotidase & alkaline phosphatase in breast cancer patients.
Carcinoma
Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.
Carcinoma
Studies of lymphocyte adenosine deaminase activity in patients with renal and transitional cell carcinoma.
Carcinoma
[Adenosine metabolism in lymphocytes and neurochemical stressor reactions in mice with metastatic Lewis carcinoma after surgical removal of the tumor]
Carcinoma
[Antimetastatic action of bacterial endotoxins and changes in the activity of the enzymes of purine metabolism in macrophages]
Carcinoma
[Effect of GMDP encapsulated into liposomes on metastatic spread of Lewis lung carcinoma]
Carcinoma
[Specificity of adenosine deaminase of living cancerous tissue of atypic rat epithelioma.]
Carcinoma
[Use of the study of DNA metabolism enzyme activities as a test system in the treatment of breast cancer]
Carcinoma, Bronchogenic
Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases. I. Bronchogenic carcinoma.
Carcinoma, Bronchogenic
Role of biochemical tests in the diagnosis of exudative pleural effusions.
Carcinoma, Bronchogenic
The association of adenosine deaminase activity with T-lymphocytes and subsets in pulmonary tuberculosis and bronchogenic carcinoma.
Carcinoma, Bronchogenic
[Studies on the activity of adenosine deaminase in plasma in cancerous diseases with special regard to bronchial carcinoma.]
Carcinoma, Ehrlich Tumor
Cell proliferation in the thymus of Ehrlich ascites tumor bearing mice.
Carcinoma, Ehrlich Tumor
Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Carcinoma, Hepatocellular
Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours.
Carcinoma, Hepatocellular
Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
Carcinoma, Hepatocellular
Adenosine deaminase gene amplification in deoxycoformycin-resistant mammalian cells.
Carcinoma, Hepatocellular
Amplification of adenosine deaminase gene sequences in deoxycoformycin-resistant rat hepatoma cells.
Carcinoma, Hepatocellular
Biochemical approaches to enhancement of antitumor drug selectivity: selective protection of cells from 6-thioguanine and 6-mercaptopurine by adenosine.
Carcinoma, Hepatocellular
Chromosome anomalies associated with amplification of the adenosine deaminase gene (ADA) in rat hepatoma cells.
Carcinoma, Hepatocellular
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Destabilization of the adenosine deaminase gene sequences in rat-rat somatic cell hybrids.
Carcinoma, Hepatocellular
Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
Carcinoma, Hepatocellular
Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
Carcinoma, Hepatocellular
Some biochemical mechanisms underlying the impairment of T and B cell immunity in C3HA mice during hepatoma growth.
Carcinoma, Hepatocellular
[Adenosine deaminase activity in hepatomas of varying degrees of malignancy]
Carcinoma, Hepatocellular
[Changes in DNA and purine nucleotide synthesis in lymphoid cells and sensitivity to glucocorticoids associated with the impairment of differentiation and immune function in mice during tumor growth. Spleen T- and B-lymphocytes]
Carcinoma, Hepatocellular
[Changes in purine metabolism and in the immune response in the thymic and splenic lymphocytes of C3HA mice during chemical hepatocarcinogenesis]
Carcinoma, Hepatocellular
[Changes in the lymphoid cells of DNA and purine nucleotide synthesis and sensitivity to glucocorticoids associated with impairment of differentiation and immune function during tumor growth in mice. Thymocytes]
Carcinoma, Lewis Lung
[Effect of GMDP encapsulated into liposomes on metastatic spread of Lewis lung carcinoma]
Carcinoma, Renal Cell
Adenosine deaminase activity in a transplantable murine renal adenocarcinoma.
Carcinoma, Renal Cell
Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.
Carcinoma, Small Cell
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Carcinoma, Squamous Cell
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Carcinoma, Squamous Cell
ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
Carcinoma, Squamous Cell
Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue.
Carcinoma, Squamous Cell
Adenosine deaminase, 5' nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues.
Carcinoma, Squamous Cell
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Characterization of adenosine deaminase from normal human epidermis and squamous cell carcinoma of the skin.
Carcinoma, Squamous Cell
Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma.
Carcinoma, Transitional Cell
Adenosine deaminase activity in patients with carcinoma of the bladder.
Carcinoma, Transitional Cell
Studies of lymphocyte adenosine deaminase activity in patients with renal and transitional cell carcinoma.
Cardiomegaly
[The enzymatic activity of adenosine metabolism in the rat heart. The effects of cardiac hypertrophy]
Cardiovascular Diseases
Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.
Cauda Equina Syndrome
[Cauda equina syndrome with elevated adenosine deaminase in a patient with HIV infection]
Celiac Disease
DNA damage, oxidative stress, and inflammation in children with celiac disease.
Cerebral Infarction
Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome.
Cerebrovascular Disorders
Diagnostic value of cerebrospinal fluid adenosine deaminase determination.
Chagas Disease
ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY.
Chagas Disease
E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.
Chemical and Drug Induced Liver Injury
AMP deaminase and adenosine deaminase activities in liver and brain regions in acute ammonia intoxication and subacute toxic hepatitis.
Chickenpox
[Adenosine deaminase deficiency associated severe combined immunodeficiency with disseminated varicella infection after vaccination: a case report]
Cholecystitis, Acute
[Dynamics of the cytokines, homocysteine contents, indices of oxydative and nitrosative stress and cytopathic hypoxia in patients after cholecystectomy for acute cholecystitis. Connection with rate of postoperative purulent-inflammatory complications]
Cholelithiasis
[Enzymatic activity of serum adenosine deaminase in different liver disorders]
Cholera
Evaluation of adenosine or related nucleosides as physiological regulators of lipolysis in adipose tissue.
Cholera
Inhibition of lipolysis and cyclic AMP accumulation by adenosine analogues in hamster epididymal adipocytes exposed to cholera toxin.
Chordoma
Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR?125a and miR?10a expression.
Choriocarcinoma
Increased expression of one of two adenosine deaminase alleles in a human choriocarcinoma cell line following selection with adenine nucleosides.
coagulation factor viia deficiency
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
Coccidioidomycosis
Coccidioidomycosis: ADA levels, serologic parameters, culture results, and PCR testing in pleural fluid.
Coinfection
Serum Adenosine Deaminase (ADA) Activity: A Novel Screening Test to Differentiate HIV Monoinfection From HIV-HBV and HIV-HCV Coinfections.
Colitis
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
Colitis
Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.
Colitis, Ulcerative
Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis.
Colonic Neoplasms
Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors.
Colonic Neoplasms
Effects of aqueous green tea extract on activities of DNA turn-over enzymes in cancerous and non-cancerous human gastric and colon tissues.
Colonic Neoplasms
Genetic variability within Adenosine Deaminase gene and uterine leiomyomas.
Colorectal Neoplasms
Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues.
Coma
Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.
Coma
Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome.
Common Variable Immunodeficiency
Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.
Common Variable Immunodeficiency
Epstein-Barr virus-induced lymphoblastoid cell lines from patients with primary immunodeficiency diseases.
Communicable Diseases
Serum adenosine deaminase and xanthine oxidase activities in silver catfish naturally infected with Ichthyophthirius multifiliis: The influence of these enzymes on inflammatory and oxidative status.
Congenital Abnormalities
Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function.
Congenital Abnormalities
Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes.
Congenital Abnormalities
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Congenital Abnormalities
[Adenosine deaminase as costimulatory molecule and marker of cellular immunity].
Connective Tissue Diseases
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
Contracture
Adenosine reduces the reverse mode of the Na+/Ca(2+) exchanger in ferret cardiac fibres.
Contracture
Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in Guinea-pig atria and papillary muscles.
Contracture
In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C.
Coronary Artery Disease
ADA*2 Allele of the Adenosine Deaminase Gene May Protect against Coronary Artery Disease.
Coronary Artery Disease
Adenosine Deaminase Genetic Polymorphism and Coronary Artery Disease.
Coronary Artery Disease
Coronary artery disease. A study of three polymorphic sites of adenosine deaminase gene.
Coronary Artery Disease
Coronary artery disease: a study on the joint role of birth weight, adenosine deaminase, and gender.
Coronary Artery Disease
Does adenosine deaminase play a key role in coronary artery disease.
Coronary Artery Disease
Genetic Polymorphism of Adenosine Deaminase and Early Neonatal Events: Is There an Association with Susceptibility to Coronary Artery Disease in Adult Life?
Coronary Artery Disease
Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants.
Coronary Artery Disease
The interaction of ACP1, ADA1, diabetes and gender in coronary artery disease.
Coronary Artery Disease
The role of plasma adenosine deaminase in chemoattractant-stimulated oxygen radical production in neutrophils.
Coronary Disease
Type-2 diabetes mellitus and the frequency of the G22A polymorphism of the adenosine deaminase gene in a mixed population in Brazil.
Coronary Occlusion
Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects.
Coronary Occlusion
Effect of adenosine deaminase inhibitors on myocardial reactive hyperaemia following brief coronary occlusions.
Coronary Occlusion
Effect of exogenous adenosine deaminase on arrhythmias and the release of adenine nucleotide catabolites in isolated rat hearts with coronary occlusion and reperfusion.
Coronary Occlusion
Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure.
Coronary Occlusion
Role of adenosine in the maintenance of coronary vasodilation distal to a severe coronary artery stenosis. Observations in conscious domestic swine.
Coronavirus Infections
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.
Cough
Development of a clinical prediction rule for tuberculous meningitis in adults in Lima, Peru.
COVID-19
Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection.
COVID-19
Molecular mechanism of inhibition of COVID-19 main protease by ?-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods.
COVID-19
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity.
COVID-19
Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities.
Crohn Disease
Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms.
Crohn Disease
Adenosine deaminase activity in patients with Crohn's disease: distinction between active and nonactive disease.
Crohn Disease
No Association Between Serum Adenosine Deaminase Activity and Disease Activity in Crohn's Disease.
Crush Syndrome
Activity of enzymes of adenyline compounds metabolism during crush and decompression of muscle tissue. Part II. Adenosine deaminase activity at experimental crush syndrome.
Cryopyrin-Associated Periodic Syndromes
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Cystic Fibrosis
Alveolar-like Stem Cell-derived Myb(neg) Macrophages Promote Recovery and Survival in Airway Disease.
Cystic Fibrosis
Evaluation of Serum Adenosine Deaminase in Cystic Fibrosis Patients in an Iranian Referral Hospital.
Cysts
Analysis of the ectoenzymes ADA, ALP, ENPP1, and ENPP3, in the contents of ovarian endometriomas as candidate biomarkers of endometriosis.
dctp diphosphatase deficiency
Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.
Deficiency Diseases
Adenosine deaminase deficiency in combined immunologic deficiency disease.
Deficiency Diseases
Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
Deficiency Diseases
Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
Deficiency Diseases
Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease.
Deficiency Diseases
S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
Deficiency Diseases
Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973.
Dementia
Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
Dementia
Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia.
Dermatitis, Atopic
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.
Dermatitis, Contact
Adenosine deaminase levels in construction workers with asbestos contact dermatitis.
Dermatofibrosarcoma
Multicentric dermatofibrosarcoma protuberans in a child with severe combined immunodeficiency due to adenosine deaminase deficiency.
Dermatomyositis
A clinical score to guide in decision making for monogenic type I IFNopathies.
Diabetes Complications
The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients.
Diabetes Mellitus
A girl with diabetes and severe combined immunodeficiency from adenosine deaminase deficiency.
Diabetes Mellitus
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus.
Diabetes Mellitus
Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
Diabetes Mellitus
Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.
Diabetes Mellitus
Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus.
Diabetes Mellitus
Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.
Diabetes Mellitus
Early-onset type 2 (non-insulin-dependent) diabetes mellitus is associated with glucokinase locus, but not with adenosine deaminase locus, in the Japanese population.
Diabetes Mellitus
Effects of coenzyme Q10 supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial.
Diabetes Mellitus
Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus.
Diabetes Mellitus
Platelet aggregation and serum adenosine deaminase (ADA) activity in pregnancy associated with diabetes, hypertension and HIV.
Diabetes Mellitus
Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus.
Diabetes Mellitus
Serum Adenosine Deaminase as a Useful Marker to Estimate Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients.
Diabetes Mellitus
Type-2 diabetes mellitus and the frequency of the G22A polymorphism of the adenosine deaminase gene in a mixed population in Brazil.
Diabetes Mellitus, Experimental
Alloxan diabetes regulates adenosine deaminase activity in mice: tissue- and age-specific correlation.
Diabetes Mellitus, Experimental
[Characteristics of purine and nucleotide metabolism in juvenile rats with alloxan diabetes]
Diabetes Mellitus, Type 1
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system.
Diabetes Mellitus, Type 1
Immunotherapy for insulin-dependent diabetes mellitus in the "BB" rat.
Diabetes Mellitus, Type 1
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.
Diabetes Mellitus, Type 1
Long-term culture and T cell receptor analysis of T cell clones isolated from a patient with adenosine deaminase deficiency and type I diabetes.
Diabetes Mellitus, Type 1
Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.
Diabetes Mellitus, Type 2
A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene.
Diabetes Mellitus, Type 2
Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?
Diabetes Mellitus, Type 2
Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Adenosine deaminase gene polymorphism is associated with obesity in Iranian population.
Diabetes Mellitus, Type 2
Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.
Diabetes Mellitus, Type 2
Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Early-onset type 2 (non-insulin-dependent) diabetes mellitus is associated with glucokinase locus, but not with adenosine deaminase locus, in the Japanese population.
Diabetes Mellitus, Type 2
Effects of coenzyme Q10 supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial.
Diabetes Mellitus, Type 2
Exclusion of adenosine deaminase gene locus on chromosome 20q12-13.1 in familial NIDDM in Taiwanese patients.
Diabetes Mellitus, Type 2
Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q.
Diabetes Mellitus, Type 2
Genetic analysis of glucokinase and the chromosome 20 diabetes susceptibility locus in families with type 2 diabetes.
Diabetes Mellitus, Type 2
Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes.
Diabetes Mellitus, Type 2
Serum Adenosine Deaminase as a Useful Marker to Estimate Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients.
Diabetes Mellitus, Type 2
Serum adenosine deaminase levels are associated with diabetic kidney disease in type 2 diabetic patients.
Diabetes Mellitus, Type 2
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms.
Diabetes, Gestational
G22A Polymorphism of Adenosine Deaminase and its Association with Biochemical Characteristics of Gestational Diabetes Mellitus in an Iranian Population.
Diabetes, Gestational
Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.
Diabetes, Gestational
Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy.
Diabetic Nephropathies
Serum adenosine deaminase levels are associated with diabetic kidney disease in type 2 diabetic patients.
Diabetic Retinopathy
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
DiGeorge Syndrome
Epstein-Barr virus-induced lymphoblastoid cell lines from patients with primary immunodeficiency diseases.
dihydropyrimidinase deficiency
Application of metabolomic principles to disorders of nucleotide metabolism reveals new metabolic perturbations.
Dihydropyrimidine Dehydrogenase Deficiency
Application of metabolomic principles to disorders of nucleotide metabolism reveals new metabolic perturbations.
Disseminated Intravascular Coagulation
Effects of enrofloxacin, flunixin meglumine and dexamethasone on disseminated intravascular coagulation, cytokine levels and adenosine deaminase activity in endotoxaemia in rats +.
double-stranded rna adenine deaminase deficiency
RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.
double-stranded rna adenine deaminase deficiency
RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
Down Syndrome
Erythrocyte adenosine deaminase, purine nucleoside phosphorylase and phosphoribosyltransferase activity in patients with Down's syndrome.
Down Syndrome
Levels of some purine metabolizing enzymes in lymphocytes from patients with Down's syndrome.
Duodenal Ulcer
Adenosine deaminase activity in the gastric mucosa of duodenal ulcer patients in relation to the severity of chronic gastritis and gastric acid secretion.
Duodenal Ulcer
Duodenal ulcer and mucosal adenosine deaminase activity. Effects of ranitidine and sucralfate.
Dyspnea
A Case of Sjögren's Syndrome with Pleural Effusion: Difficult to Distinguish from Tuberculous Pleurisy Because of a High Adenosine Deaminase Level.
Eclampsia
Relationship between erythrocyte catalase and serum adenosine deaminase activities in eclampsia.
Ehrlichiosis
Determination of Serum Oxidative Stress, Antioxidant Capacity and Protein Profiles in Dogs Naturally Infected with Ehrlichia canis.
Empyema
A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser.
Empyema
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Empyema
Evaluation of polymerase chain reaction and adenosine deaminase assay for the diagnosis of tuberculous effusions in children.
Empyema
[Diagnosis and treatment of tuberculous pleurisy--with special reference to the significance of measurement of pleural fluid cytokines]
Encephalitis
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children.
Encephalitis
Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis: A Report of Two Cases.
Encephalitis, Herpes Simplex
High levels of adenosine deaminase in a patient with herpetic encephalitis and initial negative PCR results.
Encephalitis, Viral
Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.
Encephalomyelitis
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Encephalomyelitis, Acute Disseminated
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Endometriosis
Analysis of the ectoenzymes ADA, ALP, ENPP1, and ENPP3, in the contents of ovarian endometriomas as candidate biomarkers of endometriosis.
Endometriosis
Identification of global transcriptome abnormalities and potential biomarkers in eutopic endometria of women with endometriosis: A preliminary study.
Endotoxemia
Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis.
Endotoxemia
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
Enteritis
Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.
Enteritis
Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis.
Eosinophilia
Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases.
Epilepsy
Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma?associated epilepsy.
Epilepsy
Effects of progesterone on total brain tissue adenosine deaminase activity in experimental epilepsy.
Epstein-Barr Virus Infections
Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
Erectile Dysfunction
Quercetin enhances sexual behavior and improves ectonucleotidases activity in the hypothalamus of rats treated with cyclosporine.
Essential Hypertension
The role of adenosine-related genes variants in susceptibility to essential hypertension.
Essential Hypertension
[Value of oxypurines and uric acid in plasma, renal excretion of oxypurines and uric acid as well as plasma adenosine deaminase and AMP deaminase activity in patients with essential hypertension]
Exanthema
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Exfoliation Syndrome
The Activities of Paraoxonase, Xanthine Oxidase, Adenosine Deaminase and the Level of Nitrite in Pseudoexfoliation Syndrome.
Fabry Disease
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Factor VII Deficiency
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
Familial Mediterranean Fever
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
Familial Mediterranean Fever
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Familial Mediterranean Fever
Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
Familial Mediterranean Fever
Old Dogs, New Tricks: Monogenic Autoinflammatory Disease Unleashed.
Familial Mediterranean Fever
Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Fanconi Syndrome
Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA.
Fibromyalgia
Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications.
Focal Epithelial Hyperplasia
Late-onset adenosine deaminase deficiency presenting with Heck's disease.
Food Hypersensitivity
Food allergy in a patient with adenosine deaminase deficiency undergoing enzyme replacement with polyethylene glycol-modified adenosine deaminase.
Foot-and-Mouth Disease
High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site.
Gastritis
Adenosine deaminase activity in the gastric mucosa of duodenal ulcer patients in relation to the severity of chronic gastritis and gastric acid secretion.
Gastritis
Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.
Gastritis
Mucosal adenosine deaminase activity and gastritis histology: a comparative study of partially resected and intact stomachs.
Gastritis, Atrophic
Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.
Gastritis, Atrophic
An indication for correlation between the serum ADA level and gastric cancer risk.
Gastrointestinal Diseases
Caspase-4 activation in association with decreased adenosine deaminase activity may be a factor for gastric ulcer.
GATA2 Deficiency
Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
Gaucher Disease
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Genetic Diseases, Inborn
Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Genetic Diseases, Inborn
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
Genetic Diseases, Inborn
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
Genetic Diseases, Inborn
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients.
Genetic Diseases, Inborn
Human gene therapy in gastrointestinal diseases: in vivo and in vitro approaches.
Genetic Diseases, Inborn
Metabolic and immunologic consequences of limited adenosine deaminase expression in mice.
Genetic Diseases, Inborn
Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
Genetic Diseases, Inborn
Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Genetic Diseases, Inborn
[Values and limits of adenoviral vectors for gene transfer in vivo]
Giant Cell Arteritis
A Rare Case of Adenosine Deaminase 2 Deficiency Presenting With Temporal Arteritis.
Glioblastoma
Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Glioma
ADAR3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice.
Glioma
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R.
Glioma
Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma?associated epilepsy.
Glioma
Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.
Glomerulonephritis
Aldolase and adenosine deaminase activity in lymphocytes of patients with glomerulonephritis.
Glomerulonephritis
[Guanine deaminase and adenosine deaminase activity in chronic glomerulonephritis]
Gout
Purine excretion by cultured skin fibroblasts from patients with abnormal purine metabolism.
Graft vs Host Disease
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Graft vs Host Disease
Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
Graft vs Host Disease
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Gram-Positive Bacterial Infections
Pleural effusion adenosine deaminase: a candidate biomarker to discriminate between Gram-negative and Gram-positive bacterial infections of the pleural space.
Granuloma
A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report.
Granuloma
The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study.
Granulomatous Disease, Chronic
Gene therapy for primary immunodeficiencies: current status and future prospects.
Granulomatous Disease, Chronic
Gene Therapy for the Treatment of Primary Immune Deficiencies.
Granulomatous Disease, Chronic
Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
Granulomatous Disease, Chronic
Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase--deficient severe combined immunodeficiency disease patients.
Granulomatous Disease, Chronic
Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients.
Granulomatous Disease, Chronic
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
Granulomatous Disease, Chronic
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
Granulomatous Disease, Chronic
[Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
Graves Disease
The association between serum adenosine deaminase levels and Graves' disease.
Guillain-Barre Syndrome
Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.
Hashimoto Disease
Expression of genes for certain enzymes of pyrimidine and purine salvage pathway in peripheral blood leukocytes collected from patients with Graves' or Hashimoto's disease.
Head and Neck Neoplasms
Adenosine deaminase, xanthine oxidase, superoxide dismutase, glutathione peroxidase activities and malondialdehyde levels in the sera of patients with head and neck carcinoma.
Head and Neck Neoplasms
Evaluation of adenosine deaminase activity in patients with head and neck cancer.
Heart Failure
Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-? (TNF?) concentration in chronic heart failure.
Heart Failure
The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in Chinese.
Hematologic Diseases
[Adenosine deaminase and purine nucleoside phosphorylase of thrombocytes in various hematologic diseases]
Hematologic Diseases
[Adenosine deaminase in formed blood elements: distribution and properties in normal states and in various hematologic diseases]
Hematologic Neoplasms
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
Hematologic Neoplasms
Adenosine deaminase activity in lymphocytes of normal persons, leukemic patients, and kidney-transplant recipients.
Hematologic Neoplasms
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
Hematologic Neoplasms
[Adenosine deaminase and purine nucleoside phosphorylase activities of various cultured cell lines derived from human hematologic malignancies]
Hemoglobinuria
Biologic relevance of elevated red cell adenosine deaminase activity in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria.
Hemoglobinuria, Paroxysmal
Biologic relevance of elevated red cell adenosine deaminase activity in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria.
Hemorrhagic Fever, Crimean
Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever.
Hepatitis
Activation of AMP deaminase and adenosine deaminase in the liver during ammonia poisoning and hepatitis.
Hepatitis
Adenosine deaminase activity in serum of patients with hepatitis - a useful tool in monitoring clinical status.
Hepatitis
Adenosine deaminase and guanosine deaminase activities in sera of patients with viral hepatitis.
Hepatitis
Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency.
Hepatitis
Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases.
Hepatitis
Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.
Hepatitis
Serum adenosine deaminase, 5' nucleotidase and malondialdehyde in acute infective hepatitis.
Hepatitis
Studies on the age dependent changes in serum adenosine deaminase activity and its changes in hepatitis.
Hepatitis
Studies on the serum adenosine deaminase activity test in patients with hepatitis.
Hepatitis
THE ACTIVITY OF ADENOSINE DEAMINASE IN THE BLOOD SERUM OF VIRAL HEPATITIS PATIENTS.
Hepatitis
The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.
Hepatitis
[Adenosine deaminase activity in peripheral lymphocytes during acute viral hepatitis (preliminary data)]
Hepatitis
[Guanine and adenosine deaminase activities in blood serum in the course of viral hepatitis]
Hepatitis B
Adenosine deaminase, acquired immunodeficiency syndrome (AIDS), and hepatitis B infection.
Hepatitis B
Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes.
Hepatitis, Autoimmune
Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis.
Hepatitis, Chronic
Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis.
Herpes Simplex
Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Herpes Simplex
Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Herpes Simplex
Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Herpes Simplex
Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in guinea pigs.
Herpes Simplex
Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Herpes Simplex
Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
Herpes Simplex
Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
Herpes Simplex
Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
Herpes Simplex
The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
Herpes Zoster
Adenosine effects on hormone-stimulated steroidogenesis in isolated bovine adrenal zona fasciculata cells.
HIV Infections
Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
HIV Infections
Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.
HIV Infections
Depressed activities of purine enzymes in lymphocytes of patients infected with human immunodeficiency virus.
HIV Infections
Diagnostic significance of immunoglobulins and adenosine deaminase in pleural effusion.
HIV Infections
Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis.
HIV Infections
HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
HIV Infections
Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy.
HIV Infections
Serum Adenosine Deaminase and Total Immunoglobulin G Correlate with Markers of Immune Activation and Inversely with CD4 Counts in Asymptomatic, Treatment-Naive HIV Infection.
HIV Infections
Usefulness of Adenosine Deaminase Assay in Diagnosis of Patients with HIV Infection and Pleural Tuberculosis.
HIV Infections
[Cauda equina syndrome with elevated adenosine deaminase in a patient with HIV infection]
Hodgkin Disease
Action of levamisole on E-rosette forming cells and serum adenosine deaminase in Hodgkin's disease.
Hodgkin Disease
Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
Hodgkin Disease
CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
Hodgkin Disease
Decreased adenosine deaminase (ADA) and 5'nucleotidase (5NT) activity in peripheral blood T cells in Hodgkin disease.
Hodgkin Disease
[Decreased adenosine deaminase activity in the T-lymphocytes in Hodgkin's disease]
Hydrocephalus
Pearls & Oy-sters: chronic mumps meningoencephalitis with low CSF glucose and acute hydrocephalus in an adult.
Hydrocephalus
Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome.
Hydronephrosis
[Diamond-Blackfan anemia confirmed by RPS19 gene mutation analysis: a case study and literature review of Korean patients]
Hydrothorax
CD4(+)CD25(-)Foxp3(+) T cells play a role in tuberculous hydrothorax rather than malignant hydrothorax.
Hyperalgesia
Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
Hyperalgesia
Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor.
Hyperalgesia
Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain.
Hyperalgesia
RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.
Hypercholesterolemia
Enzymes that hydrolyze adenine nucleotides in a model of hypercholesterolemia induced by Triton WR-1339: protective effects of ?-caryophyllene.
Hyperemesis Gravidarum
Alterations in lipid peroxidation and T-cell function in women with hyperemesis gravidarum.
Hyperemesis Gravidarum
Serum adenosine deaminase activity in women with hyperemesis gravidarum.
Hyperemesis Gravidarum
Serum levels of adenosine deaminase and pregnancy-related hormones in hyperemesis gravidarum.
Hyperemia
Adenosine deaminase attenuates norepinephrine-induced coronary functional hyperemia.
Hyperemia
Effect of adenosine deaminase on myocardial reactive hyperemia: preliminary report.
Hyperemia
Relative participation of adenosine and endothelium derived mediators in coronary reactive hyperemia in the dog.
Hyperemia
Role of adenosine for reactive hyperemia in normal and stunned porcine myocardium.
Hyperemia
Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure.
Hyperemia
Short-time adenosine deaminase interventions upon underperfused rat hearts in vitro--a test for the role of adenosine in the coronary flow control.
Hyperemia
Systemic adenosine deaminase administration does not reduce active hyperemia in running rats.
Hyperglycemia
Hyperglycemia alters E-NTPDases, ecto-5'-nucleotidase, and ectosolic and cytosolic adenosine deaminase activities and expression from encephala of adult zebrafish (Danio rerio).
Hyperglycemia
The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients.
Hyperhomocysteinemia
[Effect of thiolactone homocysteine loading on adenosine metabolism in rats: relationship with platelet hyper-reactivity, correction of this metabolism disorders by vitamin-microelement complex]
Hyperlipoproteinemia Type II
Human gene therapy for hereditary diseases: a review of trials.
Hyperoxaluria, Primary
Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
Hyperoxaluria, Primary
Primary hyperoxaluria and adenosine deaminase deficiency without immunodeficiency.
Hypersensitivity
Adenosine deaminase levels in construction workers with asbestos contact dermatitis.
Hypersensitivity
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938.
Hypersensitivity
Sustained Elevated Adenosine via ADORA2B Promotes Chronic Pain through Neuro-immune Interaction.
Hypertension
A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-?.
Hypertension
Adenosine deaminase activity in subjects with normal pregnancy, pregnancy induced hypertension and pre-eclampsia.
Hypertension
Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats.
Hypertension
Extracts from Almond (Terminalia catappa) leaf and stem bark mitigate the activities of crucial enzymes and oxidative stress associated with hypertension in cyclosporine A-stressed rats.
Hypertension
Intrarenal adenosine produces hypertension via renal nerves in the one-kidney, one clip rat.
Hypertension
Platelet aggregation and serum adenosine deaminase (ADA) activity in pregnancy associated with diabetes, hypertension and HIV.
Hypertension
Swimming training prevents alterations in ecto-NTPDase and adenosine deaminase activities in lymphocytes from N?-nitro-L-arginine methyl ester hydrochloride induced hypertension rats.
Hypertension, Pregnancy-Induced
Adenosine deaminase activity in subjects with normal pregnancy, pregnancy induced hypertension and pre-eclampsia.
Hyperthyroidism
Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Hyperthyroidism
Effect of thyroid status on alpha- and beta-catecholamine responsiveness of hamster adipocytes.
Hyperthyroidism
Hyperthyroidism increases adenosine transport and metabolism in the rat heart.
Hyperthyroidism
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Hyperthyroidism
Reduced binding and antilipolytic effect of prostaglandin E2 in adipocytes from patients with hyperthyroidism.
Hyperthyroidism
Short-term hyperthyroidism modulates adenosine receptors and catalytic activity of adenylate cyclase in adipocytes.
Hyperthyroidism
The effect of adenosine deaminase inhibition on the A1 adenosinergic and M2 muscarinergic control of contractility in eu- and hyperthyroid guinea pig atria.
Hyperthyroidism
[The effect of somatotropin on adenosine deaminase activity in tissues of rats with hypo- and hyperthyroidism]
Hypothyroidism
Autoimmune thyroiditis and acquired hypothyroidism in an infant with severe combined immunodeficiency due to adenosine deaminase deficiency.
Hypothyroidism
Changes in the activities of adenosine-metabolizing enzymes in six regions of the rat brain on chemical induction of hypothyroidism.
Hypothyroidism
Effect of adenosine deaminase, N6-phenylisopropyladenosine and hypothyroidism on the responsiveness of rat brown adipocytes to noradrenaline.
Hypothyroidism
Enzymes involved in adenosine metabolism in rat white and brown adipocytes. Effects of streptozotocin-diabetes, hypothyroidism, age and sex differences.
Hypothyroidism
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Hypothyroidism
Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.
Hypothyroidism
Quercetin changes purinergic enzyme activities and oxidative profile in platelets of rats with hypothyroidism.
hypoxanthine phosphoribosyltransferase deficiency
Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.
hypoxanthine phosphoribosyltransferase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
hypoxanthine phosphoribosyltransferase deficiency
Use of intact erythrocytes in the diagnosis of inherited purine and pyrimidine disorders.
Ileitis
Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis.
Immune System Diseases
First trimester diagnosis of Lesch-Nyhan syndrome: applications to other disorders of purine metabolism.
Immunoglobulin G4-Related Disease
IgG4-related disease manifesting as pericarditis with elevated adenosine deaminase and IL-10 levels in pericardial fluid.
Immunoglobulin G4-Related Disease
IgG4-related disease with elevated adenosine deaminase in pleural effusion diagnosed clinically using thoracoscopy under local anesthesia and FDG-PET-CT.
Immunoglobulin G4-Related Disease
IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report.
Immunoglobulin G4-Related Disease
Long-term spontaneous remission with active surveillance in IgG4-related pleuritis: A case report and literature review.
Infarction, Middle Cerebral Artery
[The role of adenosine deaminase in the electroacupuncture preconditioning induced rapid tolerance to focal cerebral ischemia].
Infections
Activity of the enzyme adenosine deaminase in serum, erythrocytes and lymphocytes of rats infected with Trypanosoma evansi.
Infections
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.
Infections
Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.
Infections
Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.
Infections
Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.
Infections
Adenosine deaminase, acquired immunodeficiency syndrome (AIDS), and hepatitis B infection.
Infections
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.
Infections
Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
Infections
Comparison of an adenosine deaminase assay with ELISA for the diagnosis of tuberculous meningitis infection.
Infections
Concurrent small bowel lymphoma and mycobacterial infection: use of adenosine deaminase activity and polymerase chain reaction to facilitate rapid diagnosis and treatment.
Infections
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
Infections
Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
Infections
Curcumin pre-treatment modulate the activities of adenine nucleotide and nucleoside degradation enzymes in lymphocyte of rats infected with Trypanosoma evansi.
Infections
Cutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate--a case report & review of the literature.
Infections
Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting.
Infections
Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency.
Infections
Ectonucleotidases and adenosine deaminase activity in laying hens naturally infected by Salmonella Gallinarum and their effects on the pathogenesis of the disease.
Infections
Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection.
Infections
Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae.
Infections
Elevated Adenosine Deaminase in Pleural Effusion A Case of Non-Hodgkin Lymphoma Misdiagnosis.
Infections
Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
Infections
Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Infections
Experimental infection of cattle with Listeria monocytogenes: Participation of purinergic metabolism in disease pathogenesis.
Infections
Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing.
Infections
Extracellular adenosine modulates host-pathogen interactions through regulation of systemic metabolism during immune response in Drosophila.
Infections
Genome-block expression-assisted association studies discover malaria resistance genes in Anopheles gambiae.
Infections
Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia.
Infections
Host resistance to murine malaria in mice exposed to the adenosine deaminase inhibitor, 2'-deoxycoformycin.
Infections
IgG4-related disease manifesting as pericarditis with elevated adenosine deaminase and IL-10 levels in pericardial fluid.
Infections
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
Infections
Impacts of Escherichia coli infection in young breeder chicks on the animal behavior and cerebral activity of purinergic and cholinergic enzymes involved in the regulation of molecules with neurotransmitter and neuromodulator function.
Infections
Improving the accuracy of synovial fluid analysis in the diagnosis of prosthetic joint infection with simple and inexpensive biomarkers: C-reactive protein and adenosine deaminase.
Infections
Increased plasma adenosine deaminase activity in the early phase of Legionella pneumophila infection in guinea pigs.
Infections
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.
Infections
Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors.
Infections
Lymphocytic ascites with high adenosine deaminase levels secondary to Chlamydia trachomatis infection.
Infections
Mucosal adenosine deaminase activity and gastritis histology: a comparative study of partially resected and intact stomachs.
Infections
Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong.
Infections
Pearls & Oy-sters: chronic mumps meningoencephalitis with low CSF glucose and acute hydrocephalus in an adult.
Infections
Plasma Adenosine Deaminase Enzyme Reduces with Treatment of Pulmonary Tuberculosis in Nigerian Patients: Indication for Diagnosis and Treatment Monitoring.
Infections
Prognostic significance of adenosine deaminase determinations in subjects with the lymphoadenopathy syndrome.
Infections
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy.
Infections
Serum adenosine deaminase 2 and neopterin levels are increased in a majority of hemophiliacs irrespective of infection with human immunodeficiency virus type 1.
Infections
Serum adenosine deaminase levels in intravenous drug users with and without infection due to human immunodeficiency virus.
Infections
Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection.
Infections
Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
Infections
Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis.
Infections
The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Infections
Tissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strains.
Infections
Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Infections
Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
Infections
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol.
Infections
Tuberculous pleurisy mimicking Mycoplasma pneumoniae infection in a previously healthy young adult: A case report.
Infections
Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascites.
Infections
Usefulness of Adenosine Deaminase Assay in Diagnosis of Patients with HIV Infection and Pleural Tuberculosis.
Infections
[Adenosine deaminase deficiency associated severe combined immunodeficiency with disseminated varicella infection after vaccination: a case report]
Infections
[Adenosine deaminase in differential diagnosis of peripheral lymph node tuberculosis]
Infections
[Further contribution to the study of the adenosine deaminase activity of the blood during typhoid infection]
Infectious Mononucleosis
Adenosine deaminase, purine nucleoside phosphorylase and 5'-nucleotidase activities in infectious mononucleosis.
Infertility
Sperm DNA Integrity in Leukocytospermia and Its Association with Seminal Adenosine Deaminase.
Inflammatory Bowel Diseases
Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease.
Inflammatory Bowel Diseases
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
Insulin Resistance
Alterations in response of rat white adipocytes to insulin, noradrenaline, corticotropin and glucagon after adrenalectomy. Correction of these changes by adenosine deaminase.
Insulin Resistance
Cellular cyclic AMP levels modulate insulin sensitivity and responsiveness--evidence against a significant role of Gi in insulin signal transduction.
Insulin Resistance
Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat.
Insulin Resistance
Effects of coenzyme Q10 supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial.
Insulin Resistance
Effects of insulin and norepinephrine on glucose transport and metabolism in rat brown adipocytes. Potentiation by insulin of norepinephrine-induced glucose oxidation.
Insulin Resistance
In vitro effect of adenosine agonist GR79236 on the insulin sensitivity of glucose utilisation in rat soleus and human rectus abdominus muscle.
Insulin Resistance
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Insulin Resistance
Insulin-induced subcellular redistribution of insulin-like growth factor II receptors in the rat adipose cell. Counterregulatory effects of isoproterenol, adenosine, and cAMP analogues.
Insulin Resistance
Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes.
Insulin Resistance
Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.
Insulin Resistance
Reversal of dietary-induced insulin resistance in muscle of the rat by adenosine deaminase and an adenosine-receptor antagonist.
Insulin Resistance
Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity.
Insulin Resistance
Suppression of uric acid and lactate production by sodium acetate ameliorates hepatic triglyceride accumulation in fructose-insulin resistant pregnant rats.
Insulin Resistance
Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes.
Insulin Resistance
The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients.
Intellectual Disability
Association of adenosine deaminase polymorphism with mild mental retardation.
Intellectual Disability
Mutation in ADAT3, encoding adenosine deaminase acting on transfer RNA, causes intellectual disability and strabismus.
Intellectual Disability
Novel Missense Variants in ADAT3 as a Cause of Syndromic Intellectual Disability.
Iron Overload
Iron overload as a result of transfusion therapy in a patient with adenosine deaminase deficiency.
Ischemic Stroke
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Ischemic Stroke
Recent developments and new frontiers in childhood arterial ischemic stroke.
Jaundice, Neonatal
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase.
Keratitis
Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
Kidney Failure, Chronic
Study of the activity of lymphocyte adenosine deaminase in chronic renal failure.
Kidney Failure, Chronic
[Adenosine deaminase is useful for the diagnosis of peritoneal tuberculosis in patients with end-stage renal failure]
Kidney Neoplasms
The antigen identified by a mouse monoclonal antibody raised against human renal cancer cells is the adenosine deaminase binding protein.
Laryngeal Neoplasms
Adenosine deaminase and 5'-nucleotidase activities in saliva from patients with oral and laryngeal cancer.
Laryngeal Neoplasms
Adenosine deaminase and purine phosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx.
Laryngeal Neoplasms
Serum adenosine deaminase and total superoxide dismutase activities before and after surgical removal of cancerous laryngeal tissue.
Leg Ulcer
Chronic leg ulcer revealing adenosine deaminase 2 deficiency: an atypical presentation.
Legionnaires' Disease
High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires' disease.
Legionnaires' Disease
Increased plasma adenosine deaminase activity in the early phase of Legionella pneumophila infection in guinea pigs.
Leiomyoma
Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature.
Leishmaniasis
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
Leishmaniasis, Cutaneous
Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis.
Leishmaniasis, Visceral
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.
Leishmaniasis, Visceral
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal.
Leishmaniasis, Visceral
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
Leishmaniasis, Visceral
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
Leishmaniasis, Visceral
Increased level of soluble adenosine deaminase in bone marrow of visceral leishmaniasis patients: an inverse relation with parasite load.
Leishmaniasis, Visceral
Serum nitrite level and adenosine deaminase activity is altered in visceral leishmaniasis.
Leprosy
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.
Leprosy
Lymphocyte adenosine deaminase activity (L-ADA) in leprosy, during and after treatment of reactions.
Leprosy, Multibacillary
Adenosine deaminase activity in serum and lymphocytes of multibacillary leprosy patients.
Lesch-Nyhan Syndrome
Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.
Lesch-Nyhan Syndrome
Use of intact erythrocytes in the diagnosis of inherited purine and pyrimidine disorders.
Leukemia
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.
Leukemia
A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Leukemia
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Leukemia
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
Leukemia
Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Leukemia
Adenosine deaminase (ADA) in leukemia: clinical value of plasma ADA activity and characterization of leukemic cell ADA.
Leukemia
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Leukemia
Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia.
Leukemia
Adenosine deaminase and purine nucleoside phosphorylase in acute and chronic lymphatic leukemia.
Leukemia
Adenosine deaminase and purine nucleoside phosphorylase levels in acute myeloblastic leukemia cells. Relationship to diagnosis and clinical course.
Leukemia
Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia.
Leukemia
Adenosine metabolism in plasma and platelets. IV. Elevated plasmatic adenosine deaminase activity, impaired platelet 14C-adenosine incorporation and hemostatic dysfunction in chronic myeloid leukemia.
Leukemia
Analysis by high-pressure liquid chromatography of 9-beta-D-arabinofuranosyladenine 5'-triphosphate levels in murine leukemia cells.
Leukemia
Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.
Leukemia
Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Leukemia
Biochemical and biophysical approaches to improving the anticancer effectiveness of Ara-adenine.
Leukemia
Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Leukemia
Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
Leukemia
Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Leukemia
Changes in the activities of cytidine deaminase during differentiation of HL60 cells induced by 1,25 dihydroxy D3.
Leukemia
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Leukemia
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Leukemia
Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
Leukemia
Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Leukemia
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Leukemia
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
Leukemia
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
Leukemia
Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy.
Leukemia
Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb3+ Complex.
Leukemia
Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
Leukemia
Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Leukemia
Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
Leukemia
Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.
Leukemia
Enhancement of the antitumor activity of N6-(delta 2-isopentenyl)adenosine against cultured L-1210 leukemia cells by pentostatin using a polymeric delivery system.
Leukemia
Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Leukemia
Enzymatic differences between chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia
Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity.
Leukemia
Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Leukemia
Hairy cell leukemia: a successful model for experimental therapeutics--pentostatin and new ideas.
Leukemia
Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Leukemia
Improved production of pentostatin and identification of fermentation cometabolites.
Leukemia
Increased cytotoxicity of N6-(delta 2-isopentenyl)adenosine in combination with pentostatin against L-1210 leukemia cells.
Leukemia
Induction of adenosine deaminase and 5' nucleotidase activity in cultured human blood monocytes and monocytic leukemia (THP-1) cells by differentiating agents.
Leukemia
Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Leukemia
Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.
Leukemia
Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors.
Leukemia
Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Leukemia
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
Leukemia
Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia.
Leukemia
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
Leukemia
PORPHOBILINOGEN DEAMINASE AND ADENOSINE DEAMINASE ACTIVITY AS A POSSIBLE DIAGNOSTIC AID IN LYMPHATIC LEUKEMIAS.
Leukemia
Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Leukemia
Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo.
Leukemia
Relationship between adenosine deaminase and a human thymus leukemia antigen isolated from MOLT 4 cells.
Leukemia
Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.
Leukemia
Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo.
Leukemia
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Leukemia
Surface adenosine deaminase. A novel B-cell marker in chronic lymphocytic leukemia.
Leukemia
Synthesis and biological properties of 9-(trans-4-hydroxy-2-buten-1-yl)adenine and guanine: open-chain analogues of neplanocin A.
Leukemia
[Activity of adenosine deaminase in the blood serum of children. II. Activity of adenosine deaminase in leukemias in children.]
Leukemia
[Adenosine deaminase activity in blood cells; influence of cytostatic therapy in patients with acute leukemia and with renal transplants (author's transl)]
Leukemia
[Adenosine deaminase activity in blood plasma, erythrocytes and lymphocytes in leukemias]
Leukemia
[Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants]
Leukemia
[The Auxiliary Diagnostic Value of Serum Adenosine Deaminase in Acute Leukemia at Clinical Test].
Leukemia L1210
Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
Leukemia L1210
Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Leukemia L1210
In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Leukemia L1210
Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo.
Leukemia L1210
Synthesis and biological properties of 9-(trans-4-hydroxy-2-buten-1-yl)adenine and guanine: open-chain analogues of neplanocin A.
Leukemia, Hairy Cell
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
Leukemia, Hairy Cell
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Leukemia, Hairy Cell
Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Leukemia, Hairy Cell
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
Leukemia, Hairy Cell
Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
Leukemia, Hairy Cell
Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem.
Leukemia, Hairy Cell
Improved production of pentostatin and identification of fermentation cometabolites.
Leukemia, Hairy Cell
Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Leukemia, Hairy Cell
Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia.
Leukemia, Hairy Cell
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
Leukemia, Hairy Cell
Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes.
Leukemia, Lymphocytic, Chronic, B-Cell
Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects.
Leukemia, Lymphocytic, Chronic, B-Cell
Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.
Leukemia, Lymphocytic, Chronic, B-Cell
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment.
Leukemia, Lymphocytic, Chronic, B-Cell
Adenosine deaminase and purine nucleoside phosphorylase in acute and chronic lymphatic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Deoxyribonucleoside triphosphate accumulation by leukemic cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymatic differences between chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymological studies in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
Leukemia, Lymphocytic, Chronic, B-Cell
Intralymphocytic adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNPase) activity in chronic lymphocytic leukemia (CLL): effect of thymostimulin.
Leukemia, Lymphocytic, Chronic, B-Cell
Patterns of adenosine deaminase, ecto-5'-nucleotidase, poly(A)polymerase and surface light chain expression in chronic lymphocytic leukemias.
Leukemia, Lymphocytic, Chronic, B-Cell
Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Purine nucleoside phosphorylase in chronic lymphocytic leukemia (CLL).
Leukemia, Lymphocytic, Chronic, B-Cell
Surface adenosine deaminase. A novel B-cell marker in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Leukemia, Lymphocytic, Chronic, B-Cell
[Enzymes of purine nucleotide catabolism in lymphocytes in normal states and in chronic lymphoid leukemia]
Leukemia, Lymphoid
Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemia.
Leukemia, Lymphoid
Enhancement of the antitumor activity of N6-(delta 2-isopentenyl)adenosine against cultured L-1210 leukemia cells by pentostatin using a polymeric delivery system.
Leukemia, Lymphoid
Surface adenosine deaminase. A novel B-cell marker in chronic lymphocytic leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
A biological marker model for predicting disease transitions.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Adenosine deaminase and terminal deoxynucleotidyl transferase: biochemical markers in the management of chronic myelogenous leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Adenosine metabolism in plasma and platelets. IV. Elevated plasmatic adenosine deaminase activity, impaired platelet 14C-adenosine incorporation and hemostatic dysfunction in chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Differential expression of adenosine deaminase isozymes in acute leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Combination assay of IAP and ADA in hematologic malignancies]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Comparative characteristics of the catalytic properties of platelet adenosine deaminase in normal states and in chronic myeloid leukemia]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Diagnosis and treatment of Gaucher disease in Croatia]
Leukemia, Myeloid
Adenosine metabolism in plasma and platelets. IV. Elevated plasmatic adenosine deaminase activity, impaired platelet 14C-adenosine incorporation and hemostatic dysfunction in chronic myeloid leukemia.
Leukemia, Myeloid, Acute
2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.
Leukemia, Myeloid, Acute
Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature.
Leukemia, Myeloid, Acute
Adenosine deaminase and purine nucleoside phosphorylase levels in acute myeloblastic leukemia cells. Relationship to diagnosis and clinical course.
Leukemia, Myeloid, Acute
Purine degradative enzymes and terminal transferase in acute myelogenous leukemia: clinical relevance.
Leukemia, Myeloid, Acute
[Serum adenosine deaminase and its isozyme activity in leukemia and MDS]
Leukemia, Prolymphocytic
Enzymatic differences between chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia, Prolymphocytic
Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
Leukemia, Prolymphocytic
Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Leukemia, T-Cell
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Leukemia, T-Cell
Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
Leukemia, T-Cell
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Leukemia, T-Cell
Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
Leukemia-Lymphoma, Adult T-Cell
Adenosine deaminase in plasma of patients with adult T-cell leukemia (ATL): correlation between enzyme activity and the ATL subtypes.
Leukemia-Lymphoma, Adult T-Cell
Genetic analysis of adenosine deaminase expression in adult T-cell leukemia.
Leukocytosis
Longitudinal cerebrospinal fluid assessment in a patient with tuberculous meningitis-A case report.
Leukocytosis
Self-remitting Elevation of Adenosine Deaminase Levels in the Cerebrospinal Fluid with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report and Review of the Literature.
Leukocytosis
[A case of listeria meningitis showed high levels of adenosine deaminase in cerebrospinal fluid]
Leukopenia
[Clinical characteristics of lung NK/T cell lymphoma misdiagnosed as pneumonia].
Lipodystrophy
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
Liposarcoma
Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies.
Livedo Reticularis
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Livedo Reticularis
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab.
Livedo Reticularis
Vasculitic peripheral neuropathy in deficiency of adenosine deaminase 2.
Liver Abscess, Amebic
Decreased adenosine deaminase activity in peripheral lymphocytes of patients suffering from amebic liver abscess.
Liver Cirrhosis
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.
Liver Cirrhosis
Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease.
Liver Cirrhosis
[Correlation between serum adenosine deaminase, peripheral T lymphocyte subsets and syndrome types of traditional Chinese medicine in liver-cirrhosis patients]
Liver Cirrhosis
[Determination of serum adenosine deaminase: its diagnostic value in jaundice and liver fibrosis]
Liver Cirrhosis
[Enzymatic activity of serum adenosine deaminase in different liver disorders]
Liver Cirrhosis
[Value of adenosine deaminase as indicator of tuberculosis in ascites fluid in a case of liver cirrhosis]
Liver Cirrhosis, Alcoholic
Blunted anti-inflammatory response to adenosine in alcoholic cirrhosis.
Liver Cirrhosis, Alcoholic
Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis.
Liver Diseases
Different levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease.
Liver Diseases
Lymphocyte adenosine deaminase levels in active and in inactive forms of HBsAg-positive chronic liver disease.
Liver Diseases
Observations on serum adenosine deaminase activity in experimentally produced liver diseases of cattle and sheep: yellow-wood, lantana, carbon tetrachloride and chronic copper poisoning.
Liver Diseases
Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.
Liver Diseases
Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease.
Liver Diseases
Serum adenosine deaminase, 5' nucleotidase and malondialdehyde in acute infective hepatitis.
Liver Diseases
[Adenosine deaminase activity--an indicator of inflammation in liver disease]
Liver Diseases
[Clinical characteristics of lung NK/T cell lymphoma misdiagnosed as pneumonia].
Liver Diseases
[Clinical significance of measurement of serum adenosine deaminase activity in patients with various liver diseases]
Liver Diseases
[Enzymatic activity of serum adenosine deaminase in different liver disorders]
Liver Diseases
[Serum adenosine deaminase in acute viral hepatitis and chronic liver diseases]
Liver Failure
Activation of AMP deaminase and adenosine deaminase in the liver during ammonia poisoning and hepatitis.
Liver Failure
Hyperbilirubinemia and Rapid Fatal Hepatic Failure in Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency (ADA-SCID).
Lung Diseases
Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases.
Lung Diseases
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
Lung Diseases
Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor.
Lung Diseases
Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice.
Lung Diseases
Non-infectious Lung Disease in Patients with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
Lung Diseases
Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.
Lung Diseases
[Changes in adenosine deaminase and antioxidative enzyme activity in patients with lung diseases of dust etiology]
Lung Injury
Endothelial cell-specific deficiency of the adenosine deaminase ADAR1 aggravates LPS-induced lung injury in mice via an MDA5-independent pathway.
Lung Injury
Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26.
Lung Neoplasms
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Lung Neoplasms
Adenosine deaminase and purine nucleoside phosphorylase activities in lymphocytes from patients with lung cancer.
Lung Neoplasms
Changes in lymphocyte adenosine deaminase and purine nucleoside phosphorylase levels in lung cancer after radical surgery.
Lung Neoplasms
Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.
Lung Neoplasms
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Lung Neoplasms
Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets.
Lung Neoplasms
Multienzyme patterns of serum adenosine deaminase by agar gel electrophoresis: an evaluation of the diagnostic value in lung cancer.
Lung Neoplasms
RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers.
Lung Neoplasms
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes.
Lung Neoplasms
The diagnostic value of adenosine deaminase activity in sputum in pulmonary tuberculosis.
Lung Neoplasms
The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene.
Lung Neoplasms
Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Lupus Erythematosus, Systemic
A clinical score to guide in decision making for monogenic type I IFNopathies.
Lupus Erythematosus, Systemic
Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
Lupus Erythematosus, Systemic
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28.
Lupus Erythematosus, Systemic
Pleural fluid adenosine deaminase in rheumatoid arthritis and systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Lupus Erythematosus, Systemic
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.
Lupus Erythematosus, Systemic
Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern.
Lupus Erythematosus, Systemic
Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity.
Lupus Erythematosus, Systemic
Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus.
Lymphadenopathy
Development of a clinical prediction rule for the diagnosis of pleural tuberculosis in Peru.
Lymphadenopathy
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
Lymphadenopathy
[Adenosine deaminase in differential diagnosis of peripheral lymph node tuberculosis]
Lymphocytosis
[A case of tuberculous meningitis with pleural effusion as a manifestation of a paradoxical reaction during anti-tuberculosis therapy].
Lymphocytosis
[A case of tuberculous pleurisy distinguished from pleurisy caused by Mycoplasma infection].
Lymphohistiocytosis, Hemophagocytic
A novel mutation of adenosine deaminase causing SCID presenting as hemophagocytic lymphohistiocytosis with acute kidney injury.
Lymphohistiocytosis, Hemophagocytic
Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
Lymphohistiocytosis, Hemophagocytic
[The clinical significance of serum neopterin and adenosine deaminase in patients with secondary hemophagocytic lymphohistiocytosis].
Lymphoma
A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Lymphoma
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Lymphoma
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Lymphoma
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
Lymphoma
Adenosine deaminase and terminal deoxynucleotidyl transferase in human lymphomas: an aid to the diagnosis and subclassification of lymphoblastic lymphomas.
Lymphoma
Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes.
Lymphoma
CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
Lymphoma
CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
Lymphoma
Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
Lymphoma
Concurrent small bowel lymphoma and mycobacterial infection: use of adenosine deaminase activity and polymerase chain reaction to facilitate rapid diagnosis and treatment.
Lymphoma
Diagnostic significance of adenosine deaminase in pleural effusate for primary effusion lymphoma-like lymphoma.
Lymphoma
Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Lymphoma
Immunohistochemical localization of adenosine deaminase in human lymphoid tissues and lymphomas.
Lymphoma
In-situ activated macrophages are involved in host-resistance to lymphoma metastasis by production of nitric-oxide.
Lymphoma
Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Lymphoma
Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow.
Lymphoma
Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.
Lymphoma
Modulation of adenine nucleoside excretion and incorporation in adenosine deaminase deficient human lymphoma cells.
Lymphoma
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
Lymphoma
Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
Lymphoma
Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Lymphoma
Simultaneous assay of adenosine deaminase and purine nucleoside phosphorylase activity as possible biochemical means to detect non-Hodgkin lymphomas of the oral cavity.
Lymphoma
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
Lymphoma
[A case of natural killer cell lymphoma with high adenosine deaminase level in pleural effusion]
Lymphoma, B-Cell
Immunohistochemical localization of adenosine deaminase in human benign extrathymic lymphoid tissues and B-cell lymphomas.
Lymphoma, B-Cell
Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor.
Lymphoma, Large B-Cell, Diffuse
Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Lymphoma, Large B-Cell, Diffuse
Increased level of ribonucleotide reductase in deoxyadenosine resistant adenosine deaminase deficient human histiocytic lymphoma cells.
Lymphoma, Large-Cell, Anaplastic
CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
Lymphoma, Non-Hodgkin
Adenosine deaminase activity in pleural effusions of lymphoma patients.
Lymphoma, Non-Hodgkin
Elevated Adenosine Deaminase in Pleural Effusion A Case of Non-Hodgkin Lymphoma Misdiagnosis.
Lymphoma, Non-Hodgkin
Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: An unusual presentation.
Lymphoma, Non-Hodgkin
Pyrimidine and purine activities in non-Hodgkin's lymphoma. Correlation with histological status and survival.
Lymphoma, T-Cell
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Lymphoma, T-Cell
Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells.
Lymphoma, T-Cell
CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin's lymphoma.
Lymphoma, T-Cell
Transient stimulatory adenosine deaminase activity in peripheral lymphocyte lysates from a case of T-cell lymphoma.
Lymphoma, T-Cell, Cutaneous
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
Lymphoma, T-Cell, Cutaneous
Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
Lymphopenia
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
Lymphopenia
Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.
Lymphopenia
Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
Lymphopenia
Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
Lymphopenia
Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.
Lymphopenia
Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia.
Lymphopenia
Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Lymphopenia
Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Lymphopenia
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
Lymphopenia
Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).
Lymphopenia
Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
Lymphopenia
Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Lymphopenia
[Adenosine deaminase 1 deficiency, an inborn error of metabolism underlying a severe form of combined immunodeficiency].
Lymphoproliferative Disorders
A new mixed inhibitor of adenosine deaminase produced by endophytic Cochliobolus sp. from medicinal plant seeds.
Lymphoproliferative Disorders
Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues.
Lymphoproliferative Disorders
Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.
Lymphoproliferative Disorders
Purine nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) activities examined cytochemically in unfixed lymphocytes of patients with lymphoproliferative disorders.
Lymphoproliferative Disorders
Reynoutria Japonica from Traditional Chinese Medicine: A Source of Competitive Adenosine Deaminase Inhibitors for Anticancer.
Macrophage Activation Syndrome
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Macrophage Activation Syndrome
Old Dogs, New Tricks: Monogenic Autoinflammatory Disease Unleashed.
Malaria
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.
Malaria
Adenosine deaminase in malaria infected erythrocytes: unique parasite enzyme presents a new therapeutic target.
Malaria
Host resistance to murine malaria in mice exposed to the adenosine deaminase inhibitor, 2'-deoxycoformycin.
Malaria
Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture.
Malaria
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivity.
Malaria
Studies on biochemical changes with special reference to oxidant and antioxidants in malaria patients.
Malaria
The deamination of adenosine and adenosine monophosphate in Plasmodium falciparum-infected human erythrocytes: in vitro use of 2'deoxycoformycin and AMP deaminase-deficient red cells.
Malaria, Cerebral
Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.
Malaria, Vivax
Serum erythrocyte and leukocyte adenosine deaminase activities in patients with vivax malaria in Turkey.
Malnutrition
Effect of undernutrition on some enzymes of purine metabolism in different regions of developing rat brain.
Maple Syrup Urine Disease
Evaluation of the expanded newborn screening program in New York City.
Measles
Measles Virus Defective Interfering RNAs Are Generated Frequently and Early in the Absence of C Protein and Can Be Destabilized by Adenosine Deaminase Acting on RNA-1-Like Hypermutations.
Measles
RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.
Measles
RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Measles
Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1.
Melanoma
1?, 25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells.
Melanoma
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Melanoma
Adenosine deaminase activity in lymphocyte subpopulations of B-16 melanoma and normal C57BL bearing mice.
Melanoma
Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
Melanoma
High-sensitivity capillary electrophoresis method for monitoring purine nucleoside phosphorylase and adenosine deaminase reactions by a reversed electrode polarity switching mode.
Melanoma
Nucleotide-metabolism and chromosome alterations in human-malignant melanoma xenografts.
Melanoma
Reinforcement of antitumor effect of Cordyceps sinensis by 2'-deoxycoformycin, an adenosine deaminase inhibitor.
Melanoma
Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.
Melanoma
The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
Meningeal Carcinomatosis
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Meningitis
A Hospital Based Study on Estimation of Adenosine Deaminase Activity (ADA) in Cerebrospinal Fluid (CSF) in Various Types of Meningitis.
Meningitis
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults.
Meningitis
Adenosine deaminase activity in cerebrospinal fluid and serum for the diagnosis of tuberculous meningitis.
Meningitis
Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis.
Meningitis
Adenosine deaminase and C-reactive protein in cerebrospinal fluid for differential diagnosis of tubercular meningitis in children.
Meningitis
Adenosine deaminase concentration in cerebrospinal fluid during brucella meningitis.
Meningitis
Adenosine deaminase levels in cerebrospinal fluid as a diagnostic test for tuberculous meningitis in children.
Meningitis
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Meningitis
Cerebrospinal fluid C reactive protein and adenosine deaminase in meningitis in adults.
Meningitis
Comparative analysis of cerebrospinal fluid adenosine deaminase activity in meningitis.
Meningitis
Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis.
Meningitis
Comparative study of cerebrospinal fluid adenosine deaminase activity in patients with meningitis.
Meningitis
Determination of cerebrospinal fluid adenosine deaminase activity cut-off for the diagnosis of tuberculous meningitis in Hong Kong.
Meningitis
Elevated cerebrospinal fluid adenosine deaminase levels in patients with meningitis caused by varicella-zoster virus.
Meningitis
Elevation of CSF adenosine deaminase in HIV patient with meningitis from retroviral rebound syndrome, a case report.
Meningitis
Evaluation of Cerebrospinal Fluid Adenosine Deaminase Activity for the Differential Diagnosis of Tuberculous and Nontuberculous Meningitis.
Meningitis
Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation.
Meningitis
Significance of cerebrospinal fluid adenosine deaminase isoenzymes in tuberculous (TB) meningitis.
Meningitis
The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults.
Meningitis
The value of CSF adenosine deaminase levels in the differential diagnosis of childhood meningitis.
Meningitis
[Adenosine deaminase in the complex diagnosis of different forms of extrapulmonary tuberculosis]
Meningitis
[Diagnosis of tuberculosis meningitis by detection of adenosine deaminase activity and amplification of nucleotide sequences with PCR]
Meningitis
[Meningitis caused by Listeria monocytogenes with high levels of adenosine deaminase.]
Meningitis
[The activities of 3 enzymes in serum and cerebrospinal fluid for diagnosis of tuberculous meningitis]
Meningitis, Aseptic
Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis.
Meningitis, Aseptic
Adenosine deaminase and C-reactive protein in cerebrospinal fluid for differential diagnosis of tubercular meningitis in children.
Meningitis, Aseptic
Adenosine deaminase levels in cerebrospinal fluid as a diagnostic test for tuberculous meningitis in children.
Meningitis, Aseptic
Adenosine deaminase levels in cerebrospinal fluid in the diagnosis of tuberculous meningitis.
Meningitis, Aseptic
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Meningitis, Aseptic
[Aseptic meningitis with elevated adenosine deaminase (ADA) after interruption of antiretroviral treatment.]
Meningitis, Bacterial
Adenosine deaminase levels in cerebrospinal fluid in the diagnosis of tuberculous meningitis.
Meningitis, Bacterial
Adenosine deaminase levels in cerebrospinal fluid in tuberculosis and bacterial meningitis.
Meningitis, Bacterial
Cerebrospinal fluid adenosine deaminase activity and C-reactive protein in tuberculous and partially treated bacterial meningitis.
Meningitis, Bacterial
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Meningitis, Bacterial
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children.
Meningitis, Bacterial
Diagnostic value of cerebrospinal fluid adenosine deaminase determination.
Meningitis, Bacterial
Prognostic significance of cerebrospinal fluid adenosine deaminase in acute bacterial meningitis.
Meningitis, Bacterial
Revival of old diagnostic markers in the cerebrospinal fluid for the detection of infectious meningitis.
Meningitis, Bacterial
The value of CSF adenosine deaminase levels in the differential diagnosis of childhood meningitis.
Meningitis, Cryptococcal
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Meningitis, Cryptococcal
Cerebrospinal fluid adenosine deaminase levels in a patient with cryptococcal meningitis.
Meningitis, Cryptococcal
Cryptococcal meningitis associated with increased adenosine deaminase in the cerebrospinal fluid.
Meningitis, Cryptococcal
[Cryptococcal meningitis in patients with AIDS: combined treatment with amphotericin B and fluconazole, and high levels of adenosine deaminase in cerebrospinal fluid]
Meningitis, Listeria
A case of Listeria meningitis associated with increased adenosine deaminase in cerebrospinal fluid.
Meningitis, Listeria
[A case of listeria meningitis showed high levels of adenosine deaminase in cerebrospinal fluid]
Meningitis, Viral
Diagnostic value of cerebrospinal fluid adenosine deaminase determination.
Meningoencephalitis
A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid.
Meningoencephalitis
Pearls & Oy-sters: chronic mumps meningoencephalitis with low CSF glucose and acute hydrocephalus in an adult.
Meningoencephalitis
The value of CSF adenosine deaminase levels in the differential diagnosis of childhood meningitis.
Mesothelioma
A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser.
Mesothelioma
Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Mesothelioma
Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.
Mesothelioma
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Mesothelioma
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes.
Mesothelioma, Malignant
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Mesothelioma, Malignant
Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Mesothelioma, Malignant
Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.
Mesothelioma, Malignant
Role of biochemical tests in the diagnosis of exudative pleural effusions.
Metabolic Diseases
Determination of adenosine deaminase activity in dried blood spots by a nonradiochemical assay using reversed-phase high-performance liquid chromatography.
Metabolic Diseases
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
Metabolic Diseases
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Mevalonate Kinase Deficiency
Autoinflammatory diseases in childhood, part 1: monogenic syndromes.
Mevalonate Kinase Deficiency
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Mevalonate Kinase Deficiency
Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
Mucolipidoses
Electrophoretic analysis of glycoprotein enzymes in the sialidoses and mucolipidoses.
Multiple Sclerosis
Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
Multiple Sclerosis
Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.
Multiple Sclerosis
Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis.
Multiple Sclerosis
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Multiple Sclerosis
Multiple sclerosis showing elevation of adenosine deaminase levels in the cerebrospinal fluid.
Mumps
The value of CSF adenosine deaminase levels in the differential diagnosis of childhood meningitis.
Muscular Dystrophy, Duchenne
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores.
Myasthenia Gravis
High serum adenosine deaminase activity and its correlation with lymphocyte subsets in myasthenia gravis.
Myasthenia Gravis
Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis.
Mycoses
A prospective study of magnetic resonance imaging patterns of central nervous system infections in pediatric age group and young adults and their clinico-biochemical correlation.
Mycosis Fungoides
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Mycosis Fungoides
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma.
Mycosis Fungoides
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Myelitis
Tuberculous myelitis diagnosed by elevated adenosine deaminase activity in cerebrospinal fluid.
Myelodysplastic Syndromes
Biologic relevance of elevated red cell adenosine deaminase activity in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria.
Myelodysplastic Syndromes
Elevated red cell adenosine deaminase and haemolysis in a patient with a myelodysplastic syndrome.
Myeloproliferative Disorders
[Adenosine deaminase (ADA), 5'-nucleotidase (5'N) and purine nucleoside phosphorylase (PNP) in lympho- and myeloproliferative disorders]
Myocardial Infarction
Adenosine deaminase in ischemia reperfusion injury in patients with myocardial infarction.
Myocardial Infarction
Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction.
Myocardial Infarction
AMP deaminase, 5'-nucleotidase and adenosine deaminase in rat myocardial tissue in myocardial infarction and hypothermia.
Myocardial Infarction
Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size.
Myocardial Infarction
Erythrocyte adenosine deaminase as a marker of reperfusion injury in patients with myocardial infarction.
Myocardial Infarction
Erythrocytic adenosine deaminase in post myocardial infarction angina patients.
Myocardial Infarction
Evaluation of the roles of adenosine deaminase and xanthine oxidase in reperfusion injury in patients with myocardial infarction.
Myocardial Infarction
[The involvement of adenosine and adenosine deaminase in experimental myocardial infarct]
Myocardial Ischemia
Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.
Myocardial Stunning
Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects.
Myocardial Stunning
Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Myocardial Stunning
Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.
Myocardial Stunning
Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: Hot shot drug delivery before hypothermic cardioplegia.
Myocardial Stunning
Role of adenosine for reactive hyperemia in normal and stunned porcine myocardium.
Myocardial Stunning
Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.
Neoplasm Metastasis
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Neoplasm Metastasis
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
Neoplasm Metastasis
Decreased adenosine deaminase activity in peripheral lymphocytes from tumor patients with metastasis.
Neoplasm Metastasis
Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in prostate cancer patients: Influence of Gleason score, treatment and bone metastasis.
Neoplasm Metastasis
In-situ activated macrophages are involved in host-resistance to lymphoma metastasis by production of nitric-oxide.
Neoplasm Metastasis
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Neoplasm Metastasis
[Adenosine metabolism in lymphocytes and neurochemical stressor reactions in mice with metastatic Lewis carcinoma after surgical removal of the tumor]
Neoplasm Metastasis
[Enzymes of adenosine metabolism in lymphocytes and the functional state of the sympatho-adrenal system in tumor processes]
Neoplasm Metastasis
[The effect of Leu- and Met-enkephalins on the adenosine deaminase and 5'-nucleotidase activities of the lymphocytes under conditions of stress stimulation of metastasis]
Neoplasms
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Neoplasms
A Case of Askin's Tumor Presenting with Pleural Effusion and High Level of Adenosine Deaminase.
Neoplasms
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels.
Neoplasms
A fatal case of tuberculous meningitis in a child with juvenile idiopathic arthritis: a diagnostic challenge.
Neoplasms
A new mixed inhibitor of adenosine deaminase produced by endophytic Cochliobolus sp. from medicinal plant seeds.
Neoplasms
A phase I trial of alpha-interferon in combination with pentostatin in hematologic malignancies.
Neoplasms
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
Neoplasms
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults.
Neoplasms
Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Neoplasms
Acute effect of ?-sitosterol on calcium uptake mediates anti-inflammatory effect in murine activated neutrophils.
Neoplasms
ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.
Neoplasms
Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma.
Neoplasms
Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies.
Neoplasms
Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies.
Neoplasms
Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities.
Neoplasms
Adenosine deaminase activity: to be an useful marker in distinguishing pleural effusions due to malignancy from tuberculosis.
Neoplasms
Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.
Neoplasms
Adenosine deaminase and purine phosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx.
Neoplasms
Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.
Neoplasms
Adenosine deaminase in cell transformation. Biophysical manifestation of membrane dynamics.
Neoplasms
Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.
Neoplasms
Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Neoplasms
Adenosine deaminase, nucleoside phorphorylase and xanthine oxidase in liver tumours.
Neoplasms
Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate.
Neoplasms
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
Neoplasms
Age- and gender-specific epistasis between ADA and TNF-? influences human life-expectancy.
Neoplasms
Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer.
Neoplasms
Alterations in erythrocyte adenine nucleotide pools resulting from 2'-deoxycoformycin therapy.
Neoplasms
Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity.
Neoplasms
Are contemporary methods for somatic gene therapy suitable for clinical applications?
Neoplasms
Beneficial effect of Ageratum conyzoides Linn (Asteraceae) upon inflammatory response induced by carrageenan into the mice pleural cavity.
Neoplasms
CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
Neoplasms
Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor-specific variants.
Neoplasms
Chemopreventive task of capsaicin against benzo(a)pyrene-induced lung cancer in Swiss albino mice.
Neoplasms
Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
Neoplasms
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Neoplasms
Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion.
Neoplasms
Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
Neoplasms
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
Neoplasms
Decreased adenosine deaminase activity in peripheral lymphocytes from tumor patients with metastasis.
Neoplasms
Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.
Neoplasms
Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interlukine-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.
Neoplasms
Diagnostic Performance of Different Pleural Fluid Biomarkers in Tuberculous Pleurisy.
Neoplasms
Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis.
Neoplasms
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Neoplasms
Discrimination of exudative pleural effusions based on multiple biological parameters.
Neoplasms
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
Neoplasms
Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
Neoplasms
Ectonucleotide Pyrophosphatase/Phosphodiesterase (E-NPP) and Adenosine Deaminase (ADA) activities in patients with uterine cervix neoplasia.
Neoplasms
Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis.
Neoplasms
Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Neoplasms
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.
Neoplasms
Etanercept administration prevents the inflammatory response induced by carrageenan in the murine air pouch model.
Neoplasms
Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-? (TNF?) concentration in chronic heart failure.
Neoplasms
Evaluation of serum adenosine deaminase and 5'-nucleotidase activities as probable markers in ovarian cancer.
Neoplasms
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Neoplasms
Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein.
Neoplasms
Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
Neoplasms
Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
Neoplasms
Heterogeneity of isozyme expression in tumor cells does not correlate with metastatic potential.
Neoplasms
Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation.
Neoplasms
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.
Neoplasms
Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology.
Neoplasms
Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Neoplasms
Inhibition of the NF-?B and p38 MAPK pathways by scopoletin reduce the inflammation caused by carrageenan in the mouse model of pleurisy.
Neoplasms
Kinetics of some immunological and biochemical changes of immunocompetent cells during tumor growth in rats.
Neoplasms
Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
Neoplasms
Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.
Neoplasms
Merits of HPLC-based method over spectrophotometric method for assessing the kinetics and inhibition of mammalian adenosine deaminase.
Neoplasms
Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model.
Neoplasms
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
Neoplasms
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.
Neoplasms
Mycophenolate Mofetil Has Potent Anti-inflammatory Actions in a Mouse Model of Acute Lung Injury.
Neoplasms
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Neoplasms
New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions.
Neoplasms
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Neoplasms
On the regulatory role of dipeptidyl peptidase IV (=CD=adenosine deaminase complexing protein) on adenosine deaminase activity.
Neoplasms
Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
Neoplasms
Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong.
Neoplasms
Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR?125a and miR?10a expression.
Neoplasms
Oxidative stress parameters and inflammatory and immune mediators as markers of the severity of sepsis.
Neoplasms
Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
Neoplasms
Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy.
Neoplasms
Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
Neoplasms
Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments.
Neoplasms
Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis.
Neoplasms
PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy.
Neoplasms
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Neoplasms
Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
Neoplasms
Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
Neoplasms
Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity.
Neoplasms
Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
Neoplasms
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency.
Neoplasms
Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.
Neoplasms
Rapid, reliable, and sensitive detection of adenosine deaminase activity by UHPLC-Q-Orbitrap HRMS and its application to inhibitory activity evaluation of traditional Chinese medicines.
Neoplasms
Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Neoplasms
Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
Neoplasms
Repeated Electroacupuncture Persistently Elevates Adenosine and Ameliorates Collagen-Induced Arthritis in Rats.
Neoplasms
Reynoutria Japonica from Traditional Chinese Medicine: A Source of Competitive Adenosine Deaminase Inhibitors for Anticancer.
Neoplasms
Role of adenosine deaminase in human monocyte differentiation and tumor cell cytotoxicity.
Neoplasms
Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis.
Neoplasms
Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
Neoplasms
Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis.
Neoplasms
Serum adenosine deaminase enzyme and plasma platelet factor 4 activities in active pulmonary tuberculosis, HIV-seropositive subjects and cancer patients.
Neoplasms
Serum adenosine deaminase in pulmonary tuberculosis, malignancy and non-tubercular respiratory diseases.
Neoplasms
Serum adenosine deaminase levels as an index of tumor growth in head and neck malignancy.
Neoplasms
Serum adenosine deaminase, 5'-nucleotidase & alkaline phosphatase in breast cancer patients.
Neoplasms
Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.
Neoplasms
Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.
Neoplasms
Studies on the mechanism of cytotoxicity of 3'-deoxyadenosine N1-oxide in different strains of Ehrlich ascites tumor cells.
Neoplasms
Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells.
Neoplasms
Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Neoplasms
Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia.
Neoplasms
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors.
Neoplasms
The anti-inflammatory modulatory role of Solidago chilensis Meyen in the murine model of the air pouch.
Neoplasms
The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies.
Neoplasms
The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis.
Neoplasms
The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine.
Neoplasms
The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.
Neoplasms
Tomato (Solanum lycopersicum) carotenoids & lycopenes chemistry; Metabolism, absorption, nutrition and allied health claims- A comprehensive review.
Neoplasms
Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
Neoplasms
Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis.
Neoplasms
Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties.
Neoplasms
Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
Neoplasms
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes]
Neoplasms
[Activity of adenosine metabolism enzymes and spontaneous chemiluminescence in macrophages in the tumor growth process]
Neoplasms
[Adenosine deaminase in tumors: a marker of the pleural invasion of lymphoproliferative processes?]
Neoplasms
[Age-dependent characteristics of metabolism of DNA precursors in healthy women, patients with mastopathy and breast cancer]
Neoplasms
[Dynamics of the cytokines, homocysteine contents, indices of oxydative and nitrosative stress and cytopathic hypoxia in patients after cholecystectomy for acute cholecystitis. Connection with rate of postoperative purulent-inflammatory complications]
Neoplasms
[Enzymes of adenosine metabolism in lymphocytes and the functional state of the sympatho-adrenal system in tumor processes]
Neoplasms
[Evaluation of cerebrospinal fluid and blood adenosine deaminase activity in nervous system tumors.]
Neoplasms
[Lactate dehydrogenase, adenosine deaminase and thymidine phosphorylase activity of blood and tissues in breast tumor patients]
Neoplasms
[Measurement of adenosine deaminase activity in blood plasma as tumor diagnostic test.]
Neoplasms
[Studies on increase of diagnostic possibilities in cancer; determination of activity of adenosine deaminase in plasma.]
Neoplasms
[The pool of free purine and pyrimidine nucleosides and bases in the thymocytes, and splenic T- and B-lymphocytes of C3HA mice during the growth of solid hepatoma 22a]
Nephrotic Syndrome
Lymphocyte adenosine deaminase activity in children with idiopathic nephrotic syndrome.
Nervous System Diseases
Diagnostic value of cerebrospinal fluid adenosine deaminase determination.
Nervous System Malformations
Activity of adenosine deaminase in mothers who have conceived a fetus with central nervous system malformations.
Nervous System Neoplasms
[Evaluation of cerebrospinal fluid and blood adenosine deaminase activity in nervous system tumors.]
Neuralgia
ADAR3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice.
Neuralgia
RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.
Neuroblastoma
Control of cyclic adenosine 3':5'-monophosphate-elevating effect of adenosine in C-1300 murine neuroblastoma in tissue culture.
Neuroblastoma
Effects of exogenous adenosine deaminase and erythro-9-(2-hydroxy-3-nonyl) adenine on intracellular cyclic AMP levels in C1300 murine neuroblastoma in tissue culture.
Neuroblastoma
In vitro ultrastructural localization of the catalytic activity of adenosine deaminase in murine C-1300 neuroblastoma.
Neuroblastoma
Mitochondrial Damage and Apoptosis Induced by Adenosine Deaminase Inhibition and Deoxyadenosine in Human Neuroblastoma Cell Lines.
Neurodegenerative Diseases
Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Neurofibrosarcoma
cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
Neurofibrosarcoma
Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.
Neuroinflammatory Diseases
Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult.
Neurologic Manifestations
A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-?.
Neutropenia
Adenosine Deaminase Type II Deficiency: Severe Chronic Neutropenia, Lymphoid Infiltration in Bone Marrow, and Inflammatory Features.
Neutropenia
Neutropenia and myeloid dysplasia in a patient with delayed-onset adenosine deaminase deficiency.
Neutropenia
Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).
Non-alcoholic Fatty Liver Disease
Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease.
nucleotide diphosphatase deficiency
Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.
Obesity
Adenosine deaminase gene polymorphism is associated with obesity in Iranian population.
Obesity
An exploratory investigation of genetic linkage with body composition and fatness phenotypes: the Québec Family Study.
Obesity
Prostaglandin E2 action and binding in human adipocytes: effects of sex, age, and obesity.
Obesity
Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity.
Obesity
The relationship between serum total sialic acid levels and adenosine deaminase activity in obesity.
Obesity
[Peripheral blood albumin level in significantly correlated with the severity of atherosclerosis in hypertensive patients].
Opportunistic Infections
Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
ornithine carbamoyltransferase deficiency
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy.
ornithine carbamoyltransferase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
Ornithine Carbamoyltransferase Deficiency Disease
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy.
Ornithine Carbamoyltransferase Deficiency Disease
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
Osteoarthritis
Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis.
Osteoarthritis
Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
Otitis Media
Malondialdehyde level and adenosine deaminase activity in adenoid tissue of patients with OME and obstructive adenoid hypertrophy.
Otitis Media with Effusion
Malondialdehyde level and adenosine deaminase activity in adenoid tissue of patients with OME and obstructive adenoid hypertrophy.
Ovarian Neoplasms
Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies.
Ovarian Neoplasms
Evaluation of serum adenosine deaminase and 5'-nucleotidase activities as probable markers in ovarian cancer.
Ovarian Neoplasms
Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
Overweight
Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult.
Overweight
Erythrocyte adenosine deaminase and purine nucleoside phosphorylase activity in gout.
Pancreatitis
Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites.
Paramyxoviridae Infections
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol.
Paraplegia
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
Parasitemia
Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture.
Parasitic Diseases
Genome-block expression-assisted association studies discover malaria resistance genes in Anopheles gambiae.
Parkinson Disease
A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson's disease.
Parkinson Disease
Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease.
Parkinson Disease
[Serum adenosine deaminase and its isozyme activities in patients with Parkinson's disease]
Peptic Ulcer
Adenosine deaminase activity in the gastric mucosa in patients with gastric ulcer. Effects of ranitidine and sucralfate.
Pericardial Effusion
A 30-year-old female Behçet's disease patient with recurrent pleural and pericardial effusion and elevated adenosine deaminase levels: case report.
Pericardial Effusion
Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis.
Pericardial Effusion
Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis.
Pericardial Effusion
Adenosine deaminase in the diagnosis of tuberculous pericardial effusion.
Pericardial Effusion
Diagnostic value of adenosine deaminase activity in pericardial fluids.
Pericardial Effusion
Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients.
Pericardial Effusion
IgG4-related disease manifesting as pericarditis with elevated adenosine deaminase and IL-10 levels in pericardial fluid.
Pericardial Effusion
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Pericardial Effusion
Pericardial Effusion and Adenosine Deaminase False Positivity Due to Parvovirus B19.
Pericardial Effusion
The usefulness of adenosine deaminase in the diagnosis of tuberculous pericarditis.
Pericardial Effusion
[A case of tuberculous pericarditis with marked high level of adenosine deaminase (ADA) activity in pericardial effusion]
Pericardial Effusion
[A case of tuberculous pericarditis, the diagnosis of which was complicated by the delay in the rise of adenosine deaminase in the pericardial effusion]
Pericardial Effusion
[Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers]
Pericardial Effusion
[The value of measuring adenosine deaminase activity in pericardial effusion fluid for diagnosing the etiology of pericardial effusion]
Pericarditis
A 30-year-old female Behçet's disease patient with recurrent pleural and pericardial effusion and elevated adenosine deaminase levels: case report.
Pericarditis
Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients.
Pericarditis
IgG4-related disease manifesting as pericarditis with elevated adenosine deaminase and IL-10 levels in pericardial fluid.
Pericarditis
New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions.
Pericarditis, Constrictive
The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis.
Pericarditis, Tuberculous
A case of tuberculous pericarditis--use of adenosine deaminase activity (ADA) in early diagnosis.
Pericarditis, Tuberculous
Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis.
Pericarditis, Tuberculous
Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis.
Pericarditis, Tuberculous
Adenosine deaminase and tuberculous pericarditis-A systematic review with meta-analysis.
Pericarditis, Tuberculous
Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis.
Pericarditis, Tuberculous
Correlation study between ADA and IFN-? gene polymorphisms and the risk of developing tuberculous pericarditis.
Pericarditis, Tuberculous
Diagnostic accuracy of adenosine deaminase for tuberculous pericarditis: a meta-analysis.
Pericarditis, Tuberculous
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-? in a high burden setting: a prospective study.
Pericarditis, Tuberculous
Diagnostic values of Xpert MTB/RIF, T-SPOT.TB and adenosine deaminase for HIV-negative tuberculous pericarditis in a high burden setting: a prospective observational study.
Pericarditis, Tuberculous
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Pericarditis, Tuberculous
Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis.
Pericarditis, Tuberculous
The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis.
Pericarditis, Tuberculous
The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV.
Pericarditis, Tuberculous
The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis.
Pericarditis, Tuberculous
The usefulness of adenosine deaminase in the diagnosis of tuberculous pericarditis.
Pericarditis, Tuberculous
Tuberculous pericarditis: importance of adenosine deaminase activity in pericardial fluid.
Pericarditis, Tuberculous
Video-assisted thoracoscopic pericardial fenestration for tuberculous pericardial effusion.
Pericarditis, Tuberculous
[A case of tuberculous pericarditis with marked high level of adenosine deaminase (ADA) activity in pericardial effusion]
Pericarditis, Tuberculous
[A case of tuberculous pericarditis, the diagnosis of which was complicated by the delay in the rise of adenosine deaminase in the pericardial effusion]
Pericarditis, Tuberculous
[Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers]
Pericarditis, Tuberculous
[Surgical intervention to tuberculous pericarditis: a case report]
Pericarditis, Tuberculous
[Tuberculous pericarditis: diagnostic value of adenosine deaminase]
Pericarditis, Tuberculous
[Tuberculous pericarditis: value of adenosine deaminase activity level assessment]
Periodontitis
Evaluation of biochemical and clinical effects of hyaluronic acid on non-surgical periodontal treatment: a randomized controlled trial.
Peripheral Nervous System Diseases
Vasculitic peripheral neuropathy in deficiency of adenosine deaminase 2.
Peritoneal Neoplasms
Pelvic-peritoneal tuberculosis simulating peritoneal carcinomatosis: high clinical suspicion and a minimally invasive procedure.
Peritoneal Neoplasms
Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis.
Peritoneal Neoplasms
[Peritoneal carcinomatosis with elevated adenosine deaminase (ADA) in ascitic fluid]
Peritonitis
A rapid and non-invasive 2-step algorithm for diagnosing tuberculous peritonitis using a T cell-based assay on peripheral blood and peritoneal fluid mononuclear cells together with peritoneal fluid adenosine deaminase.
Peritonitis
Abdominal Ascites of Unknown Origin: Diagnostic Accuracy of Adenosine Deaminase for Tuberculous Peritonitis.
Peritonitis
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.
Peritonitis
Anti-inflammatory and antimicrobial effect of lectin from Lonchocarpus sericeus seeds in an experimental rat model of infectious peritonitis.
Peritonitis
Ascites adenosine deaminase activity is decreased in tuberculous ascites with low protein content.
Peritonitis
Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States.
Peritonitis
Ascitic fluid gamma interferon concentrations and adenosine deaminase activity in tuberculous peritonitis.
Peritonitis
Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb3+ Complex.
Peritonitis
Diagnostic accuracy of adenosine deaminase for tuberculous peritonitis: a meta-analysis.
Peritonitis
Diagnostic evaluation of ascitic adenosine deaminase activity in tubercular peritonitis.
Peritonitis
Diagnostic value of ascites gamma interferon levels in tuberculous peritonitis. Comparison with adenosine deaminase activity.
Peritonitis
Elevated adenosine deaminase activity in patients with HIV and tuberculous peritonitis.
Peritonitis
Measurement of Adenosine Deaminase in Ascitic Fluid Contributed to the Diagnosis in a Case of Tuberculous Peritonitis.
Peritonitis
Molecular forms of adenosine deaminase do not aid the diagnosis of tuberculosis.
Peritonitis
Multicenter evaluation of the acid-fast bacillus smear, mycobacterial culture, Xpert MTB/RIF assay, and adenosine deaminase for the diagnosis of tuberculous peritonitis in China.
Peritonitis
Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: An unusual presentation.
Peritonitis
Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis.
Peritonitis
Role of ascitic fluid adenosine deaminase (ADA) and serum CA-125 in the diagnosis of tuberculous peritonitis.
Peritonitis
Should We Use Adenosine Deaminase Assay for the Differential Diagnosis of Tuberculous Peritonitis in CAPD Patients?
Peritonitis
Systematic review: tuberculous peritonitis--presenting features, diagnostic strategies and treatment.
Peritonitis
The negative impact of increasing age and underlying cirrhosis on the sensitivity of adenosine deaminase in the diagnosis of tuberculous peritonitis: a cross-sectional study in eastern China.
Peritonitis
The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis.
Peritonitis
Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome.
Peritonitis
Tuberculous peritonitis--reports of 26 cases, detailing diagnostic and therapeutic problems.
Peritonitis
Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report.
Peritonitis
Use of adenosine deaminase measurements and QuantiFERON in the rapid diagnosis of tuberculous peritonitis.
Peritonitis
Utility of Ascitic Fluid Adenosine Deaminase Levels in the Diagnosis of Tuberculous Peritonitis in General Medical Practice.
Peritonitis
Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis.
Peritonitis
[A case of tuberculous peritonitis accompanied by lymphadenitis in a patient with liver cirrhosis in which lymph node biopsy was useful for establishing the diagnosis].
Peritonitis
[Adenosine deaminase is useful for the diagnosis of peritoneal tuberculosis in patients with end-stage renal failure]
Peritonitis
[Clinico-statistical study on tuberculous peritonitis and genital tuberculosis in elderly women]
Peritonitis
[Etiologic and laboratory analyses of ascites in patients who underwent diagnostic paracentesis]
Peritonitis
[Tuberculous peritonitis: the diagnostic value of adenosine deaminase (ADA) in the ascitic fluid]
Persistent Infection
A study on the status of inflammatory systems in camels naturally infected with Toxoplasma gondii.
Persistent Infection
ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.
Persistent Infection
Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii.
Plague
[A method of differentiating the plague and pseudotuberculosis microbes by adenosine deaminase]
Plasmacytoma
[Considerations on the origin of the diversity of immunoglobulins (author's transl)]
Pleural Effusion
A Case of Askin's Tumor Presenting with Pleural Effusion and High Level of Adenosine Deaminase.
Pleural Effusion
A Case of Sjögren's Syndrome with Pleural Effusion: Difficult to Distinguish from Tuberculous Pleurisy Because of a High Adenosine Deaminase Level.
Pleural Effusion
A chocolate effusion - An unusual cause of elevated adenosine deaminase in the pleural fluid.
Pleural Effusion
A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.
Pleural Effusion
A comparative study of clinical manifestations caused by tuberculosis in immunocompromised and non-immunocompromised patients.
Pleural Effusion
A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser.
Pleural Effusion
A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion.
Pleural Effusion
A rare case of fever of unknown origin: subcutaneous panniculitis-like T-cell lymphoma (SPTCL).
Pleural Effusion
Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis.
Pleural Effusion
Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature.
Pleural Effusion
ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid.
Pleural Effusion
Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy.
Pleural Effusion
Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis.
Pleural Effusion
Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.
Pleural Effusion
Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis.
Pleural Effusion
Adenosine deaminase activity in pleural fluid--a diagnostic test of tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase activity in pleural fluids--a diagnostic aid in tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients.
Pleural Effusion
Adenosine deaminase activity in the diagnosis of lymphocytic pleural effusions of tuberculous, neoplastic and lymphomatous origin.
Pleural Effusion
Adenosine deaminase activity in tuberculous pleural effusions: a diagnostic test.
Pleural Effusion
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts.
Pleural Effusion
Adenosine deaminase activity level as a tool for diagnosing tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase activity: to be an useful marker in distinguishing pleural effusions due to malignancy from tuberculosis.
Pleural Effusion
Adenosine deaminase estimations in the differentiation of pleural effusions.
Pleural Effusion
Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
Pleural Effusion
Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Pleural Effusion
Adenosine deaminase in pleural fluid--an enzymatic test for tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase in the diagnosis of tuberculous pleural effusion: is it really an ideal test? A word of caution.
Pleural Effusion
Adenosine deaminase in the diagnosis of tuberculous pleural effusions. A report of 218 patients and review of the literature.
Pleural Effusion
Adenosine deaminase level in pleural fluid and the diagnosis of tuberculous pleural effusion.
Pleural Effusion
Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions.
Pleural Effusion
Adenosine deaminase, alpha 1 antitrypsin, alpha 1 acid glycoprotein, ceruloplasmin and protein in the diagnosis of tuberculous pleural effusion.
Pleural Effusion
Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Pleural Effusion
Biomarkers of Distinguishing Neutrophil-Predominant Tuberculous Pleural Effusion from Parapneumonic Pleural Effusion.
Pleural Effusion
C-reactive protein, sialic acid and adenosine deaminase levels in serum and pleural fluid from patients with pleural effusion.
Pleural Effusion
Carcinomatous and tuberculous pleural effusions. Comparison of tumor markers.
Pleural Effusion
Cell-free Mycobacterium tuberculosis DNA test in pleural effusion for tuberculous pleurisy: a diagnostic accuracy study.
Pleural Effusion
Clinical and laboratory parameters in the differential diagnosis of pleural effusion secondary to tuberculosis or cancer.
Pleural Effusion
Clinical and Laboratory Predictors associated with Complicated Scrub Typhus.
Pleural Effusion
Clinical diagnostic utility of adenosine deaminase, interferon-?, interferon-?-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions.
Pleural Effusion
Clinical relevance and characteristics of pleural effusion in patients with Mycoplasma pneumoniae pneumonia.
Pleural Effusion
Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion.
Pleural Effusion
Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
Pleural Effusion
Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
Pleural Effusion
Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion.
Pleural Effusion
Combined detections of interleukin 27, interferon-?, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
Pleural Effusion
Combined detections of interleukin-33 and adenosine deaminase for diagnosis of tuberculous pleural effusion.
Pleural Effusion
Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
Pleural Effusion
Comparative Study of Adenosine Deaminase and Other Conventional Diagnostic Parameters in Diagnosis of Tuberculous Pleural Effusion.
Pleural Effusion
Concurrent measurement of adenosine deaminase and dipeptidyl peptidase IV activity in the diagnosis of tuberculous pleural effusion.
Pleural Effusion
Cryptococcal pleural infection in a recurrent pleural effusion: a case report.
Pleural Effusion
Cryptococcal Pleuritis Containing a High Level of Adenosine Deaminase in a Patient with AIDS: A Case Report.
Pleural Effusion
Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.
Pleural Effusion
Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.
Pleural Effusion
Diagnosing tuberculous pleural effusion: comparative sensitivity of mycobacterial culture, histopathology and adenosine deaminase activity.
Pleural Effusion
Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma.
Pleural Effusion
Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-? immunospot assay in a tuberculosis-endemic population: A prospective cohort study.
Pleural Effusion
Diagnostic Accuracy of CYFRA21-1 in the Differential Diagnosis of Pleural Effusions.
Pleural Effusion
Diagnostic accuracy of interleukin-22 and adenosine deaminase for tuberculous pleural effusions.
Pleural Effusion
Diagnostic Accuracy of Pleural Fluid Adenosine Deaminase for Diagnosing Tuberculosis. Meta-analysis of Spanish Studies.
Pleural Effusion
Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interlukine-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.
Pleural Effusion
Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients.
Pleural Effusion
Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting.
Pleural Effusion
Diagnostic role of pleural fluid adenosine deaminase in tuberculous pleural effusion.
Pleural Effusion
Diagnostic significance of adenosine deaminase in pleural effusate for primary effusion lymphoma-like lymphoma.
Pleural Effusion
Diagnostic significance of immunoglobulins and adenosine deaminase in pleural effusion.
Pleural Effusion
Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and serum of tuberculous and non-tuberculous respiratory disease patients.
Pleural Effusion
Diagnostic Utility Of Pleural Fluid Adenosine Deaminase Level In Tuberculous Pleural Effusion.
Pleural Effusion
Diagnostic value of adenosine deaminase and gamma-interferon in tuberculous and malignant pleural effusions.
Pleural Effusion
Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions.
Pleural Effusion
Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis.
Pleural Effusion
Diagnostic value of adenosine deaminase to differentiate exudates and transudates.
Pleural Effusion
Diagnostic value of pleural adenosine deaminase in tuberculous effusions of immunocompromised hosts.
Pleural Effusion
Diagnostic Value of Pleural Effusion Mononuclear Cells Count and Adenosine Deaminase for Tuberculous Pleurisy Patients in China: A Case-Control Study.
Pleural Effusion
Diagnostic value of pleural fluid interferon-gamma and adenosine deaminase in patients with pleural tuberculosis in Qatar.
Pleural Effusion
Diagnostic value of simultaneous determination of pleural adenosine deaminase and pleural lysozyme/serum lysozyme ratio in pleural effusions.
Pleural Effusion
Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-?, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
Pleural Effusion
DIFFERENCES IN CLINICAL MANIFESTATIONS AND PLEURAL FLUID CHARATERISTICS BETWEEN TUBERCULOUS AND MALIGNANT PLEURAL EFFUSIONS.
Pleural Effusion
Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
Pleural Effusion
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Pleural Effusion
Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
Pleural Effusion
Discrimination of exudative pleural effusions based on multiple biological parameters.
Pleural Effusion
Discrimination of tuberculous from carcinomatous pleural effusion by biochemical markers: adenosine deaminase, lysozyme, fibronectin and carcinoembryonic antigen.
Pleural Effusion
Early diagnosis of tuberculous pleural effusion: apart from pleural fluid adenosine deaminase, pleural biopsy still has a role.
Pleural Effusion
Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.
Pleural Effusion
Elevated Adenosine Deaminase in Pleural Effusion A Case of Non-Hodgkin Lymphoma Misdiagnosis.
Pleural Effusion
Etiology and pleural fluid characteristics of large and massive effusions.
Pleural Effusion
Evaluation of a diagnostic flow chart applying medical thoracoscopy, adenosine deaminase and T-SPOT.TB in diagnosis of tuberculous pleural effusion.
Pleural Effusion
Evaluation of adenosine deaminase activity for the diagnosis of pleural TB in lymphocytic pleural effusions.
Pleural Effusion
Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian meta-analysis.
Pleural Effusion
Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study.
Pleural Effusion
High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires' disease.
Pleural Effusion
High adenosine deaminase level in pleural effusion due to bronchoalveolar carcinoma.
Pleural Effusion
High adenosine deaminase level in pleural effusion due to Waldenström's macroglobulinemia.
Pleural Effusion
High adenosine deaminase level in the pleural effusion of a case with leukemia.
Pleural Effusion
Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Pleural Effusion
IgG4-related disease with elevated adenosine deaminase in pleural effusion diagnosed clinically using thoracoscopy under local anesthesia and FDG-PET-CT.
Pleural Effusion
IgG4-related pleural effusion with high adenosine deaminase levels: A case report and literature review.
Pleural Effusion
IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report.
Pleural Effusion
Improved early diagnosis of difficult cases of tuberculous pleural effusion by combination of thoracoscopy with immunological tests.
Pleural Effusion
Increased adenosine deaminase activity in Q fever pneumonia with pleural effusion.
Pleural Effusion
Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.
Pleural Effusion
Influence of storage time and temperature on pleural fluid adenosine deaminase determination.
Pleural Effusion
Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence.
Pleural Effusion
Intracerebral tuberculomas: A rare cause of seizure in an immunocompetent young male.
Pleural Effusion
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Pleural Effusion
Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Pleural Effusion
Level of antibodies against mycobacterial glycolipid in the effusion for diagnosis of tuberculous pleural effusion.
Pleural Effusion
Lymphocytic Pleural Effusion and an Enzyme Involved in Purine Metabolism: A Tertiary Care Experience in Karachi, Pakistan.
Pleural Effusion
Mantle cell lymphoma involvement of the pleura and tuberculous pleurisy with pulmonary tuberculosis: a case report and literature review.
Pleural Effusion
Markers for differentiation of tubercular pleural effusion from non-tubercular effusion.
Pleural Effusion
Meta-analysis of Indian studies evaluating adenosine deaminase for diagnosing tuberculous pleural effusion.
Pleural Effusion
Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.
Pleural Effusion
Molecular forms of adenosine deaminase do not aid the diagnosis of tuberculosis.
Pleural Effusion
Mycobacterial load affects adenosine deaminase 2 levels of tuberculous pleural effusion.
Pleural Effusion
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Pleural Effusion
Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Pleural Effusion
Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong.
Pleural Effusion
Pleural adenosine deaminase cut-off value for the diagnosis of tuberculous pleural effusion using the Diazyme assay.
Pleural Effusion
Pleural adenosine deaminase in the diagnostic workup of tuberculous pleural effusion.
Pleural Effusion
Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions.
Pleural Effusion
Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy.
Pleural Effusion
Pleural effusion adenosine deaminase is not accurate in diagnosis of pediatric tuberculous pleural effusion: a retrospective study.
Pleural Effusion
Pleural effusion adenosine deaminase: a candidate biomarker to discriminate between Gram-negative and Gram-positive bacterial infections of the pleural space.
Pleural Effusion
Pleural effusion during acute myeloid leukemia induction chemotherapy: a perplexing case.
Pleural Effusion
Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis.
Pleural Effusion
Pleural fluid ADA activity in tuberculous pleurisy can be low in elderly, critically ill patients with multi-organ failure.
Pleural Effusion
Pleural fluid adenosine deaminase (pfada) in the diagnosis of tuberculous effusions in a low incidence population.
Pleural Effusion
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.
Pleural Effusion
Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.
Pleural Effusion
Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.
Pleural Effusion
Pleural IFN-? release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Pleural Effusion
Pleurisy Caused by Mycobacterium abscessus in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature.
Pleural Effusion
Pleuritis associated with immunoglobulin G4-related disease under normal thoracoscopic findings: a case report.
Pleural Effusion
Pleuro-peritoneal lymphomatosis with concurrent tonsillar involvement in T-cell nonHodgkin's lymphoma: Clinical presentation mimicking disseminated tuberculosis.
Pleural Effusion
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Pleural Effusion
Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
Pleural Effusion
Predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis among Other Exudative Etiologies.
Pleural Effusion
Radiologic and laboratory differences in patients with tuberculous and parapneumonic pleural effusions showing non-lymphocytic predominance and high adenosine deaminase levels.
Pleural Effusion
Rapid automated determination of adenosine deaminase and lysozyme for differentiating tuberculous and nontuberculous pleural effusions.
Pleural Effusion
Rapid detection of cell-free Mycobacterium tuberculosis DNA in tuberculous pleural effusion.
Pleural Effusion
Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions.
Pleural Effusion
Retrospective study of pleural parasitic infestations: a practical diagnostic approach.
Pleural Effusion
Role of Adenosine Deaminase Estimation in Differentiation of Tuberculous and Non-tuberculous Exudative Pleural Effusions.
Pleural Effusion
Role of biochemical tests in the diagnosis of exudative pleural effusions.
Pleural Effusion
Role of interleukin-6, gamma interferon and adenosine deaminase markers in management of pleural effusion patients.
Pleural Effusion
Significance of adenosine deaminase in diagnosing tuberculous pleural effusion.
Pleural Effusion
Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy.
Pleural Effusion
Simple method for rapid diagnosis of tuberculosis pleuritis: a statistical approach.
Pleural Effusion
Simultaneous measurements of adenosine deaminase activity and tuberculostearic acid in pleural effusions for the diagnosis of tuberculous pleuritis.
Pleural Effusion
Soluble Fas ligand is another good diagnostic marker for tuberculous pleurisy.
Pleural Effusion
The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients.
Pleural Effusion
The diagnostic role of pentraxin-3 in the differential diagnosis of pleural effusions
Pleural Effusion
The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions.
Pleural Effusion
The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
Pleural Effusion
The diagnostic value of the adenosine deaminase activity in the pleural fluid of renal transplant patients with tuberculous pleural effusion.
Pleural Effusion
The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study.
Pleural Effusion
The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.
Pleural Effusion
The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.
Pleural Effusion
The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase.
Pleural Effusion
The role of genexpert in the diagnosis of tubercular pleural effusion in India.
Pleural Effusion
Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Pleural Effusion
Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase.
Pleural Effusion
Tuberculous pleurisy mimicking Mycoplasma pneumoniae infection in a previously healthy young adult: A case report.
Pleural Effusion
Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
Pleural Effusion
Use of anabolic-androgenic steroids masking the diagnosis of pleural tuberculosis: a case report.
Pleural Effusion
Use of Pleural Fluid Interferon-gamma Enzyme-linked Immunospot Assay in the Diagnosis of Pleural Tuberculosis.
Pleural Effusion
Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis.
Pleural Effusion
Usefulness of serum lactate dehydrogenase/pleural fluid adenosine deaminase ratio for differentiating Mycoplasma pneumoniae parapneumonic effusion and tuberculous pleural effusion.
Pleural Effusion
Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease.
Pleural Effusion
Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis.
Pleural Effusion
Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
Pleural Effusion
When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculous pleuritis.
Pleural Effusion
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes]
Pleural Effusion
[A case of Mycobacterium avium pulmonary disease accompanied with pleural effusion]
Pleural Effusion
[A case of Mycobacterium intracellulare pleurisy without active lung lesion]
Pleural Effusion
[A case of natural killer cell lymphoma with high adenosine deaminase level in pleural effusion]
Pleural Effusion
[A case of pneumonia due to Mycoplasma pneumoniae accompanying high adenosine deaminase activity in pleural effusion]
Pleural Effusion
[A case of primary effusion lymphoma with elevation of ADA activity in pleural effusion].
Pleural Effusion
[A case of pulmonary tuberculosis and tuberculous pleuritis during treatment with etanercept for rheumatoid arthritis]
Pleural Effusion
[A case of systemic IgG4-related disease with bilateral pleural effusions].
Pleural Effusion
[A case of tuberculous pleural effusion diagnosed by polymerase chain reaction (PCR)--with reference to tuberculous pleurisy using polymerase chain reaction]
Pleural Effusion
[A case of tuberculous pleurisy developing contralateral effusion during anti-tuberculosis chemotherapy].
Pleural Effusion
[A case of tuberculous pleurisy distinguished from pleurisy caused by Mycoplasma infection].
Pleural Effusion
[A case of tuberculous pleurisy with a rapid decrease in pleural effusion]
Pleural Effusion
[A case report of tuberculous pleuritis diagnosed by thoracoscopy using fiberoptic bronchoscope]
Pleural Effusion
[Activities and isozymes of adenosine deaminase and lactate dehydrogenase in tuberculous pleural effusion with special reference to the presence of mycobacterium tuberculosis]
Pleural Effusion
[Adenosine deaminase activity and isozymes in pleural effusion: an aid to differential diagnosis between carcinomatous and tuberculous pleurisy]
Pleural Effusion
[Adenosine deaminase activity in the pleural effusion. A study of 64 cases]
Pleural Effusion
[Adenosine deaminase as a diagnostic parameter in tuberculous pleural effusion]
Pleural Effusion
[Adenosine deaminase assay for the diagnosis of tuberculous pleural effusion]
Pleural Effusion
[Adenosine deaminase in pleural effusions. Its usefulness in the diagnosis of tuberculous pleurisy]
Pleural Effusion
[Adenosine deaminase in the blood cells and serum of patients with tuberculous pleurisy]
Pleural Effusion
[Adenosine deaminase: etiologic marker in the diagnosis of pleural effusions]
Pleural Effusion
[An elderly case with nontuberculous mycobacteria acompanied by unilateral massive pleural effusion following the video-assisted thoracic surgery (VATS) for lung cancer]
Pleural Effusion
[Analysis of adenosine deaminase and its subfractions as a diagnostic parameter in tuberculous pleural effusion]
Pleural Effusion
[Autopsy case of diffuse pleural thickening presenting respiratory impairment and benign asbestos pleurisy]
Pleural Effusion
[Clinical analysis of lymphoma with chest involvement: report of 25 cases]
Pleural Effusion
[Clinical analysis of nontuberculous mycobacterial infection complicated by pleurisy].
Pleural Effusion
[Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy]
Pleural Effusion
[Clinical significance of measurement of adenosine deaminase activity in pleural effusion for differential diagnosis of pleuritis--influence of the hemolysis in pleural effusion on ADA activity]
Pleural Effusion
[Clinical significance of serum CA125 in patients with tuberculous pleurisy]
Pleural Effusion
[Comparative significance of the biochemical markers of cell-mediated immunity in the diagnosis of tuberculous pleurisy]
Pleural Effusion
[Cuttoff values of biochemical tests on pleural fluid: their usefulness in differential diagnosis of 1,040 patients with pleural effusion]
Pleural Effusion
[Determination of adenosine deaminase activity in pleural effusion. Correct interpretation of results]
Pleural Effusion
[Determination of adenosine deaminase activity in the pleural effusion and its clinical significance--a study using experimental pleuritis in rabbits]
Pleural Effusion
[Diagnosis of mycobacterial disease by biochemical and immunological parameters]
Pleural Effusion
[Diagnostic value of serum and pleural fluid adenosine deaminase activity in tuberculous pleurisy]
Pleural Effusion
[Empiric antituberculous therapy in patients with unexplained exsudative pleural effusion. Is it valid in Senegal?]
Pleural Effusion
[Epidemiologic study on tuberculosis in the health area of Santiago de Compostela in 1995, 1996, 1997, and 1998]
Pleural Effusion
[Epidemiological study of tuberculosis in the health area of Santiago de Compostella in 1992, 1993 and 1994]
Pleural Effusion
[Evaluation of the diagnostic value of adenosine deaminase activity in tuberculous pleuritis]
Pleural Effusion
[Exploratory research on diagnostic essentials of pediatric tuberculous pleurisy].
Pleural Effusion
[Gamma-interferon and adenosine deaminase in the diagnosis of tuberculous pleurisy]
Pleural Effusion
[Investigation on differential diagnostic value of multi-index detection of pleural effusion.]
Pleural Effusion
[Measurement of adenosine deaminase (ADA) activity in pleural effusion with special reference to carcinomatous and tuberculosis pleuritis (author's transl)]
Pleural Effusion
[Measurement of adenosine deaminase activity in bronchoalveolar lavage fluids as a tool for diagnosing miliary tuberculosis]
Pleural Effusion
[Nontuberculous Mycobacterium pulmonary infection with pleural effusion caused by Mycobacterium kansasii]
Pleural Effusion
[PULMONARY TUBERCULOSIS AND TUBERCULOUS PLEURISY COMPLICATED WITH RIFAMPICIN-INDUCED HYPOTHYROIDISM: A CASE REPORT].
Pleural Effusion
[Rheumatoid nodule diagnosed by thoracoscopy using flexible fiberoptic bronchoscope]
Pleural Effusion
[The clinical significance of detection of anti-PPD-IgG secreting cell, adenosine deaminase and anti-PPD-IgG antibody in pleural effusion]
Pleural Effusion
[Thoracoscopy with two bronchoscopes in 50 patients with pleural effusion of unknown origin]
Pleural Effusion
[Tuberculosis in Santiago de Compostela from 1999 to 2002. An epidemiological study]
Pleural Effusion
[Value of determining the activity of adenosine deaminase (ADA) in the differential diagnosis of pleural effusions]
Pleural Effusion, Malignant
Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Pleural Effusion, Malignant
Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
Pleural Effusion, Malignant
Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
Pleural Effusion, Malignant
Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
Pleural Effusion, Malignant
Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.
Pleural Effusion, Malignant
Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interlukine-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.
Pleural Effusion, Malignant
Diagnostic value of adenosine deaminase and gamma-interferon in tuberculous and malignant pleural effusions.
Pleural Effusion, Malignant
Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
Pleural Effusion, Malignant
Etiology and pleural fluid characteristics of large and massive effusions.
Pleural Effusion, Malignant
Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas.
Pleural Effusion, Malignant
Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.
Pleural Effusion, Malignant
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Pleural Effusion, Malignant
Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
Pleural Effusion, Malignant
Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
Pleural Effusion, Malignant
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Pleural Effusion, Malignant
Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Pleural Effusion, Malignant
Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
Pleural Effusion, Malignant
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes.
Pleural Effusion, Malignant
Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
Pleural Effusion, Malignant
[Adenosine deaminase activity in tuberculous and malignant pleural effusions]
Pleurisy
A 30-year-old female Behçet's disease patient with recurrent pleural and pericardial effusion and elevated adenosine deaminase levels: case report.
Pleurisy
A comparison study of IFN-gamma, ADA, and CA125 as the diagnostic parameters in tuberculous pleuritis.
Pleurisy
Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis.
Pleurisy
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts.
Pleurisy
Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis.
Pleurisy
Cryptococcal Pleuritis Containing a High Level of Adenosine Deaminase in a Patient with AIDS: A Case Report.
Pleurisy
Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.
Pleurisy
Development of Adenosine Deaminase-Specific IgY Antibodies: Diagnostic and Inhibitory Application.
Pleurisy
Diagnosis of tuberculosis in patients with pleural effusion in an area of HIV infection and limited diagnostic facilities.
Pleurisy
Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis.
Pleurisy
Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy.
Pleurisy
Diagnostic Value of Pleural Fluid Adenosine Deaminase in Tuberculous Pleuritis at Thammasat University Hospital.
Pleurisy
Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis.
Pleurisy
Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan.
Pleurisy
Factors Influencing Pleural Adenosine Deaminase Level in Patients With Tuberculous Pleurisy.
Pleurisy
Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.
Pleurisy
IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report.
Pleurisy
Increased pleural fluid adenosine deaminase in brucellosis is difficult to differentiate from tuberculosis.
Pleurisy
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Pleurisy
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.
Pleurisy
PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy.
Pleurisy
Simultaneous measurements of adenosine deaminase activity and tuberculostearic acid in pleural effusions for the diagnosis of tuberculous pleuritis.
Pleurisy
Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia.
Pleurisy
The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients.
Pleurisy
The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions.
Pleurisy
The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase.
Pleurisy
The use of adenosine deaminase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis.
Pleurisy
Tuberculous pericarditis: importance of adenosine deaminase activity in pericardial fluid.
Pleurisy
Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis.
Pleurisy
Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis.
Pleurisy
Useful tests on the pleural fluid in the management of patients with pleural effusions.
Pleurisy
When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculous pleuritis.
Pleurisy
[A case of pulmonary tuberculosis and tuberculous pleuritis during treatment with etanercept for rheumatoid arthritis]
Pleurisy
[A CASE OF SUBPHRENIC ABSCESS WITH PARADOXICAL RESPONSE CAUSED BY MYCOBACTERIUM TUBERCULOSIS].
Pleurisy
[A case report of tuberculous pleuritis diagnosed by thoracoscopy using fiberoptic bronchoscope]
Pleurisy
[Adenosine deaminase in pleural effusions. Its usefulness in the diagnosis of tuberculous pleurisy]
Pleurisy
[Adenosine deaminase in the complex diagnosis of different forms of extrapulmonary tuberculosis]
Pleurisy
[Analysis of 90 cases of pleural tuberculosis in relation to adenosine deaminase levels]
Pleurisy
[Determination of adenosine deaminase activity in the pleural effusion and its clinical significance--a study using experimental pleuritis in rabbits]
Pleurisy
[Diagnosis and treatment of tuberculous pleurisy--with special reference to the significance of measurement of pleural fluid cytokines]
Pleurisy
[Diagnostic performance of T-SPOT.TB on peripheral blood in combination with adenosine deaminase on pleural fluid for the diagnosis of tuberculous pleurisy within different age group].
Pleurisy
[Evaluation of the diagnostic value of adenosine deaminase activity in tuberculous pleuritis]
Pleurisy
[Lymphocyte activation in tuberculous pleuritis . Correlation with adenosine deaminase (ADA), peripheral blood lymphocytes, T cell receptor subfamilies, radiographic extension and levels of Il-6 and soluble Il-2 receptor]
Pleurisy
[Measurement of adenosine deaminase (ADA) activity in pleural effusion with special reference to carcinomatous and tuberculosis pleuritis (author's transl)]
Pleurisy
[Measurement of adenosine deaminase activity in bronchoalveolar lavage fluids as a tool for diagnosing miliary tuberculosis]
Pleurisy
[The determination of adenosine deaminase activity in the diagnosis of tuberculous pleuritis]
Pleurisy
[The diagnostic value of adenosine deaminase coefficient in patients with tuberculous exudative pleurisy]
Pleurisy
[The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study]
Pleurisy
[Value of determining the activity of adenosine deaminase (ADA) in the differential diagnosis of pleural effusions]
Pneumoconiosis
[Changes in adenosine deaminase and antioxidative enzyme activity in patients with lung diseases of dust etiology]
Pneumonia
A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.
Pneumonia
Adenosine deaminase activity in the aetiological diagnosis of community-acquired pneumonia.
Pneumonia
Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
Pneumonia
Efficiency of Galanti and Guisti Method of ADA Estimation in Comparison with the Gold Standard.
Pneumonia
Gene expression profiling in inflammatory airway disease associated with elevated adenosine.
Pneumonia
Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice.
Pneumonia
Increased adenosine deaminase activity in Q fever pneumonia with pleural effusion.
Pneumonia
Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction.
Pneumonia
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Pneumonia
Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children.
Pneumonia
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol.
Pneumonia
[A case of pneumonia due to Mycoplasma pneumoniae accompanying high adenosine deaminase activity in pleural effusion]
Pneumonia, Bacterial
Adenosine deaminase activity and free IL-2 receptor levels in serum from patients with mycoplasma pneumonia.
Pneumonia, Mycoplasma
Adenosine deaminase activity and free IL-2 receptor levels in serum from patients with mycoplasma pneumonia.
Pneumonia, Mycoplasma
[Usefulness of serum adenosine deaminase activity in the early diagnosis of Mycoplasma pneumonia]
Polyarteritis Nodosa
A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-?.
Polyarteritis Nodosa
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review.
Polyarteritis Nodosa
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Polyarteritis Nodosa
Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.
Polyarteritis Nodosa
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Polyarteritis Nodosa
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Polyarteritis Nodosa
Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
Polyarteritis Nodosa
Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.
Polyarteritis Nodosa
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab.
Polyarteritis Nodosa
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Polyarteritis Nodosa
Thirty Years of Followup in 3 Patients with Familial Polyarteritis Nodosa due to Adenosine Deaminase 2 Deficiency.
Polyarteritis Nodosa
Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
Polycystic Ovary Syndrome
Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS.
Polycystic Ovary Syndrome
Dipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome.
Polycystic Ovary Syndrome
Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity.
Polycystic Ovary Syndrome
Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome.
Polyneuropathies
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Polyomavirus Infections
Host Response to Polyomavirus Infection Is Modulated by RNA Adenosine Deaminase ADAR1 but Not by ADAR2.
Pre-Eclampsia
Adenosine deaminase activity in subjects with normal pregnancy, pregnancy induced hypertension and pre-eclampsia.
Pre-Eclampsia
Clinical correlation between adenosine deaminase activity and pre-eclampsia severity.
Pre-Eclampsia
Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia.
Pre-Eclampsia
Elevated circulatingadenosine deaminase activity in women with preeclampsia: association with pro-inflammatory cytokine production and uric acid levels.
Pre-Eclampsia
Evaluation of the Relationship between Adenosine Deaminase, Myeloperoxidase, Cholinesterase, Preeclampsia Severity and Neonatal Outcomes.
Pre-Eclampsia
Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia.
Pre-Eclampsia
Relation between adenosine deaminase activities and cytokine-producing T cells in women with preeclampsia.
Pre-Eclampsia
Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia.
Pre-Eclampsia
The measurement of nucleoside deaminases by high performance liquid chromatography and their use in clinical chemistry.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Adenosine deaminase levels in blood type A patients with metastatic tumor.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Control of adenosine deaminase levels in human lymphoblasts.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemia children and their parents.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Deoxyribonucleoside triphosphate accumulation by leukemic cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognostic significance of adenosine deaminase in children with malignancies.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Purine metabolism in relation to leukemia and lymphoid cell differentiation.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Serum adenosine deaminase and arylsulphatase A as an index of early infiltration of central nervous system in acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Adenosine deaminase activity in the cerebrospinal fluid of children with acute lymphoblastic leukemia]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Combination assay of IAP and ADA in hematologic malignancies]
Priapism
Adenosine Deaminase Enzyme Therapy Prevents and Reverses the Heightened Cavernosal Relaxation in Priapism.
Priapism
Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.
Primary Immunodeficiency Diseases
Adenosine deaminase in patients with primary immunodeficiency syndromes: The analysis of serum ADA1 and ADA2 activities.
Primary Immunodeficiency Diseases
B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
Primary Immunodeficiency Diseases
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China.
Primary Immunodeficiency Diseases
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders.
Primary Immunodeficiency Diseases
The acquired immunodeficiency syndrome in infants and children.
Primary Immunodeficiency Diseases
Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
Primary Immunodeficiency Diseases
[Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)]
Primary Myelofibrosis
Acquired hemoglobin H disease associated with idiopathic myelofibrosis and hereditary adenosine deaminase deficiency.
Prostatic Neoplasms
Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer.
Prostatic Neoplasms
Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
Prostatic Neoplasms
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor.
Prostatic Neoplasms
Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in prostate cancer patients: Influence of Gleason score, treatment and bone metastasis.
Protein Deficiency
[Dynamics of asparaginase and adenosine deaminase activity in the liver with intraperitoneal administration of aminosol and amikin preparations of parenteral nitrogen nutrition]
Proteinuria
Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.
Proteinuria
Effect of dietary protein restriction on renal purines and purine-metabolizing enzymes in adriamycin nephrosis in rats: a mechanism for protection against acute proteinuria involving xanthine oxidase inhibition.
Pseudolymphoma
Pyrimidine and purine activities in non-Hodgkin's lymphoma. Correlation with histological status and survival.
Psoriasis
Adenosine deaminase activity in peripheral lymphocytes of psoriasis and Sézary's syndrome: possible significance in T-lymphocyte dysfunction.
Psoriasis
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Psoriasis
Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis.
Psoriasis
Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis.
Psoriasis
First report of the coexistence of dyschromatosis symmetrica hereditaria and psoriasis: one novel TCT to A mutation in the double-RNA-specific adenosine deaminase gene.
Psoriasis
Serum adenosine deaminase activity in monitoring disease activity and response to therapy in severe psoriasis.
Psoriasis
Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.
Pulmonary Alveolar Proteinosis
Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
Pulmonary Disease, Chronic Obstructive
Adenosine deaminase activity in COPD patients and healthy subjects.
Pulmonary Disease, Chronic Obstructive
Adenosine Metabolism in COPD: A Study on Adenosine Levels, 5'-Nucleotidase, Adenosine Deaminase and Its Isoenzymes Activity in Serum, Lymphocytes and Erythrocytes.
Pulmonary Disease, Chronic Obstructive
Alveolar-like Stem Cell-derived Myb(neg) Macrophages Promote Recovery and Survival in Airway Disease.
Pulmonary Disease, Chronic Obstructive
Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.
Pulmonary Disease, Chronic Obstructive
The diagnostic value of adenosine deaminase activity in sputum in pulmonary tuberculosis.
Pulmonary Edema
Adenosine Protected Against Pulmonary Edema through Transporter- and Receptor A2-Mediated Endothelial Barrier Enhancement.
Pulmonary Edema
Clinical and Laboratory Predictors associated with Complicated Scrub Typhus.
Pulmonary Fibrosis
Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine.
Pulmonary Heart Disease
[The effect of aminophylline on plasma oxypurines in patients with bronchial asthma or cor pulmonale]
purine-nucleoside phosphorylase deficiency
Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.
purine-nucleoside phosphorylase deficiency
Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
purine-nucleoside phosphorylase deficiency
Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
purine-nucleoside phosphorylase deficiency
Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.
purine-nucleoside phosphorylase deficiency
Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes.
purine-nucleoside phosphorylase deficiency
Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
purine-nucleoside phosphorylase deficiency
Canine cyclic hematopoiesis is associated with abnormal purine and pyrimidine metabolism.
purine-nucleoside phosphorylase deficiency
Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.
purine-nucleoside phosphorylase deficiency
Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
purine-nucleoside phosphorylase deficiency
Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
purine-nucleoside phosphorylase deficiency
Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
purine-nucleoside phosphorylase deficiency
Evidence that X-linked severe combined immunodeficiency is not a differentiation defect of T lymphocytes.
purine-nucleoside phosphorylase deficiency
High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
purine-nucleoside phosphorylase deficiency
Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
purine-nucleoside phosphorylase deficiency
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
purine-nucleoside phosphorylase deficiency
Nucleoside kinases in T and B lymphoblasts distinguished by autoradiography.
purine-nucleoside phosphorylase deficiency
Polymorphism of S-adenosylhomocysteine hydrolase in Italy.
purine-nucleoside phosphorylase deficiency
Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
purine-nucleoside phosphorylase deficiency
Purine nucleoside modulation of functions of human lymphocytes.
purine-nucleoside phosphorylase deficiency
Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
purine-nucleoside phosphorylase deficiency
Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency.
purine-nucleoside phosphorylase deficiency
The acquired immunodeficiency syndrome in infants and children.
purine-nucleoside phosphorylase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
purine-nucleoside phosphorylase deficiency
Use of the integrated steady state rate equation to investigate product inhibition of human red cell adenosine deaminase and its relevance to immune dysfunction.
purine-nucleoside phosphorylase deficiency
[Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)]
purine-nucleoside phosphorylase deficiency
[Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency]
Purpura, Thrombocytopenic, Idiopathic
Three kinds of foamy cells in the spleen: comparative histochemical and ultrastructural studies.
Pyoderma Gangrenosum
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
Pyometra
Evaluation of adenosine deaminase in saliva and serum, and salivary ?-amylase, in canine pyometra at diagnosis and after ovariohysterectomy.
pyrimidine-nucleoside phosphorylase deficiency
Demonstration of Epstein-Barr virus in immunoblastic sarcoma of B-cells arising in a child with primary immunodeficiency disease.
pyrimidine-nucleoside phosphorylase deficiency
[Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency]
pyruvate kinase deficiency
Studies on pyruvate kinase deficiency, pyrimidine 5-'nucleotidase deficiency and adenosine deaminase overproduction.
Pythiosis
Complex Interaction of Deferasirox and Pythium insidiosum: Iron-Dependent Attenuation of Growth In Vitro and Immunotherapy-Like Enhancement of Immune Responses In Vivo.
Red-Cell Aplasia, Pure
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
Red-Cell Aplasia, Pure
Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
Renal Insufficiency, Chronic
Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease.
Reperfusion Injury
Adenosine deaminase in ischemia reperfusion injury in patients with myocardial infarction.
Reperfusion Injury
Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion.
Reperfusion Injury
Erythrocyte adenosine deaminase as a marker of reperfusion injury in patients with myocardial infarction.
Reperfusion Injury
Evaluation of the roles of adenosine deaminase and xanthine oxidase in reperfusion injury in patients with myocardial infarction.
Reperfusion Injury
Is adenosine 5'-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleoside transport in myocardial reperfusion injury.
Reperfusion Injury
On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: Role of adenosine A1 receptor.
Reperfusion Injury
Protective effects of an adenosine deaminase inhibitor on ischemia-reperfusion injury in isolated perfused rat heart.
Reperfusion Injury
The beneficial effect of 2'-deoxycoformycin in renal ischemia-reperfusion is mediated both by preservation of tissue ATP and inhibition of lipid peroxidation.
Reperfusion Injury
[Adenosine deaminase inhibitor (EHNA) on ischemia-reperfusion injury in isolated perfused rat hearts]
Respiratory Distress Syndrome
Adenosine deaminase levels in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Respiratory Tract Diseases
[Lymphocytic adenosine deaminase activity in children with acute and chronic respiratory tract diseases]
Retinal Perforations
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Rheumatic Diseases
Synovial fluid ferritin, lactoferrin and adenosine deaminase in rheumatic diseases.
Rheumatic Diseases
[Activity of adenosine deaminase in the serum of children ill with rheumatism and chronic progressive arthritis]
Rheumatic Fever
Plasma adenosine deaminase activity in children with rheumatic fever and rheumatoid arthritis.
Riboflavin Deficiency
[ENZYMATIC ACTIVITIES AND NUTRITIONAL STATES. II. ADENOSINE DEAMINASE. 2. ADENOSINE DEAMINASE OF THE SPLEEN AND KIDNEYS IN RIBOFLAVIN DEFICIENCY.]
Rosacea
Role of Adenosine Deaminase in Patients with Erythematotelangiectatic Rosacea and Demodex folliculorum Positivity.
Salmonella Infections
Tissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strains.
Sarcoidosis
Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis.
Sarcoidosis
Angiotensin-converting enzyme, lysozyme, beta-2-microglobulin and adenosine deaminase in sarcoidosis.
Sarcoidosis
Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy.
Sarcoidosis
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
Sarcoidosis
YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Sarcoidosis
[Adenosine deaminase activity in bronchoalveolar lavage fluid of sarcoidosis patients]
Sarcoidosis
[Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis]
Sarcoma
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH).
Sarcoma
Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.
Sarcoma 180
C(2')-substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotides.
Sarcoma 180
Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.
Sarcoma, Avian
Absence of adenosine deaminase activity in a mammalian cell line transformed by Rous sarcoma virus.
Sarcoma, Avian
Reduced levels of adenosine deaminase in chick embryo fibroblasts transformed by Rous sarcoma virus.
Scleroderma, Systemic
Recombinant adenosine deaminase ameliorates inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis.
Scleroderma, Systemic
Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders.
Scleroderma, Systemic
[Antibodies to enzymes of purine metabolism as a factor of gastrointestinal tract lesions in systemic scleroderma]
Scrub Typhus
Optimal cutoff value of serum adenosine deaminase activity for diagnosing acute scrub typhus.
Seizures
Adenosine deaminase in convulsions along with its regional, cellular and synaptosomal distribution in rat brain.
Seizures
Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism.
Seizures
Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Seizures
Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.
Seizures
Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome.
Seizures, Febrile
Adenosine deaminase and C-reactive protein in cerebrospinal fluid for differential diagnosis of tubercular meningitis in children.
Seizures, Febrile
Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.
Sepsis
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.
Sepsis
Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis.
Sepsis
Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis.
Sepsis
Oxidative stress parameters and inflammatory and immune mediators as markers of the severity of sepsis.
Sepsis
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomized laboratory investigation.
Severe Combined Immunodeficiency
2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
Severe Combined Immunodeficiency
A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation.
Severe Combined Immunodeficiency
A family of adenosine deaminase deficiency with severe combined immunodeficiency.
Severe Combined Immunodeficiency
A girl with diabetes and severe combined immunodeficiency from adenosine deaminase deficiency.
Severe Combined Immunodeficiency
A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
Severe Combined Immunodeficiency
A homozygous 5 base-pair deletion in exon 10 of the adenosine deaminase (ADA) gene in a child with severe combined immunodeficiency and very low levels of ADA mRNA and protein.
Severe Combined Immunodeficiency
A missense mutation in exon 4 of the human adenosine deaminase gene causes severe combined immunodeficiency.
Severe Combined Immunodeficiency
A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease.
Severe Combined Immunodeficiency
A novel mutation in the ADA gene causing severe combined immunodeficiency in an Arab patient: a case report.
Severe Combined Immunodeficiency
A point mutation in the 5' splice region of intron 7 causes a deletion of exon 7 in adenosine deaminase mRNA.
Severe Combined Immunodeficiency
A role for adenosine deaminase in human monocyte maturation.
Severe Combined Immunodeficiency
A(2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Adenosine 5'-triphosphate (ATP)-mediated stimulation and suppression of DNA synthesis in lymphoid cells. II. Suppressive effect of ATP on murine T-cell functions.
Severe Combined Immunodeficiency
Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
Severe Combined Immunodeficiency
Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
Severe Combined Immunodeficiency
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.
Severe Combined Immunodeficiency
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.
Severe Combined Immunodeficiency
Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Adenosine deaminase activity in recipients of bone marrow from immunodeficient mice homozygous for the wasted mutation.
Severe Combined Immunodeficiency
Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency and severe combined immunodeficiency disease.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency as the first target disorder in gene therapy.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency can present with features of Omenn syndrome.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency due to heterozygous abnormality consisting of a deletion of exon 7 and the absence of enzyme mRNA.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency in a child with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Severe Combined Immunodeficiency
Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency.
Severe Combined Immunodeficiency
Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.
Severe Combined Immunodeficiency
Adenosine deaminase is a specific partner for the Grb2 isoform Grb3-3.
Severe Combined Immunodeficiency
Adenosine deaminase is not required for the generation of superoxide anion.
Severe Combined Immunodeficiency
Adenosine deaminase levels in blood type A patients with metastatic tumor.
Severe Combined Immunodeficiency
Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Adenosine-deaminase deficiency in a child diagnosed prenatally.
Severe Combined Immunodeficiency
Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor.
Severe Combined Immunodeficiency
Advances in the understanding and treatment of human severe combined immunodeficiency.
Severe Combined Immunodeficiency
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.
Severe Combined Immunodeficiency
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.
Severe Combined Immunodeficiency
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
Severe Combined Immunodeficiency
Aminohydrolases acting on adenine, adenosine and their derivatives.
Severe Combined Immunodeficiency
An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.
Severe Combined Immunodeficiency
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
Severe Combined Immunodeficiency
Analysis of normal and mutant forms of human adenosine deaminase - a review.
Severe Combined Immunodeficiency
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Are contemporary methods for somatic gene therapy suitable for clinical applications?
Severe Combined Immunodeficiency
Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
Severe Combined Immunodeficiency
Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.
Severe Combined Immunodeficiency
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Autoimmune thyroiditis and acquired hypothyroidism in an infant with severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Severe Combined Immunodeficiency
Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.
Severe Combined Immunodeficiency
Beware the lymphopenia: A case of severe combined immunodeficiency.
Severe Combined Immunodeficiency
Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency.
Severe Combined Immunodeficiency
Bone marrow gene therapy for adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Bone marrow transplantation in a case of severe combined immunodeficiency with adenosine deaminase deficiency [proceedings]
Severe Combined Immunodeficiency
Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.
Severe Combined Immunodeficiency
Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
Severe Combined Immunodeficiency
Caspase-4 activation in association with decreased adenosine deaminase activity may be a factor for gastric ulcer.
Severe Combined Immunodeficiency
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
Severe Combined Immunodeficiency
Cellular radiosensitivity in human severe-combined-immunodeficiency (SCID) syndromes.
Severe Combined Immunodeficiency
Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
Severe Combined Immunodeficiency
Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
Severe Combined Immunodeficiency
Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
Severe Combined Immunodeficiency
Chest Radiographs for Distinguishing ADA-SCID from Other Forms of SCID.
Severe Combined Immunodeficiency
Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).
Severe Combined Immunodeficiency
Clinical applications of gene therapy for primary immunodeficiencies.
Severe Combined Immunodeficiency
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
Severe Combined Immunodeficiency
Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
Severe Combined Immunodeficiency
Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
Severe Combined Immunodeficiency
Comparison of elapegademase and pegademase in ADA-deficient patients and mice.
Severe Combined Immunodeficiency
Complete suppression of skin allograft rejection in rats treated with continuous infusion of 2'deoxycoformycin.
Severe Combined Immunodeficiency
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Contributory role of adenosine deaminase in metabolic syndrome.
Severe Combined Immunodeficiency
Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.
Severe Combined Immunodeficiency
Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
Severe Combined Immunodeficiency
Deficiency of adenosine deaminase not associated with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Deoxyadenosine inhibits DNA synthesis in cultured human fibroblasts.
Severe Combined Immunodeficiency
Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy.
Severe Combined Immunodeficiency
Determination of adenosine deaminase activity in dried blood spots by a nonradiochemical assay using reversed-phase high-performance liquid chromatography.
Severe Combined Immunodeficiency
Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and LC-MS/MS method for their characterization.
Severe Combined Immunodeficiency
Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Early prenatal investigation of a pregnancy at risk of adenosine deaminase deficiency using chorionic villi.
Severe Combined Immunodeficiency
Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease.
Severe Combined Immunodeficiency
Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Severe Combined Immunodeficiency
Electrophoretic separation of erythrocyte adenosine deaminase in three families with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Elevation of serum IgE level and peripheral eosinophil count during T lymphocyte-directed gene therapy for ADA deficiency: implication of Tc2-like cells after gene transduction procedure.
Severe Combined Immunodeficiency
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function.
Severe Combined Immunodeficiency
Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes.
Severe Combined Immunodeficiency
Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.
Severe Combined Immunodeficiency
Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: case report and review of the literature.
Severe Combined Immunodeficiency
Epstein-Barr virus-induced lymphoblastoid cell lines from patients with primary immunodeficiency diseases.
Severe Combined Immunodeficiency
Erratum to: Adenosine Deaminase Deficient Severe Combined Immunodeficiency Presenting as Atypical Haemolytic Uraemic Syndrome.
Severe Combined Immunodeficiency
Errors of morphogenesis and inborn errors of immunity 20 years after the discovery of DiGeorge anomaly.
Severe Combined Immunodeficiency
Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Severe Combined Immunodeficiency
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects.
Severe Combined Immunodeficiency
Expression of a functional human adenosine deaminase in transgenic tobacco plants.
Severe Combined Immunodeficiency
Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines.
Severe Combined Immunodeficiency
Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
Severe Combined Immunodeficiency
Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
Severe Combined Immunodeficiency
Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5' splice site.
Severe Combined Immunodeficiency
Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID.
Severe Combined Immunodeficiency
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.
Severe Combined Immunodeficiency
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Gene therapy for primary immunodeficiencies: current status and future prospects.
Severe Combined Immunodeficiency
Gene therapy for primary immunodeficiency diseases: recent progress and misgivings.
Severe Combined Immunodeficiency
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
Severe Combined Immunodeficiency
Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency.
Severe Combined Immunodeficiency
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients.
Severe Combined Immunodeficiency
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders.
Severe Combined Immunodeficiency
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.
Severe Combined Immunodeficiency
Gene transfer into hematopoietic stem cells using lentiviral vectors.
Severe Combined Immunodeficiency
Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.
Severe Combined Immunodeficiency
Gene-transferred oligoclonal T cells predominantly persist in peripheral blood from an adenosine deaminase-deficient patient during gene therapy.
Severe Combined Immunodeficiency
Generation of normal lymphocyte populations following transplantation of adenosine-deaminase-deficient fetal liver cells.
Severe Combined Immunodeficiency
Genetic and biochemical consequences of adenosine deaminase deficiency in humans.
Severe Combined Immunodeficiency
Genetic Engineering and Manufacturing of Hematopoietic Stem Cells.
Severe Combined Immunodeficiency
Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines.
Severe Combined Immunodeficiency
Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
Severe Combined Immunodeficiency
Genetic heterogeneity in partial adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Giant-cell fibroblastoma in a patient with a bone-marrow transplant.
Severe Combined Immunodeficiency
Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
Severe Combined Immunodeficiency
Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase--deficient severe combined immunodeficiency disease patients.
Severe Combined Immunodeficiency
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.
Severe Combined Immunodeficiency
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
Severe Combined Immunodeficiency
Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities.
Severe Combined Immunodeficiency
Homozygosity for a missense mutation (G20R) associated with neonatal onset adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID).
Severe Combined Immunodeficiency
Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID).
Severe Combined Immunodeficiency
Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Severe Combined Immunodeficiency
Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains.
Severe Combined Immunodeficiency
Human adenosine deaminase. cDNA and complete primary amino acid sequence.
Severe Combined Immunodeficiency
Hyperbilirubinemia and Rapid Fatal Hepatic Failure in Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency (ADA-SCID).
Severe Combined Immunodeficiency
Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients.
Severe Combined Immunodeficiency
Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
Severe Combined Immunodeficiency
Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
Severe Combined Immunodeficiency
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Immunological and metabolic reconstitution following successful bone marrow transplantation from a HLA-identical sibling in an infant with adenosine deaminase deficiency and severe combined immunodeficiency: partial restoration of purine metabolism.
Severe Combined Immunodeficiency
IMMUNOSUPPRESSIVE EFFECT OF 2'-DEOXYCOFORMYCIN (PENTOSTATIN(®)) FOR RAT ISLET ALLOTRANSPLANTATION.
Severe Combined Immunodeficiency
Immunosuppressive effect of 2'-deoxycoformycin (Pentostatin) for rat islet allotransplantation.
Severe Combined Immunodeficiency
In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase.
Severe Combined Immunodeficiency
In vitro platelet abnormality in adenosine deaminase deficiency and severe combined immunodeficiency.
Severe Combined Immunodeficiency
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.
Severe Combined Immunodeficiency
Increased extracellular adenosine in Drosophila that are deficient in adenosine deaminase activates a release of energy stores leading to wasting and death.
Severe Combined Immunodeficiency
Induction of Apoptosis and c-myc in L1210 Lymphocytic Leukemia Cells by Adenosine.
Severe Combined Immunodeficiency
Inhibition of lymphoid cell growth by adenine ribonucleotide accumulation. The role of phosphoribosylpyrophosphate-depletion induced pyrimidine starvation.
Severe Combined Immunodeficiency
Inhibition of mitogen mediated lymphocyte blastogenesis by adenosine.
Severe Combined Immunodeficiency
Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.
Severe Combined Immunodeficiency
Lack of adenosine deaminase deficiency in the mutant mouse wasted.
Severe Combined Immunodeficiency
Late-onset adenosine deaminase deficiency presenting with Heck's disease.
Severe Combined Immunodeficiency
Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients.
Severe Combined Immunodeficiency
Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Localization of human adenosine deaminase (ADA) gene sequences to the q12----q13.11 region of chromosome 20 by in situ hybridization.
Severe Combined Immunodeficiency
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
Severe Combined Immunodeficiency
Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells.
Severe Combined Immunodeficiency
Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
Severe Combined Immunodeficiency
Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID).
Severe Combined Immunodeficiency
Lymphocyte subpopulations in primary immunodeficiency disorders.
Severe Combined Immunodeficiency
Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow.
Severe Combined Immunodeficiency
Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).
Severe Combined Immunodeficiency
Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.
Severe Combined Immunodeficiency
Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.
Severe Combined Immunodeficiency
Metabolic and immunologic consequences of limited adenosine deaminase expression in mice.
Severe Combined Immunodeficiency
Metabolic findings in a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
Severe Combined Immunodeficiency
Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
Severe Combined Immunodeficiency
Molecular form of adenosine deaminase in severe combined immunodeficiency.
Severe Combined Immunodeficiency
Mouse models in hematopoietic stem cell gene therapy and genome editing.
Severe Combined Immunodeficiency
Multicentric dermatofibrosarcoma protuberans in a child with severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.
Severe Combined Immunodeficiency
Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
Severe Combined Immunodeficiency
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
Severe Combined Immunodeficiency
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
Severe Combined Immunodeficiency
Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry.
Severe Combined Immunodeficiency
New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy.
Severe Combined Immunodeficiency
Non-infectious Lung Disease in Patients with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
Severe Combined Immunodeficiency
Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy.
Severe Combined Immunodeficiency
Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency.
Severe Combined Immunodeficiency
Novel immunotherapeutic approaches in targeting dendritic cells with virus vectors.
Severe Combined Immunodeficiency
Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
Severe Combined Immunodeficiency
One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.
Severe Combined Immunodeficiency
Outcome of hematopoietic stem cell transplantation for adenosine deaminase deficient severe combined immunodeficiency.
Severe Combined Immunodeficiency
Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
Severe Combined Immunodeficiency
Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
Severe Combined Immunodeficiency
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
Severe Combined Immunodeficiency
PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Perspectives of gene therapy for primary immunodeficiencies.
Severe Combined Immunodeficiency
Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
Severe Combined Immunodeficiency
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Prenatal detection of a probable heterozygote for ADA deficiency and severe combined immunodeficiency disease using a microradioassay.
Severe Combined Immunodeficiency
Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
Severe Combined Immunodeficiency
Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
Severe Combined Immunodeficiency
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
Severe Combined Immunodeficiency
Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
Severe Combined Immunodeficiency
Recombinant Adeno-Associated Virus-Mediated Gene Transfer for the Potential Therapy of Adenosine Deaminase-Deficient Severe Combined Immune Deficiency.
Severe Combined Immunodeficiency
Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients.
Severe Combined Immunodeficiency
Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency.
Severe Combined Immunodeficiency
Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome.
Severe Combined Immunodeficiency
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Severe Combined Immunodeficiency
Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo.
Severe Combined Immunodeficiency
Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion.
Severe Combined Immunodeficiency
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.
Severe Combined Immunodeficiency
Serum adenosine deaminase activity and its isoenzyme pattern in women with normal pregnancies.
Severe Combined Immunodeficiency
Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.
Severe Combined Immunodeficiency
Severe combined immunodeficiency and adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.
Severe Combined Immunodeficiency
Severe combined immunodeficiency disease with adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.
Severe Combined Immunodeficiency
Severe combined immunodeficiency disease: a model of T-cell dysfunction.
Severe Combined Immunodeficiency
Severe combined immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
Severe Combined Immunodeficiency
Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Severe Combined Immunodeficiency
Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.
Severe Combined Immunodeficiency
Severe phenotype of severe combined immunodeficiency caused by adenosine deaminase deficiency in a patient with a homozygous mutation due to uniparental disomy.
Severe Combined Immunodeficiency
Somatic cell genetics of adenosine deaminase expression and severe combined immunodeficiency disease in humans.
Severe Combined Immunodeficiency
Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
Severe Combined Immunodeficiency
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.
Severe Combined Immunodeficiency
Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
Severe Combined Immunodeficiency
Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
Severe Combined Immunodeficiency
Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Successful Reconstitution of Immunity in ADA-SCID by Stem Cell Gene Therapy Following Cessation of PEG-ADA and Use of Mild Preconditioning.
Severe Combined Immunodeficiency
Suppression of an antibody to adenosine-deaminase (ADA) in an ADA-deficient patient receiving polyethylene glycol modified adenosine deaminase.
Severe Combined Immunodeficiency
T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Severe Combined Immunodeficiency
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.
Severe Combined Immunodeficiency
T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation.
Severe Combined Immunodeficiency
The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.
Severe Combined Immunodeficiency
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
Severe Combined Immunodeficiency
The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Severe Combined Immunodeficiency
The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase.
Severe Combined Immunodeficiency
Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
Severe Combined Immunodeficiency
Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Severe Combined Immunodeficiency
Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions.
Severe Combined Immunodeficiency
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
Severe Combined Immunodeficiency
Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
Severe Combined Immunodeficiency
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol.
Severe Combined Immunodeficiency
Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
Severe Combined Immunodeficiency
Twenty-five years of gene therapy for ADA-SCID: from "bubble babies" to an approved drug.
Severe Combined Immunodeficiency
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
Severe Combined Immunodeficiency
Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease.
Severe Combined Immunodeficiency
[Adenosine deaminase activity and immune dysfunction (author's transl)]
Severe Combined Immunodeficiency
[Adenosine deaminase activity in blood cells; influence of cytostatic therapy in patients with acute leukemia and with renal transplants (author's transl)]
Severe Combined Immunodeficiency
[Adenosine deaminase as costimulatory molecule and marker of cellular immunity].
Severe Combined Immunodeficiency
[Adenosine deaminase deficiency and severe combined immunodeficiency]
Severe Combined Immunodeficiency
[Adenosine deaminase deficiency associated severe combined immunodeficiency with disseminated varicella infection after vaccination: a case report]
Severe Combined Immunodeficiency
[Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)]
Severe Combined Immunodeficiency
[Adenosine deaminase deficit in severe combined immunodeficiency (author's transl)]
Severe Combined Immunodeficiency
[Development of gene therapy for hematopoietic stem cell using viral vectors]
Severe Combined Immunodeficiency
[Present status and future prospects of human gene therapy]
Severe Combined Immunodeficiency
[Restoration of mixed and severe immunologic deficiency, by fetal liver and thymus graft]
Severe Combined Immunodeficiency
[Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)]
Severe Combined Immunodeficiency
[Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency]
Severe Combined Immunodeficiency
[Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol]
Severe Combined Immunodeficiency
[Treatment of monogenic disorders with viral transduced haematopoietic stem cells].
Simian Acquired Immunodeficiency Syndrome
Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Skin Diseases
Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
Skin Ulcer
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Sleep Deprivation
Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation.
Sleep Initiation and Maintenance Disorders
Changed signals of blood adenosine and cytokines are associated with parameters of sleep and/or cognition in the patients with chronic insomnia disorder.
Spondylitis, Ankylosing
Lack of association of the G22A polymorphism of the ADA gene in patients with ankylosing spondylitis.
Squamous Cell Carcinoma of Head and Neck
Adenosine Deaminase - a Novel Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.
Starvation
Altered lipolytic response to glucagon and adenosine deaminase in adipocytes from starved rats.
Starvation
Antilipolytic action of insulin in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase.
Starvation
Antilipolytic effects of N6-phenylisopropyladenosine and prostaglandin E2 in fat-cells of obese volunteers before and during energy restriction.
Starvation
Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase.
Starvation
[Asparaginase and adenosine deaminase activity in the liver tissue of rats parenterally administered nitrogenous preparations in protein starvation]
Still's Disease, Adult-Onset
Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Stomach Neoplasms
Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma.
Stomach Neoplasms
Adenosine deaminase, 5'-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer.
Stomach Neoplasms
Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.
Stomach Neoplasms
Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer.
Stomach Neoplasms
An indication for correlation between the serum ADA level and gastric cancer risk.
Stomach Ulcer
Adenosine deaminase activity in the gastric mucosa in patients with gastric ulcer. Effects of ranitidine and sucralfate.
Stomach Ulcer
Caspase-4 activation in association with decreased adenosine deaminase activity may be a factor for gastric ulcer.
Stomatitis, Aphthous
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Strabismus
Mutation in ADAT3, encoding adenosine deaminase acting on transfer RNA, causes intellectual disability and strabismus.
Stroke
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Stroke
A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke.
Stroke
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults.
Stroke
Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Stroke
Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
Stroke
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.
Stroke
Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Stroke
Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments.
Stroke
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab.
Subacute Sclerosing Panencephalitis
Double-stranded RNA adenosine deaminase activity during measles virus infection.
Subarachnoid Hemorrhage
Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.
Synovitis
[Adenosine deaminase in the complex diagnosis of different forms of extrapulmonary tuberculosis]
Systemic Vasculitis
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
Systemic Vasculitis
Deficiency of adenosine deaminase 2 (DADA2) in Adults and Children: Experience from India.
Systemic Vasculitis
Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2.
Systemic Vasculitis
Vasculitic peripheral neuropathy in deficiency of adenosine deaminase 2.
T-Lymphocytopenia, Idiopathic CD4-Positive
Adenosine deaminase (ADA) deficiency as the unexpected cause of CD4+ T-lymphocytopenia in two HIV-negative adult female siblings.
Tachycardia
5'-Nucleotidase and adenosine deaminase activities in hypertrophied rat heart. The effect of tachycardia.
Tachycardia
Chronotropic and vasodilatory responses to adenosine and isoproterenol in mouse heart: effects of adenosine A1 receptor overexpression.
Tachycardia
Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE? in mice.
Tachycardia, Ventricular
Adenosine deaminase and adenosine attenuate ventricular arrhythmias caused by norepinephrine.
Telangiectasis
Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia.
Testicular Neoplasms
Hematopoietic stem cell gene therapy with drug resistance genes: an update.
Thalassemia
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
Thalassemia
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Thiamine Deficiency
[ENZYME ACTIVITIES AND NUTRITIONAL STATES. II. ADENOSINE DEAMINASE. 1. ADENOSINE DEAMINASE IN THE SPLEEN AND KIDNEYS IN ASCORBIC ACID, BIOTIN AND THIAMINE DEFICIENCIES.]
Thrombocytopenia
"Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children.
Thrombocytopenia
A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke.
Thyroid Diseases
Expression of genes for certain enzymes of pyrimidine and purine salvage pathway in peripheral blood leukocytes collected from patients with Graves' or Hashimoto's disease.
Thyroiditis
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Thyroiditis, Autoimmune
Autoimmune thyroiditis and acquired hypothyroidism in an infant with severe combined immunodeficiency due to adenosine deaminase deficiency.
Tonsillitis
Assessment of adenosine deaminase (ADA) activity and oxidative stress in patients with chronic tonsillitis.
Toxoplasmosis, Cerebral
Adenosine deaminase in cerebrospinal fluid of cerebral toxoplasmosis in AIDS.
Triple Negative Breast Neoplasms
Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer.
Trypanosomiasis, African
Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
Tuberculoma
Intramedullary Conus Medullaris Tuberculoma: A Case Report and Review of the Literature.
Tuberculosis
A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report.
Tuberculosis
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels.
Tuberculosis
A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser.
Tuberculosis
A Never-Ending Challenge: Intestinal Tuberculosis or Inflammatory Bowel Disease.
Tuberculosis
A prospective study of magnetic resonance imaging patterns of central nervous system infections in pediatric age group and young adults and their clinico-biochemical correlation.
Tuberculosis
A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion.
Tuberculosis
Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis.
Tuberculosis
Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature.
Tuberculosis
ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid.
Tuberculosis
Adenosine deaminase (ADA) in peritoneal tuberculosis: diagnostic value in ascitic fluid and serum.
Tuberculosis
Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis.
Tuberculosis
Adenosine deaminase activity and lysozyme levels in children with tuberculosis.
Tuberculosis
Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis.
Tuberculosis
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.
Tuberculosis
Adenosine deaminase activity: to be an useful marker in distinguishing pleural effusions due to malignancy from tuberculosis.
Tuberculosis
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis.
Tuberculosis
Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis.
Tuberculosis
Adenosine deaminase estimation and multiplex polymerase chain reaction in diagnosis of extra-pulmonary tuberculosis.
Tuberculosis
Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings.
Tuberculosis
Adenosine deaminase levels in cerebrospinal fluid in tuberculosis and bacterial meningitis.
Tuberculosis
Ascites adenosine deaminase activity is decreased in tuberculous ascites with low protein content.
Tuberculosis
Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients.
Tuberculosis
Auxiliary tools in tuberculosis. The hemolysis in pleural fluids underestimate the values of adenosine deaminase activity determined by the method of Giusti.
Tuberculosis
CA-125, adenosine deaminase, and PCR for Mycobacterium tuberculosis in the diagnosis of peritoneal tuberculosis.
Tuberculosis
Combined evaluation of adenosine deaminase level and histopathological findings from pleural biopsy with Cope's needle for the diagnosis of tuberculous pleurisy.
Tuberculosis
Combined use of the polymerase chain reaction and detection of adenosine deaminase activity on pleural fluid improves the rate of diagnosis of pleural tuberculosis.
Tuberculosis
Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.
Tuberculosis
Development and evaluation of multiplex PCR in rapid diagnosis of abdominal tuberculosis.
Tuberculosis
Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis.
Tuberculosis
Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-? immunospot assay in a tuberculosis-endemic population: A prospective cohort study.
Tuberculosis
Diagnostic Accuracy of Pleural Fluid Adenosine Deaminase for Diagnosing Tuberculosis. Meta-analysis of Spanish Studies.
Tuberculosis
Diagnostic efficacy of adenosine deaminase levels in cerebrospinal fluid in patients of tubercular meningitis: A comparison with PCR for Mycobacterium Tuberculosis.
Tuberculosis
Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting.
Tuberculosis
Diagnostic scoring system for tuberculous meningitis among adult patients with non-suppurative and non-bacterial meningitis.
Tuberculosis
Diagnostic significance of immunoglobulins and adenosine deaminase in pleural effusion.
Tuberculosis
Diagnostic value of adenosine deaminase in ascites for tuberculosis ascites: a meta-analysis.
Tuberculosis
Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions.
Tuberculosis
Diagnostic value of ascites gamma interferon levels in tuberculous peritonitis. Comparison with adenosine deaminase activity.
Tuberculosis
Diagnostic value of combined pleural interleukin-33, adenosine deaminase and peripheral blood tuberculosis T cell spot detection TB for tuberculous pleurisy.
Tuberculosis
Diagnostic value of interferon-gamma assay in tuberculosis pericardial effusions: study on a cohort of Iranian patients.
Tuberculosis
Diagnostic value of serum adenosine deaminase level in pulmonary tuberculosis.
Tuberculosis
Diagnostic value of synovial fluid adenosine deaminase level in tuberculous arthritis.
Tuberculosis
Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan.
Tuberculosis
Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
Tuberculosis
Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report.
Tuberculosis
Evaluation of adenosine deaminase activity and antibody to Mycobacterium tuberculosis antigen 5 in cerebrospinal fluid and the radioactive bromide partition test for the early diagnosis of tuberculosis meningitis.
Tuberculosis
Evaluation of adenosine deaminase activity in the Mycobacterium tuberculosis culture supernatants.
Tuberculosis
Evaluation of adenosine deaminase seric activity in the diagnosis of bovine tuberculosis.
Tuberculosis
Evaluation of polymerase chain reaction for detection of Mycobacterium tuberculosis in pleural fluid.
Tuberculosis
Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis.
Tuberculosis
Factors Influencing Pleural Adenosine Deaminase Level in Patients With Tuberculous Pleurisy.
Tuberculosis
Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.
Tuberculosis
High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires' disease.
Tuberculosis
Identification of risk factors and diagnostic methodology in serositis by M. tuberculosis
Tuberculosis
IgG4-related disease manifesting as pericarditis with elevated adenosine deaminase and IL-10 levels in pericardial fluid.
Tuberculosis
Importance of ascites adenosine deaminase in diagnosing abdominal tuberculosis with ascites.
Tuberculosis
Importance of contrast-enhanced fluid-attenuated inversion recovery imaging to detect paradoxical expansion of tuberculoma.
Tuberculosis
Improved early diagnosis of difficult cases of tuberculous pleural effusion by combination of thoracoscopy with immunological tests.
Tuberculosis
Increased pleural fluid adenosine deaminase in brucellosis is difficult to differentiate from tuberculosis.
Tuberculosis
Intracerebral tuberculomas: A rare cause of seizure in an immunocompetent young male.
Tuberculosis
Intramedullary Conus Medullaris Tuberculoma: A Case Report and Review of the Literature.
Tuberculosis
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
Tuberculosis
Laboratory investigations on the diagnosis of tuberculosis in the malnourished tribal population of melghat, India.
Tuberculosis
Medical Thoracoscopy for the Management of Exudative Pleural Effusion: A Retrospective Study.
Tuberculosis
Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.
Tuberculosis
Molecular forms of adenosine deaminase do not aid the diagnosis of tuberculosis.
Tuberculosis
Mycobacterium tuberculosis ESAT6 and CPF10 Induce Adenosine Deaminase 2 mRNA Expression in Monocyte-Derived Macrophages.
Tuberculosis
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Tuberculosis
New approaches to the diagnosis of tuberculosis in childhood with special reference to neurotuberculosis.
Tuberculosis
New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions.
Tuberculosis
Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: An unusual presentation.
Tuberculosis
Periodontal disease as the initial oral manifestation of abdominal tuberculosis.
Tuberculosis
Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy.
Tuberculosis
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.
Tuberculosis
Pleural fluid adenosine deaminase and lymphocyte proportion: clinical usefulness in the diagnosis of tuberculosis.
Tuberculosis
Pleural fluid adenosine deaminase and lysozyme levels in the diagnosis of tuberculosis.
Tuberculosis
Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.
Tuberculosis
Poor diagnostic value of adenosine deaminase in pleural, peritoneal & cerebrospinal fluids in tuberculosis.
Tuberculosis
Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Tuberculosis
Primary tuberculous abscess of the spleen in an immununocompetent patient diagnosed by biochemical markers and radiologic findings.
Tuberculosis
Rapid detection of cell-free Mycobacterium tuberculosis DNA in tuberculous pleural effusion.
Tuberculosis
Rapid, reliable, and sensitive detection of adenosine deaminase activity by UHPLC-Q-Orbitrap HRMS and its application to inhibitory activity evaluation of traditional Chinese medicines.
Tuberculosis
Self-remitting Elevation of Adenosine Deaminase Levels in the Cerebrospinal Fluid with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report and Review of the Literature.
Tuberculosis
Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis.
Tuberculosis
Serum adenosine deaminase activity and its isoenzyme in patients treated for tuberculosis.
Tuberculosis
Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions.
Tuberculosis
Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis.
Tuberculosis
The case against performing pleural biopsies for the aetiological diagnosis of exudates.
Tuberculosis
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes.
Tuberculosis
The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis.
Tuberculosis
The comparison of adenosine deaminase activity values with polymerase chain reaction results in patients with tuberculosis.
Tuberculosis
The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients.
Tuberculosis
The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
Tuberculosis
The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase.
Tuberculosis
The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV.
Tuberculosis
The role of plasma adenosine deaminase in chemoattractant-stimulated oxygen radical production in neutrophils.
Tuberculosis
The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis.
Tuberculosis
The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis.
Tuberculosis
The value of adenosine deaminase (ADA) determination in the diagnosis of tuberculous ascites.
Tuberculosis
Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy.
Tuberculosis
Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase.
Tuberculosis
Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis.
Tuberculosis
Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study.
Tuberculosis
Use of anabolic-androgenic steroids masking the diagnosis of pleural tuberculosis: a case report.
Tuberculosis
Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis.
Tuberculosis
Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis.
Tuberculosis
Value of Serum Adenosine Deaminase (ADA) in Distinguishing between Tuberculous and Non-tuberculous Lymphadenopathies.
Tuberculosis
When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculous pleuritis.
Tuberculosis
[A case of listeria meningitis showed high levels of adenosine deaminase in cerebrospinal fluid]
Tuberculosis
[A comparative study for adenosine deaminase and anti-antigen A-60 antibodies detection for the diagnosis of tuberculous meningitis].
Tuberculosis
[Activities and isozymes of adenosine deaminase and lactate dehydrogenase in tuberculous pleural effusion with special reference to the presence of mycobacterium tuberculosis]
Tuberculosis
[Adenosine deaminase activity in ascitic fluid. Importance in the diagnosis of peritoneal tuberculosis]
Tuberculosis
[Adenosine deaminase in differential diagnosis of peripheral lymph node tuberculosis]
Tuberculosis
[Adenosine deaminase in the complex diagnosis of different forms of extrapulmonary tuberculosis]
Tuberculosis
[Adenosine deaminase is useful for the diagnosis of peritoneal tuberculosis in patients with end-stage renal failure]
Tuberculosis
[Basic and clinical evaluation of rapid diagnosis of tuberculosis by detecting tuberculostearic acid]
Tuberculosis
[BCG antigens and adenosine deaminase activity in pleura fluids obtained from patients with and without tuberculosis]
Tuberculosis
[Cardiac tamponade with paroxysmal atrial flutter controlled by antituberculous therapy]
Tuberculosis
[Comparative analysis of a new modification of segmental tuberculin test with the routine Koch test]
Tuberculosis
[Cuttoff values of biochemical tests on pleural fluid: their usefulness in differential diagnosis of 1,040 patients with pleural effusion]
Tuberculosis
[Diagnosis of mycobacterial disease by biochemical and immunological parameters]
Tuberculosis
[Early diagnosis of pleuroperitoneal tuberculosis by the determination of adenosine deaminase]
Tuberculosis
[Measurement of adenosine deaminase (ADA) activity in pleural effusion with special reference to carcinomatous and tuberculosis pleuritis (author's transl)]
Tuberculosis
[Predictive factors and biomarkers of exudative lymphocytic tuberculous pleurisy].
Tuberculosis
[Prospects for determining the activity of adenosine deaminase in biological fluids in tuberculosis]
Tuberculosis
[Serum adenosine deaminase (ADA) activity in patients with active pulmonary tuberculosis]
Tuberculosis
[Thoracoscopy with two bronchoscopes in 50 patients with pleural effusion of unknown origin]
Tuberculosis
[Value of adenosine deaminase as indicator of tuberculosis in ascites fluid in a case of liver cirrhosis]
Tuberculosis
[Value of assaying adenosine deaminase level in patients with neuromeningeal tuberculosis]
Tuberculosis
[Value of determining the activity of adenosine deaminase (ADA) in the differential diagnosis of pleural effusions]
Tuberculosis
[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Diagnostic role of adenosine deaminase activity measurement in tuberculosis]
Tuberculosis, Bovine
Evaluation of adenosine deaminase activity in serum of cattle and buffaloes in the diagnosis of bovine tuberculosis.
Tuberculosis, Bovine
Evaluation of adenosine deaminase seric activity in the diagnosis of bovine tuberculosis.
Tuberculosis, Central Nervous System
Intramedullary Conus Medullaris Tuberculoma: A Case Report and Review of the Literature.
Tuberculosis, Lymph Node
[A case of tuberculous peritonitis accompanied by lymphadenitis in a patient with liver cirrhosis in which lymph node biopsy was useful for establishing the diagnosis].
Tuberculosis, Lymph Node
[Adenosine deaminase in differential diagnosis of peripheral lymph node tuberculosis]
Tuberculosis, Meningeal
A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
Tuberculosis, Meningeal
A Hospital Based Study on Estimation of Adenosine Deaminase Activity (ADA) in Cerebrospinal Fluid (CSF) in Various Types of Meningitis.
Tuberculosis, Meningeal
A study on cerebrospinal fluid adenosine deaminase level in Tubercular meningitis.
Tuberculosis, Meningeal
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.
Tuberculosis, Meningeal
Abdominal cyst formation following ventriculoperitoneal shunt in a case of hydrocephalus due to cryptococcal meningitis. Case report: completely cured by surgical removal of the cyst and treatment with a newly developed anti-fungal drug (Difulcan).
Tuberculosis, Meningeal
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults.
Tuberculosis, Meningeal
Adenosine deaminase activity as a diagnostic aid in tuberculous meningitis.
Tuberculosis, Meningeal
Adenosine deaminase activity in cerebrospinal fluid and serum for the diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Adenosine deaminase activity in cerebrospinal fluid: a useful test for meningeal tuberculosis, even in patients with AIDS.
Tuberculosis, Meningeal
Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis.
Tuberculosis, Meningeal
Adenosine deaminase and C-reactive protein in cerebrospinal fluid for differential diagnosis of tubercular meningitis in children.
Tuberculosis, Meningeal
Adenosine deaminase in CSF and pleural fluid for diagnosis of tubercular meningitis and pulmonary tuberculosis.
Tuberculosis, Meningeal
Adenosine deaminase levels in cerebrospinal fluid and serum in the diagnosis of tubercular meningitis.
Tuberculosis, Meningeal
Adenosine deaminase levels in cerebrospinal fluid as a diagnostic test for tuberculous meningitis in children.
Tuberculosis, Meningeal
Adenosine deaminase levels in cerebrospinal fluid in the diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Adenosine Deaminase Levels in CSF of Tuberculous Meningitis Patients.
Tuberculosis, Meningeal
Analysis of adenosine deaminase isoenzyme-2 (ADA(2)) in cerebrospinal fluid in the diagnosis of tuberculosis meningitis.
Tuberculosis, Meningeal
Aseptic meningitis in Kikuchi's disease mimicking tuberculous meningitis.
Tuberculosis, Meningeal
Cerebrospinal fluid adenosine deaminase activity and C-reactive protein in tuberculous and partially treated bacterial meningitis.
Tuberculosis, Meningeal
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults.
Tuberculosis, Meningeal
Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children.
Tuberculosis, Meningeal
Cerebrospinal fluid adenosine deaminase activity: A complimentary tool in the early diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Cerebrospinal fluid adenosine deaminase levels and adverse neurological outcome in pediatric tuberculous meningitis.
Tuberculosis, Meningeal
Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis.
Tuberculosis, Meningeal
Comparative study of cerebrospinal fluid adenosine deaminase activity in patients with meningitis.
Tuberculosis, Meningeal
Comparison of an adenosine deaminase assay with ELISA for the diagnosis of tuberculous meningitis infection.
Tuberculosis, Meningeal
Cryptococcal meningitis associated with increased adenosine deaminase in the cerebrospinal fluid.
Tuberculosis, Meningeal
Determination and Validation of a Lower Cut Off Value of Cerebrospinal Fluid Adenosine Deaminase (CSF-ADA) Activity in Diagnosis of Tuberculous Meningitis.
Tuberculosis, Meningeal
Determination of cerebrospinal fluid adenosine deaminase activity cut-off for the diagnosis of tuberculous meningitis in Hong Kong.
Tuberculosis, Meningeal
Diagnostic accuracy of cerebrospinal fluid adenosine deaminase in detecting Tuberculous Meningitis.
Tuberculosis, Meningeal
Diagnostic efficacy of adenosine deaminase levels in cerebrospinal fluid in patients of tubercular meningitis: A comparison with PCR for Mycobacterium Tuberculosis.
Tuberculosis, Meningeal
Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis - An update.
Tuberculosis, Meningeal
Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis.
Tuberculosis, Meningeal
Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis.
Tuberculosis, Meningeal
Diagnostic value of cerebrospinal fluid adenosine deaminase determination.
Tuberculosis, Meningeal
Elevation of CSF adenosine deaminase in HIV patient with meningitis from retroviral rebound syndrome, a case report.
Tuberculosis, Meningeal
Evaluation of adenosine deaminase activity and antibody to Mycobacterium tuberculosis antigen 5 in cerebrospinal fluid and the radioactive bromide partition test for the early diagnosis of tuberculosis meningitis.
Tuberculosis, Meningeal
Evaluation of Cerebrospinal Fluid Adenosine Deaminase Activity for the Differential Diagnosis of Tuberculous and Nontuberculous Meningitis.
Tuberculosis, Meningeal
New approaches to the diagnosis of tuberculosis in childhood with special reference to neurotuberculosis.
Tuberculosis, Meningeal
Raised adenosine deaminase in the cerebrospinal fluid: A tool for the diagnosis of tuberculous meningitis in developing countries.
Tuberculosis, Meningeal
Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Revival of old diagnostic markers in the cerebrospinal fluid for the detection of infectious meningitis.
Tuberculosis, Meningeal
Role of cerebrospinal fluid adenosine deaminase level estimation in diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
Shortfalls in the use of adenosine deaminase in tuberculous meningitis.
Tuberculosis, Meningeal
The bromide partition test and CSF adenosine deaminase activity in the diagnosis of tuberculosis meningitis in children.
Tuberculosis, Meningeal
The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults.
Tuberculosis, Meningeal
The simultaneous determination of cerebrospinal fluid and plasma adenosine deaminase activity as a diagnostic aid in tuberculous meningitis.
Tuberculosis, Meningeal
The use of adenosine deaminase activity as a biochemical marker for the diagnosis of tuberculous meningitis.
Tuberculosis, Meningeal
To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis.
Tuberculosis, Meningeal
[Adenosine deaminase in the quick diagnosis of tuberculous meningitis]
Tuberculosis, Meningeal
[Cerebrospinal fluid adenosine deaminase and its dynamic changes in tuberculous meningitis].
Tuberculosis, Meningeal
[Determination of adenosine deaminase in tuberculous meningitis: initial false negative reactions exist in adults]
Tuberculosis, Meningeal
[Diagnosis of tuberculosis meningitis by detection of adenosine deaminase activity and amplification of nucleotide sequences with PCR]
Tuberculosis, Meningeal
[Measurement of adenosine deaminase activity (ADA) of the cerebrospinal fluid in patients with tuberculous meningitis]
Tuberculosis, Meningeal
[The activities of 3 enzymes in serum and cerebrospinal fluid for diagnosis of tuberculous meningitis]
Tuberculosis, Meningeal
[Time-course of adenosine deaminase activity in the cerebrospinal fluid in patients with tuberculous meningitis]
Tuberculosis, Meningeal
[Unusual increase of the activity of adenosine deaminase during tuberculostatic treatment of tuberculous meningitis. Predictive value for the appearance of arachnoid complications]
Tuberculosis, Meningeal
[Usefulness of adenosine deaminase determination in cerebrospinal fluid for the diagnosis of meningeal tuberculosis: 4 years experience at a public hospital]
Tuberculosis, Meningeal
[Value of determining the activity of adenosine deaminase in tuberculous meningitis]
Tuberculosis, Miliary
[Measurement of adenosine deaminase activity in bronchoalveolar lavage fluids as a tool for diagnosing miliary tuberculosis]
Tuberculosis, Pleural
A Case of Sjögren's Syndrome with Pleural Effusion: Difficult to Distinguish from Tuberculous Pleurisy Because of a High Adenosine Deaminase Level.
Tuberculosis, Pleural
Accuracy of enzyme-linked immunospot assay for diagnosis of pleural tuberculosis: a meta-analysis.
Tuberculosis, Pleural
ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid.
Tuberculosis, Pleural
Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy.
Tuberculosis, Pleural
Adenosine deaminase activity in tuberculous pleural effusions: a diagnostic test.
Tuberculosis, Pleural
Adenosine deaminase activity, not diagnostic for tuberculous pleurisy.
Tuberculosis, Pleural
Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis.
Tuberculosis, Pleural
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis.
Tuberculosis, Pleural
Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings.
Tuberculosis, Pleural
Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-?, IP-10 and adenosine deaminase.
Tuberculosis, Pleural
Auxiliary tools in tuberculosis. The hemolysis in pleural fluids underestimate the values of adenosine deaminase activity determined by the method of Giusti.
Tuberculosis, Pleural
Can pleural adenosine deaminase (ADA) levels in pleural tuberculosis predict the presence of pulmonary tuberculosis? A CT analysis.
Tuberculosis, Pleural
Carcinomatous and tuberculous pleural effusions. Comparison of tumor markers.
Tuberculosis, Pleural
Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Clinical investigation on diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme for tuberculous pleurisy.
Tuberculosis, Pleural
Combined detections of interleukin 27, interferon-?, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
Tuberculosis, Pleural
Combined evaluation of adenosine deaminase level and histopathological findings from pleural biopsy with Cope's needle for the diagnosis of tuberculous pleurisy.
Tuberculosis, Pleural
Combined use of the polymerase chain reaction and detection of adenosine deaminase activity on pleural fluid improves the rate of diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
Tuberculosis, Pleural
Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma.
Tuberculosis, Pleural
Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-? immunospot assay in a tuberculosis-endemic population: A prospective cohort study.
Tuberculosis, Pleural
Diagnostic accuracy of adenosine deaminase and lymphocyte proportion in pleural fluid for tuberculous pleurisy in different prevalence scenarios.
Tuberculosis, Pleural
Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis.
Tuberculosis, Pleural
Diagnostic Potential of Circulating Biomarkers in Adenosine Deaminase Diagnosed Pleural Tuberculosis Cases.
Tuberculosis, Pleural
Diagnostic significance of adenosine deaminase in pleural tuberculosis.
Tuberculosis, Pleural
Diagnostic utility of serum and pleural levels of adenosine deaminase 1-2, and interferon-? in the diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Diagnostic value of adenosine deaminase and lysozyme in tuberculous pleurisy.
Tuberculosis, Pleural
Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis.
Tuberculosis, Pleural
Diagnostic value of combined pleural interleukin-33, adenosine deaminase and peripheral blood tuberculosis T cell spot detection TB for tuberculous pleurisy.
Tuberculosis, Pleural
Diagnostic Value of Pleural Effusion Mononuclear Cells Count and Adenosine Deaminase for Tuberculous Pleurisy Patients in China: A Case-Control Study.
Tuberculosis, Pleural
Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy.
Tuberculosis, Pleural
Diagnostic value of pleural fluid interferon-gamma and adenosine deaminase in patients with pleural tuberculosis in Qatar.
Tuberculosis, Pleural
Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?
Tuberculosis, Pleural
Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian meta-analysis.
Tuberculosis, Pleural
Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Evaluation of real-time polymerase chain reaction, interferon-gamma, adenosine deaminase, and immunoglobulin A for the efficient diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Factors associated with negative pleural adenosine deaminase results in the diagnosis of childhood pleural tuberculosis.
Tuberculosis, Pleural
Factors Influencing Pleural Adenosine Deaminase Level in Patients With Tuberculous Pleurisy.
Tuberculosis, Pleural
High pleural ammonia negatively interferes with the measurement of adenosine deaminase activity.
Tuberculosis, Pleural
IgG4-related disease with elevated adenosine deaminase in pleural effusion diagnosed clinically using thoracoscopy under local anesthesia and FDG-PET-CT.
Tuberculosis, Pleural
IgG4-related pleural effusion with high adenosine deaminase levels: A case report and literature review.
Tuberculosis, Pleural
IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report.
Tuberculosis, Pleural
Influence of storage time and temperature on pleural fluid adenosine deaminase determination.
Tuberculosis, Pleural
Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence.
Tuberculosis, Pleural
Performance of the quantification of adenosine deaminase and determination of the lactate dehydrogenase/adenosine deaminase ratio for the diagnosis of pleural tuberculosis in children and adolescents.
Tuberculosis, Pleural
Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy.
Tuberculosis, Pleural
Pleurisy Caused by Mycobacterium abscessus in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature.
Tuberculosis, Pleural
Role of adenosine deaminase and the influence of age on the diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
Simple method for rapid diagnosis of tuberculosis pleuritis: a statistical approach.
Tuberculosis, Pleural
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes.
Tuberculosis, Pleural
The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis.
Tuberculosis, Pleural
The comparative value of pleural fluid adenosine deaminase and neopterin levels in diagnostic utility of pleural tuberculosis.
Tuberculosis, Pleural
The use of real-time polymerase chain reaction and an adenosine deaminase assay for diagnosing pleural tuberculosis.
Tuberculosis, Pleural
The Utility of Pleural Fluid Lactate Dehydrogenase to Adenosine Deaminase Ratio in Pleural Tuberculosis.
Tuberculosis, Pleural
Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase.
Tuberculosis, Pleural
Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy.
Tuberculosis, Pleural
Use of anabolic-androgenic steroids masking the diagnosis of pleural tuberculosis: a case report.
Tuberculosis, Pleural
Usefulness of Adenosine Deaminase Assay in Diagnosis of Patients with HIV Infection and Pleural Tuberculosis.
Tuberculosis, Pleural
[Activities and isozymes of adenosine deaminase and lactate dehydrogenase in tuberculous pleural effusion with special reference to the presence of mycobacterium tuberculosis]
Tuberculosis, Pleural
[Activity of pleural fluid adenosine deaminase in tuberculous pleurisy]
Tuberculosis, Pleural
[Adenosine deaminase activity and isozyme test for differentiation diagnosis of tuberculous pleurisy]
Tuberculosis, Pleural
[Adenosine deaminase activity and isozymes in pleural effusion: an aid to differential diagnosis between carcinomatous and tuberculous pleurisy]
Tuberculosis, Pleural
[Adenosine deaminase activity in tuberculous and malignant pleural effusions]
Tuberculosis, Pleural
[Adenosine deaminase in pleural effusions. Its usefulness in the diagnosis of tuberculous pleurisy]
Tuberculosis, Pleural
[Adenosine deaminase in the blood cells and serum of patients with tuberculous pleurisy]
Tuberculosis, Pleural
[Analysis of 90 cases of pleural tuberculosis in relation to adenosine deaminase levels]
Tuberculosis, Pleural
[Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy]
Tuberculosis, Pleural
[Comparison of interferon-gamma release assays and adenosine deaminase of pleural fluid for the diagnosis of pleural tuberculosis].
Tuberculosis, Pleural
[Critically appraised article: Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A metaanalyses]
Tuberculosis, Pleural
[Determination of adenosine deaminase activity in the diagnosis of tuberculous pleurisy]
Tuberculosis, Pleural
[Diagnostic characteristics of adenosine deaminase test in Byelorussian patients with tuberculous pleurisy]
Tuberculosis, Pleural
[Diagnostic performance of T-SPOT.TB on peripheral blood in combination with adenosine deaminase on pleural fluid for the diagnosis of tuberculous pleurisy within different age group].
Tuberculosis, Pleural
[Diagnostic value of serum and pleural fluid adenosine deaminase activity in tuberculous pleurisy]
Tuberculosis, Pleural
[Gamma-interferon and adenosine deaminase in the diagnosis of tuberculous pleurisy]
Tuberculosis, Pleural
[Informative value of adenosine deaminase and 2-deoxyadenosine deaminase in the diagnosis of tuberculous pleurisy]
Tuberculosis, Pleural
[Pleural adenosine deaminase levels in tuberculous pleurisy--its diagnostic performance under the different prevalences in the different age of population]
Tuberculosis, Pleural
[Rheumatoid nodule diagnosed by thoracoscopy using flexible fiberoptic bronchoscope]
Tuberculosis, Pulmonary
Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis.
Tuberculosis, Pulmonary
Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis.
Tuberculosis, Pulmonary
Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients.
Tuberculosis, Pulmonary
Adenosine deaminase in childhood pulmonary tuberculosis: diagnostic value in serum.
Tuberculosis, Pulmonary
Adenosine deaminase in CSF and pleural fluid for diagnosis of tubercular meningitis and pulmonary tuberculosis.
Tuberculosis, Pulmonary
Can pleural adenosine deaminase (ADA) levels in pleural tuberculosis predict the presence of pulmonary tuberculosis? A CT analysis.
Tuberculosis, Pulmonary
Changes of serum adenosine deaminase level in new cases of pulmonary tuberculosis before and after intensive phase treatment.
Tuberculosis, Pulmonary
Combination of adenosine deaminase activity and polymerase chain reaction in bronchoalveolar lavage fluid in the diagnosis of smear-negative active pulmonary tuberculosis.
Tuberculosis, Pulmonary
Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.
Tuberculosis, Pulmonary
Diagnostic Accuracy of Interleukin-27 in Bronchoalveolar Lavage Fluids for Pulmonary Tuberculosis.
Tuberculosis, Pulmonary
Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and serum of tuberculous and non-tuberculous respiratory disease patients.
Tuberculosis, Pulmonary
Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis.
Tuberculosis, Pulmonary
Diagnostic value of serum adenosine deaminase level in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Diagnostic value of sputum adenosine deaminase (ADA) level in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Pancreatic tuberculosis: a clinical and imaging review of 32 cases.
Tuberculosis, Pulmonary
Plasma Adenosine Deaminase Enzyme Reduces with Treatment of Pulmonary Tuberculosis in Nigerian Patients: Indication for Diagnosis and Treatment Monitoring.
Tuberculosis, Pulmonary
Relation of serum adenosine deaminase (ADA) levels with sputum smear conversion in patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
Serum adenosine deaminase activity in bacillary or paucibacillary pulmonary tuberculosis.
Tuberculosis, Pulmonary
Serum adenosine deaminase enzyme and plasma platelet factor 4 activities in active pulmonary tuberculosis, HIV-seropositive subjects and cancer patients.
Tuberculosis, Pulmonary
Serum adenosine deaminase in pulmonary tuberculosis, malignancy and non-tubercular respiratory diseases.
Tuberculosis, Pulmonary
Sputum adenosine deaminase and alkaline phosphatase activity in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Study of adenosine deaminase activity in pulmonary tuberculosis and other common respiratory diseases.
Tuberculosis, Pulmonary
The association of adenosine deaminase activity with T-lymphocytes and subsets in pulmonary tuberculosis and bronchogenic carcinoma.
Tuberculosis, Pulmonary
The course of serum adenosine deaminase levels in patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
The diagnostic value of adenosine deaminase activity in sputum in pulmonary tuberculosis.
Tuberculosis, Pulmonary
The usefulness of serum adenosine deaminase 2 (ADA2) activity in adults for the diagnosis of pulmonary tuberculosis.
Tuberculosis, Pulmonary
[A case of pulmonary tuberculosis and tuberculous pleuritis during treatment with etanercept for rheumatoid arthritis]
Tuberculosis, Pulmonary
[Diagnostic and prognostic significance of adenosine deaminase in acutely progressive pulmonary tuberculosis]
Tuberculosis, Pulmonary
[Immunity indicators and the degree of adenosine deaminase activity in patients with pulmonary tuberculosis]
Tuberculosis, Pulmonary
[Natural killer cells and adenosine deaminase activity in patients with pulmonary tuberculosis]
Tuberculosis, Pulmonary
[Relationship between the activity of serum adenosine deaminase including its isozymes and lymphocyte subpopulation in patients with pulmonary tuberculosis]
Tuberculosis, Pulmonary
[Serum adenosine deaminase (ADA) activity in patients with active pulmonary tuberculosis]
Tuberculosis, Pulmonary
[The activity of adenosine deaminase and its isoenzymes in patients with different forms of pulmonary tuberculosis]
Tularemia
Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.
Tularemia
Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy.
Typhoid Fever
A study on the serum adenosine deaminase activity in patients with typhoid Fever and other febrile illnesses.
Typhoid Fever
Selectively increased adenosine deaminase levels in T cells during typhoid fever.
Typhoid Fever
T cell activation in typhoid fever detected by increased levels of adenosine deaminase.
Typhoid Fever
[Adenosine deaminase activity of lymphocytes during typhoid fever (preliminary data)]
Typhoid Fever
[Evaluation of the efficacy of laboratory diagnosis of typhoid infection. (Latex test, conditioned hemagglutination, adenosine deaminase activity in the serum)]
Typhoid Fever
[Further contribution to the study of the adenosine deaminase activity of the blood during typhoid infection]
Uremia
Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Urinary Bladder Neoplasms
Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study.
Urinary Bladder Neoplasms
Adenosine deaminase, 5'nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human bladder tissues.
Urinary Bladder Neoplasms
Host-mediated inhibition of rat bladder cancer growth by cyclophosphamide and purine salvage pathway-related enzyme activity of lymphocytes.
Urinary Bladder Neoplasms
Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.
Uveitis
Correction: Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis.
Uveitis
Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis.
Uveitis
[Adenosine deaminase in the complex diagnosis of different forms of extrapulmonary tuberculosis]
Uveitis
[Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis]
Uveomeningoencephalitic Syndrome
Vogt-Koyanagi-Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels.
Vaccinia
Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
Vaccinia
Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.
Vaccinia
The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
Vaccinia
Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Vascular Diseases
Recombinant adenosine deaminase ameliorates inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis.
Vasculitis
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia.
Vasculitis
A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2.
Vasculitis
Case Report: An Adult Patient With Deficiency of Adenosine Deaminase 2 Resembled Unilateral Frosted Branch Angiitis.
Vasculitis
Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
Vasculitis
Deficiency of adenosine deaminase 2 (DADA2): two cases of multisystem vasculitis managed in a South Indian tertiary care centre.
Vasculitis
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Vasculitis
Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Vasculitis
Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Vasculitis
Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Vasculitis
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
Vasculitis
Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments.
Vasculitis
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Vasculitis
Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.
Ventricular Dysfunction
Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
Ventricular Fibrillation
Myocardial protection in beating heart cardiac surgery: I: Pre- or postconditioning with inhibition of es-ENT1 nucleoside transporter and adenosine deaminase attenuates post-MI reperfusion-mediated ventricular fibrillation and regional contractile dysfunction.
Vesicular Stomatitis
RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.
Virus Diseases
Biosynthesis of 2' -chloropentostatin and 2' -amino-2' -deoxyadenosine highlights a single gene cluster performing two independent pathways in Actinomadura sp. ATCC 39365.
Virus Diseases
Double-stranded RNA adenosine deaminase activity during measles virus infection.
Virus Diseases
Increased erythrocyte adenosine deaminase activity in children with perinatal human immunodeficiency virus infection.
Virus Diseases
Platelet aggregation and serum adenosine deaminase (ADA) activity in pregnancy associated with diabetes, hypertension and HIV.
Virus Diseases
[Evaluation of serum adenosine deaminase as a prognostic marker in the treatment of human immunodeficiency virus infection with zidovudine]
Virus Diseases
[Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin]
Vitreous Hemorrhage
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Waldenstrom Macroglobulinemia
High adenosine deaminase level in pleural effusion due to Waldenström's macroglobulinemia.
Waldenstrom Macroglobulinemia
Increased adenosine deaminase activity in peripheral lymphocytes in Waldenström's macroglobulinemia.
Warts
Recalcitrant palmoplantar warts associated with adult-onset adenosine deaminase deficiency.
Werner Syndrome
Normal thermostability of hypoxanthine guanine phosphoribosyltransferase in erythrocytes from Werner's syndrome patients.
Whooping Cough
3-Morpholinylsydnonimine inhibits glutamatergic transmission in rat rostral ventrolateral medulla via peroxynitrite formation and adenosine release.
Whooping Cough
CL316243 induces phosphatidylinositol 3,4,5-triphosphate production in rat adipocytes in an adenosine deaminase-, pertussis toxin-, or wortmannin-sensitive manner.
Whooping Cough
Effects of pertussis toxin treatment on metabolism in hamster brown adipocytes.
Whooping Cough
Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
Whooping Cough
Pertussis toxin effects on adenylate cyclase activity, cyclic AMP accumulation and lipolysis in adipocytes from hypothyroid, euthyroid and hyperthyroid rats.
Whooping Cough
Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes.
Wiskott-Aldrich Syndrome
Clinical applications of gene therapy for primary immunodeficiencies.
Wiskott-Aldrich Syndrome
Gene therapy for primary immunodeficiencies: current status and future prospects.
Wiskott-Aldrich Syndrome
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.
Wiskott-Aldrich Syndrome
Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
Wiskott-Aldrich Syndrome
Progress and prospects: gene therapy for inherited immunodeficiencies.
Wiskott-Aldrich Syndrome
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
Wiskott-Aldrich Syndrome
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
Wiskott-Aldrich Syndrome
[Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
X-Linked Combined Immunodeficiency Diseases
Advances of gene therapy for primary immunodeficiencies.
X-Linked Combined Immunodeficiency Diseases
Clinical applications of gene therapy for primary immunodeficiencies.
X-Linked Combined Immunodeficiency Diseases
Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy.
X-Linked Combined Immunodeficiency Diseases
Gene Therapies for Primary Immune Deficiencies.
X-Linked Combined Immunodeficiency Diseases
Gene therapy for monogenic disorders of the bone marrow.
X-Linked Combined Immunodeficiency Diseases
Gene therapy for primary adaptive immune deficiencies.
X-Linked Combined Immunodeficiency Diseases
Gene Therapy for the Treatment of Primary Immune Deficiencies.
X-Linked Combined Immunodeficiency Diseases
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders.
X-Linked Combined Immunodeficiency Diseases
Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
X-Linked Combined Immunodeficiency Diseases
Genotoxicity of retroviral hematopoietic stem cell gene therapy.
X-Linked Combined Immunodeficiency Diseases
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
X-Linked Combined Immunodeficiency Diseases
Immunodeficiency is a tough nut to CRAC: the importance of calcium flux in T cell activation.
X-Linked Combined Immunodeficiency Diseases
Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients.
X-Linked Combined Immunodeficiency Diseases
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
X-Linked Combined Immunodeficiency Diseases
Restoring balance to B cells in ADA deficiency.
X-Linked Combined Immunodeficiency Diseases
Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.
X-Linked Combined Immunodeficiency Diseases
[Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
xanthine oxidase deficiency
Atmospheric pressure ionization mass spectrometry of purine and pyrimidine markers of inherited metabolic disorders.
xanthine oxidase deficiency
Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
Xeroderma Pigmentosum
Selective inhibition of repair of active genes by hyperthermia is due to inhibition of global and transcription coupled repair pathways.
Xeroderma Pigmentosum
Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.01728
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme, wild-type enzyme (refolded)
0.02064
adenosine
pH 8.0, temperature not specified in the publication, wild-type enzyme
0.026
adenosine
-
25°C, 50 mM Tris-HCl buffer, pH 7.4, enzyme concentration 1.5 nM
0.03874
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A
0.05641
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A (refolded)
additional information
additional information
-
isozymes ADA1 and ADA2 are kinetically distinct
-
additional information
additional information
-
kinetics of the large and the small isozyme
-
additional information
additional information
-
optimization of a spectrometric kinetic measurement method using Hut78 cell extract, kinetics in presence of substrate, product and inhibitor, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
5.35
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A (refolded)
28.69
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A
40.71
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme, wild-type enzyme (refolded)
80.04
adenosine
pH 8.0, temperature not specified in the publication, wild-type enzyme
180
adenosine
-
25°C, 50 mM Tris-HCl buffer, pH 7.4, enzyme concentration 1.5 nM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
90
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A (refolded)
740
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme M155A
2360
adenosine
pH 8.0, temperature not specified in the publication, mutant enzyme, wild-type enzyme (refolded)
3880
adenosine
pH 8.0, temperature not specified in the publication, wild-type enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.018
N6-methyladenosine
-
25°C, 50 mM Tris-HCl buffer, pH 7.4, enzyme concentration 1.5 nM
0.008
purine riboside
-
25°C, 50 mM Tris-HCl buffer, pH 7.4, enzyme concentration 1.5 nM
additional information
additional information
-
inhibition kinetics of the large isozyme
-
0.00045
1-deaza-erythro-9-(2-hydroxy-3-nonyl)adenine
-
pleural fluid large isozyme
0.000025
3-deaza-erythro-9-(2-hydroxy-3-nonyl)adenine
-
blood serum large isozyme
0.000036
3-deaza-erythro-9-(2-hydroxy-3-nonyl)adenine
-
pleural fluid large isozyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
additional information
additional information
-
activity in cerebrospinal fluid of healthy persons and tuberculous or non-infectious meningitis patients
additional information
-
enzyme activity in T-lymphocytes of healthy persons and multiple sclerosis patients
additional information
-
patients with fever attack have significantly higher adenosine deaminase levels in plasma compared to attack-free periods and healthy control group
additional information
-
tADA and ADA2 levels are higher in patients with Chronic Granulomatous Disease (CGD), Leukocyte Adhesion Deficiency (LAD), hyper IgM (HIM) and Wiskott-Aldrich Syndrome (WAS) than those of corresponding controls. There is a significant elevation of tADA and ADA1 activities in IgA deficiency patients as compared to healthy individuals
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
7.4
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH RANGE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
6.5 - 8
-
pH 6.5: about 85% of maximal activity, pH 8.0: about 70% of maximal activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
ADA2 is secreted by promonocytic cell lines and blood monocytes differentiated into macrophages and dendritic cells
brenda
-
the activity of isozyme ADA2 is increased in individuals with cancer
brenda
-
adenosine deaminase activity is significantly higher in patients with renal cell carcinoma than in controls
brenda
-
enzyme activity is not significantly different between patients with fibromyalgia syndrome and controls
brenda
-
the enzyme activity is highest in tuberculous meningitis patients, followed by non-infectious meningitis patients and healthy persons, the latter showing the lowest activity
brenda
-
trophoblast, enzyme activity and its isoenzyme pattern in women with recurrent spontaneous abortions
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
-
isoyzme ADA2 is secreted by activated monocytes to blood plasma
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
physiological function
isozyme ADA2 but not ADA1 induces T cell-dependent differentiation of monocytes into macrophages and stimulates macrophage proliferation. ADA2 exhibits a growth factor activity and increases proliferation of CD4+ T cells. ADA2 binds to cells via proteoglycans and adenosine receptors
malfunction
-
apoptosis is enhanced in ADAR1-deficient cells following infection with wild type and V knockout measles virus but not following infection with C knockout measles virus or treatment with tumor necrosis factor-alpha or staurosporine
physiological function
physiological function
-
ADAR1 deaminase increases exogenous gene expression at the translational level by decreasing protein kinase regulated by RNA-dependent eIF-2alpha phosphorylation
physiological function
-
ADAR1 is a proviral, antiapoptotic host factor in the context of measles virus infection. ADAR1 enhances the growth of measles virus. ADAR1 suppresses wild type and V knockout measles virus-induced apoptosis. ADAR1 does not protect against tumor necrosis factor-alpha- or staurosporine-induced apoptosis. ADAR1 suppresses wild type and V knockout measles virus-induced protein kinase regulated by RNA activation. ADAR1 suppresses interferon regulatory transcription factor-3 activation by wild type and V knockout measles viruses
physiological function
isozyme ADA1 does not induce T cell-dependent differentiation of monocytes into macrophages
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable).
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). ADA2_HUMAN
511
1
58934
Swiss-Prot
Secretory Pathway (Reliability: 2)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PDB
SCOP
CATH
UNIPROT
ORGANISM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
298000
42000
-
a second band of 300000 Da is detected for the complex of adenosine deaminase 1 with dipeptidyl peptidase IV, non-denaturing PAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
dimer
monomer
additional information
-
the enzyme exists as large and small isozymes, SADA and LADA, the latter is formed by the catalytic subunit monomer, the first by SADA complexed with the ADA complexing protein, i.e. the dipeptidyl peptidase IV
monomer
-
1 * 42000, in human liver the adenosine deaminase 1 mainly exists as a complex with dipeptidyl peptidase IV. The molar ratio of adenosine deaminase 1 to dipeptidyl peptidase IV appears to be 2:1, SDS-PAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
isozyme ADA2, 138.3fold by immunoglobulin and heparin affinity chromatography in two alternated sequences, and gel filtration
recombinant isozyme ADA2 is purified by heparin affinity column chromatography, Ni-chelate column chromatography, and gel filtration
homogeneity, protamine sulfate treatment, Q Sepharose chromatography, purine riboside-Sepharose chromatography
-
isozyme ADA2 400fold from plasma by ammonium sulfate fractionation, anion exchange chromatography, adsorption chromatography, and gel filtration
-
purification of the soluble large isozyme complexed with dipeptidyl peptidase IV from blood serum and pleural fluid by anion exchange chromatography, gel filtration, and affinity chromatography steps to about 90% purity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
the activity of human adenosine deaminase (hADA) expressed in transgenic seeds of three different plant species: pea (Pisum sativum L.), Nicotiana benthamiana L. and tarwi (Lupinus mutabilis Sweet) is compared. All three species are transformed with the same expression vector containing the hADA gene driven by the seed-specific promoter LegA2 with an apoplast targeting pinII signal peptide. During the study, several independent transgenic lines are generated and screened from each plant species and only lines with a single copy of the gene of interest are used for hADA expression analysis. A stable transgenic canola line expressing the ADA protein, under the control of 35S constitutive promoter is used as both as a positive control and for comparative study with the seed specific promoter. The highest activity of the hADA enzyme (U/g seed) is reported in tarwi (4.26 U/g) followed by pea (3.23 U/g) and Nicotiana benthamiana (1.69 U/g)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
enzyme activity is lowered in gastric tissues treated with the static magnetic field
-
no change of activity is observed in the enzyme activity of colon tissues treated with the static magnetic field
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
APPLICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
medicine
ADA2 is a drug candidate to modulate the immune responses during inflammation and cancer. ADA2 and its inhibitors are drug candidates to activate the immune systems of immunocompromised patients and to treat various types of blood cancers
analysis
-
a capillary electrophoresis method for simultaneous analysis of adenosine deaminase in red blood cells is developed. The method is also successfully applied in the inhibitor screening from traditional Chinese medicines
diagnostics
drug development
-
enzyme inhibitor FR234938 might be effective as an anti-rheumatic and anti-inflammatory drug by modulating the host-defense concentrations of adenosine
medicine
diagnostics
-
adenosine deaminase activity in pleural effusions due to Legionnaires disease may be as high as that in pleural effusions due to tuberculosis. In countries where the prevalence of tuberculosis is high and pleural fluid adenosine deaminase activities are frequently measured, Legionnaires disease should be included in the differential diagnosis of an exudative pleural effusion with a high ADA activity
diagnostics
-
adenosine deaminase analysis is a sensitive marker of tuberculous pleuritis even in HIV patients with very low CD4 counts in a high tuberculosis endemic region. The adenosine deaminase assay is inexpensive, rapid, and simple to perform and is of great value for the immediate diagnosis of tuberculous pleuritis while waiting for culture result and this has a positive impact on patient outcome
diagnostics
-
adenosine deaminase is a very useful biochemical parameter in diagnostic analysis tuberculous pleural effusion. When combined with cytologic examination the results are even better
diagnostics
-
adenosine deaminase may be used as a supportive marker to differentiate familial mediterranean fever attacks from attack-free periods
diagnostics
-
serum tADA and ADA2 may serve as useful indicators for diagnosis of CGD, LADs, IgA deficiency, SCID, HIM and WAS patients as a supplementary laboratory test in combination with clinical, immunological, and other laboratory findings
diagnostics
-
adenosine deaminase activity is significantly higher in patients with renal cell carcinoma than in controls. The marker adenosine deaminase might be potentially important as an additional biochemical tool for diagnosing renal cell carcinoma
medicine
-
therapy for adenosine-deficient patients with combined immunodeficiency
medicine
genetic polymorphisms of adenosine receptors A1 and A2A are associated with aspirin-intolerant asthma, suggesting that adenosine might play a crucial role in the development of aspirin-intolerant asthma through interactions with the A1 and A2A receptors. In this study no association between ADA and aspirin-intolerant asthma development is found
medicine
-
the adenosine deaminase-adenosine pathway plays a significant role in hemolytic-anemia-associated pulmonary hypertension, and modulation of this pathway may offer protective/therapeutic effects in hemolysis-associated pulmonary hypertension, in particular, under conditions of severe NO deficiency/NO resistance
medicine
-
the mean values for total ADA and ADA2 activities in the serum and tumor of benign breast disease and breast cancer are significantly higher than those of healthy controls
medicine
-
the adenosine deaminase activity in the cerebrospinal fluid is a good tool for early initiation of anti-tuberculous therapy while waiting for definite confirmation. A simple algorithm is identified that combines adenosine deaminase activity and some readily available biochemical parameters in cerebrospinal fluid, adenosine deaminase above 11.5 U/l + glucose above 65 mg/dl + leukocytes aboved 13.5 cell/mm3, as the better predictor to guide prompt initiation of anti-tuberculous therapy and should be considered in patients with low prevalence of tuberculosis
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Akedo, H.; Nishihara, H.; Shinkai, K.; Komatsu, K.; Ishikawa, S.
Multiple forms of human adenosine deaminase. 1. Purification and characterization of two molecular species
Biochim. Biophys. Acta
276
257-271
1972
Homo sapiens
brenda
Osborne, W.R.A.; Spencer, N.
Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes
Biochem. J.
133
117-123
1973
Homo sapiens
brenda
Van der Weyden, M.B.; Kelley, W.N.
Human adenosine deaminase, Distributions and properties
J. Biol. Chem.
251
5448-5456
1976
Homo sapiens
brenda
Crabbe, M.J.; Kavanagh, J.P.
The purification and preliminary investigation of fumarase, peroxidase, diamine oxidase and adenosine deaminase from human seminal plasma
Biochem. Soc. Trans.
5
735-737
1977
Homo sapiens
brenda
Agarwal, R.P.; Parks, R.E.
Adenosine deaminase from human erythrocytes
Methods Enzymol.
67
502-507
1978
Bos taurus, Homo sapiens
-
brenda
Philips, A.V.; Robbins, D.J.; Coleman, M.S.
Immunoaffinity purification and fluorescence studies of human adenosine deaminase
Biochemistry
26
2893-2903
1987
Homo sapiens
brenda
Daddona, P.E.; Wiesmann, W.P.; Lambros, C.; Kelley, W.N.; Webster, H.K.
Human malaria parasite adenosine deaminase
J. Biol. Chem.
259
1472-1475
1984
Homo sapiens, Plasmodium falciparum
brenda
Daddona, P.E.
Human adenosine deaminase: Properties and turnover in cultured T and B lymphoblasts
J. Biol. Chem.
256
12496-12501
1981
Homo sapiens
brenda
Wiginton, D.A.; Coleman, M.S.; Hutton, J.J.
Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes
Biochem. J.
195
389-397
1981
Homo sapiens
brenda
Centelles, J.J.; Franco, R.
Slight differences between adenosine deaminase from different species. An immunochemical study
Arch. Int. Physiol. Biochim.
98
421-431
1990
Homo sapiens, Rattus norvegicus
brenda
Schrader, W.P.; West, C.A.; Miczek, A.D.; Norton, E.K.
Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction
J. Biol. Chem.
265
19312-19318
1990
Cavia porcellus, Oryctolagus cuniculus, Homo sapiens, Platyrrhini, Mus musculus
brenda
Lupidi, G.; Marmocchi, F.; Cristalli, G.
Inhibition studies on membrane adenosine deaminase from human placenta
Biochem. Mol. Biol. Int.
46
1071-1080
1998
Homo sapiens
brenda
Iwaki-Egawa, S.; Watanabe, Y.
Characterization and purification of adenosine deaminase 1 from human and chicken liver
Comp. Biochem. Physiol. B
133
173-182
2002
Gallus gallus, Homo sapiens
brenda
Sharoyan, S.; Antonyan, A.; Mardanyan, S.; Lupidi, G.; Cristalli, G.
Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase
Acta Biochim. Pol.
53
539-546
2006
Bos taurus, Homo sapiens
brenda
Zavialov, A.V.; Engstroem, A.
Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity
Biochem. J.
391
51-57
2005
Homo sapiens (Q9NZK5), Homo sapiens
brenda
Iwaki-Egawa, S.; Yamamoto, T.; Watanabe, Y.
Human plasma adenosine deaminase 2 is secreted by activated monocytes
Biol. Chem.
387
319-321
2006
Homo sapiens
brenda
Kashyap, R.S.; Kainthla, R.P.; Mudaliar, A.V.; Purohit, H.J.; Taori, G.M.; Daginawala, H.F.
Cerebrospinal fluid adenosine deaminase activity: a complimentary tool in the early diagnosis of tuberculous meningitis
Cerebrospinal Fluid Res.
3
5
2006
Homo sapiens
brenda
Aghaei, M.; Karami-Tehrani, F.; Salami, S.; Atri, M.
Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities
Clin. Biochem.
38
887-891
2005
Homo sapiens
brenda
Hitoglou, S.; Zournatzi, V.; Gougoustamou, D.; Hatzistilianou, M.; Tzafettas, J.
Adenosine deaminase activity and its isoenzyme pattern in women with recurrent spontaneous abortions
Gynecol. Obstet. Invest.
58
126-129
2004
Homo sapiens
brenda
Paul, M.K.; Grover, V.; Mukhopadhyay, A.K.
Merits of HPLC-based method over spectrophotometric method for assessing the kinetics and inhibition of mammalian adenosine deaminase
J. Chromatogr. B
822
146-153
2005
Bos taurus, Homo sapiens
brenda
Vivekanandhan, S.; Soundararajan, C.C.; Tripathi, M.; Maheshwari, M.C.
Adenosine deaminase and 5'-nucleotidase activities in peripheral blood T cells of multiple sclerosis patients
Neurochem. Res.
30
453-456
2005
Homo sapiens
brenda
Okur, E.; Inanc, F.; Yildirim, I.; Kilinc, M.; Kilic, M.A.
Malondialdehyde level and adenosine deaminase activity in nasal polyps
Otolaryngol. Head Neck Surg.
134
37-40
2006
Homo sapiens
brenda
Kuno, M.; Seki, N.; Tsujimoto, S.; Nakanishi, I.; Kinoshita, T.; Nakamura, K.; Terasaka, T.; Nishio, N.; Sato, A.; Fujii, T.
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938
Eur. J. Pharmacol.
534
241-249
2006
Homo sapiens
brenda
Sadat Hayatshahi, S.H.; Abdolmaleki, P.; Ghiasi, M.; Safarian, S.
QSARs and activity predicting models for competitive inhibitors of adenosine deaminase
FEBS Lett.
581
506-514
2007
Homo sapiens
brenda
Tyler, P.C.; Taylor, E.A.; Froehlich, R.F.; Schramm, V.L.
Synthesis of 5-methylthio coformycins: specific inhibitors for malarial adenosine deaminase
J. Am. Chem. Soc.
129
6872-6879
2007
Bos taurus, Homo sapiens, Plasmodium falciparum
brenda
Poursharifi, P.; Saghiri, R.; Ebrahimi-Rad, M.; Nazem, H.; Pourpak, Z.; Moin, M.; Shams, S.
Adenosine deaminase in patients with primary immunodeficiency syndromes: The analysis of serum ADA1 and ADA2 activities
Clin. Biochem.
42
1438-1443
2008
Homo sapiens
brenda
Kisacik, B.; Akdogan, A.; Yilmaz, G.; Karadag, O.; Yilmaz, F.M.; Koklu, S.; Yuksel, O.; Ertenli, A.I.; Kiraz, S.
Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever
Eur. J. Intern. Med.
20
44-47
2009
Homo sapiens
brenda
Gracia, E.; Cortes, A.; Meana, J.J.; Garcia-Sevilla, J.; Herhsfield, M.S.; Canela, E.I.; Mallol, J.; Lluis, C.; Franco, R.; Casado, V.
Human adenosine deaminase as an allosteric modulator of human A(1) adenosine receptor: abolishment of negative cooperativity for [H](R)-pia binding to the caudate nucleus
J. Neurochem.
107
161-170
2008
Homo sapiens
brenda
Zaric, B.; Kuruc, V.; Milovancev, A.; Markovic, M.; Sarcev, T.; Canak, V.; Pavlovic, S.
Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?
Lung
186
233-240
2008
Homo sapiens
brenda
Tofovic, S.P.; Jackson, E.K.; Rafikova, O.
Adenosine deaminase-adenosine pathway in hemolysis-associated pulmonary hypertension
Med. Hypotheses
72
713-719
2009
Homo sapiens
brenda
Baba, K.; Hoosen, A.A.; Langeland, N.; Dyrhol-Riise, A.M.
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts
PLoS ONE
3
e2788
2008
Homo sapiens
brenda
Kim, S.H.; Kim, Y.K.; Park, H.W.; Kim, S.H.; Kim, S.H.; Ye, Y.M.; Min, K.U.; Park, H.S.
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma
Respir. Med.
103
356-363
2009
Homo sapiens (P00813), Homo sapiens
brenda
Dikensoy, O.; Fakili, F.; Elbek, O.; Uysal, N.
High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires disease
Respirology
13
473-474
2008
Homo sapiens
brenda
Zavialov, A.V.; Gracia, E.; Glaichenhaus, N.; Franco, R.; Zavialov, A.V.; Lauvau, G.
Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages
J. Leukoc. Biol.
88
279-290
2010
Homo sapiens (P00813), Homo sapiens (Q9NZK5), Homo sapiens
brenda
Aghaei, M.; Karami-Tehrani, F.; Salami, S.; Atri, M.
Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors
Arch. Med. Res.
41
14-18
2010
Homo sapiens
brenda
Durak, Z.E.; Kocao?lu, E.H.; Oztuerk, B.
Static magnetic field inhibits adenosine deaminase activity in cancerous and noncancerous human gastric tissues
Cancer Biother. Radiopharm.
29
162-165
2014
Homo sapiens
brenda
Lu, J.; Grenache, D.G.
Development of a rapid, microplate-based kinetic assay for measuring adenosine deaminase activity in body fluids
Clin. Chim. Acta
413
1637-1640
2012
Homo sapiens
brenda
Qi, Y.; Li, Y.; Bao, J.J.
Development of a capillary electrophoresis method for analyzing adenosine deaminase and purine nucleoside phosphorylase and its application in inhibitor screening
Anal. Biochem.
506
31-44
2016
Homo sapiens, Mus musculus (P03958)
brenda
Jaruwat, A.; Riangrungroj, P.; Ubonprasert, S.; Sae-Ueng, U.; Kuaprasert, B.; Yuthavong, Y.; Leartsakulpanich, U.; Chitnumsub, P.
Crystal structure of Plasmodium falciparum adenosine deaminase reveals a novel binding pocket for inosine
Arch. Biochem. Biophys.
667
6-13
2019
Homo sapiens (P00813), Homo sapiens, Plasmodium falciparum (Q8IJA9), Plasmodium falciparum
brenda
Parra-Ruiz, J.; Ramos, V.; Duenas, C.; Coronado-Alvarez, N.M.; Cabo-Magadan, R.; Portillo-Tunon, V.; Vinuesa, D.; Munoz-Medina, L.; Hernandez-Quero, J.
Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis
Infection
43
531-535
2015
Homo sapiens
brenda
Ruggiero, V.; Cacace, E.; Era, B.; Fais, A.
Soluble adenosine deaminase activity in fibromyalgia syndrome
J. Musculoskelet. Pain
23
79-80
2015
Homo sapiens
-
brenda
Pirincci, N.; Kaya, T.Y.; Kaba, M.; Ozan, T.; Gecit, I.; Oezveren, H.; Eren, H.; Ceylan, K.
Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma
Redox Rep.
22
252-256
2017
Homo sapiens
brenda
Doshi, K.M.; Loukanina, N.N.; Polowick, P.L.; Holbrook, L.A.
Seed specific expression and analysis of recombinant human adenosine deaminase (hADA) in three host plant species
Transgenic Res.
25
629-637
2016
Homo sapiens (P00813), Homo sapiens
brenda
EXTERNAL LINKS (specific for EC-Number 3.5.4.4)
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
